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Abstract 
 
This research project is multidisciplinary in nature. It involves the use of biomolecular 
design –peptide design – and the synthesis of small organic compounds to generate 
conformational switching in peptide structures. 
In this thesis, we demonstrate that we can design and synthesize de novo peptide 
sequences with the necessary information to assemble as α-helical coiled-coil 
structures when associated with their corresponding peptide partners. In addition, 
some of the peptide structures are designed to form both α-helical coiled-coils and 
fibrous systems.  
Since we aim to promote conformational changes in the initial folding states of our 
peptide assemblies, the design of these individual sequences that we refer to as 
chassis peptides includes tuneable positions which after being modified will help these 
changes to happen.  
We make use of the Negishi reaction to synthesize unnatural amino acids – pyridyl-
alanine analogues – for metal-binding investigations. The insertion of these novel 
amino acids into our self-assembling peptide systems provides different 
conformational changes depending on the positions in which these amino acids are 
inserted. These experiments are an attempt to form novel metal-based chiral 
biocatalysts. They also allow us to investigate to what extent peptide self-assembly can 
control metal binding and to what extent the metal binding can control peptide self-
assembly. 
This research project also includes the synthesis of an azobenzene derivative for trans-
to-cis and cis-to-trans photoisomerization. We successfully attached an azobenzene 
linker to three different coiled-coil forming peptide structures, exhibiting different 
switching efficiency in each. By using these photoswitches we induce conformational 
changes in the secondary structure of the peptide structures by the use of light. Some 
of these are reversible structural changes which makes it a potential power source for 
protein motors. 
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Chapter 1 
Introduction and background 
Proteins are large biomolecules able to perform many different functions within living 
organisms. They are not only single polypeptide chains but also more complex 
structures which can bear metal ions able to provide specific functionality depending 
on the task of the corresponding macromolecule. Nature exhibits a rich variety of 
proteins which contain self-assembling polypeptide sequences responsible for 
functionality in the systems they form. The nature of these sequences has been the 
object of study for many years due to the importance of their functionality. This 
investigation has covered the nature of the amino acids of each of the polypeptide 
sequences, their order in the sequence, their structural layout, and the driving forces 
that allow the sequences to self-assemble. 
By investigating why some natural functionalized polypeptides assemble we can mimic 
what nature offers. The process of mimicking provides an important method for 
understanding how such assemblies and structures work. After this is achieved there is 
then a wide range of possibilities for tuning these polypeptidic systems to try either to 
provide new functionality or improve that which already exists in Nature. However, 
this is not a simple task as it involves what is known as the “protein-folding problem”.1 
This issue is related to the rules followed by a sequence in forming a 3D structure and 
therefore it is essential to completely understand how different sequences provide 
different structures, interactions, stability, and functions. To accomplish this goal we 
need toolkits that help to determine ideally all the necessary aspects for the synthesis 
of improved sequences. Synthetic biology is the field of science and the tool used for 
this purpose, for protein engineering, or engineering of biological systems in its 
broadest sense. In addition, computational approaches can use design algorithms to 
construct new systems, however, the ability to design de novo systems reliably is 
limited to a small number of specific examples, such as α-helical coiled-coils, zinc 
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fingers and collagens. Here we focus on α-helical coiled-coil systems because α-helical 
secondary structures are the most common polypeptide structures found in Nature 
and have been investigated for many years as fibrous biomaterials for potential 
applications in biotechnology. There is, therefore, a wealth of information available to 
aid the design and synthesis of de novo α-helical peptide sequences from the bottom-
up. 
In the first part of this project, we design and synthesize de novo programmed α-
helical coiled-coil self-assembling peptide sequences, some of which contain 
information for fibre assembly formation. Once this has been achieved, mutants of 
these polypeptide sequences are synthesized to provide reactive sites capable of 
generating conformational switching. These molecular components are synthetic 
amino acid analogues (pyridylalanine derivatives) for metal-binding and an azobenzene 
derivative for reversible photoisomerization. By incorporating novel amino acids into 
self-assembling peptide systems we aim to form both novel chiral metal-based 
biocatalysts but also to investigate to what extent the self-assembly can control metal-
binding and to what extent the metal-binding can control self-assembly. By using 
azobenzene derivatives, which can be photoswitched between trans and cis isomers, 
we can induce conformational changes in the secondary structure of our coiled-coil 
peptide designs and provide a potential power source for protein motors.  
 
1.1 Hierarchical organization of biomolecular components and the 
basic units of polypeptides: amino acids 
Nature exhibits complexity at a range of different length scales. This spans from basic 
units to complex functionalized systems – which emerge from the combination of 
lower-order units in the hierarchical organization of biomolecular components (Figure 
1.1).2 Amino acids, nucleic acids, sugars and lipids are the basic units which after self-
association or polymerization move up to a higher-order of complexity known as 
tectons. The term tecton has been borrowed from supramolecular chemistry to 
indicate that they contain the information required for further assembly in a 
programmed mode, e.g. a tecton could be programmed tracks of α-helices or β-
Introduction and background 
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strands. Thus, combination of tectons that adopt defined reproducible structures lead 
to the next level of complexity in the hierarchy, known as self-assembled units. For the 
examples mentioned, α-helices would give way to α-helical coiled-coils structures and 
β-strands would form β-sheets. 
 
Figure 1.1:  Schematic representation of the hierarchical organization of biomolecular components in 
the synthetic biology space – this space refers to the vast arena where synthetic biologists can operate 
(adapted picture from reference 2). 
 
Moving up in complexity, functional assemblies are described as higher-order 
associations of self-assembled units which provide complex structures and functions, 
and collections of functional assemblies that can perform multiple or complex chemical 
reactions is what we refer to as systems.3  
Synthetic biology can address each of these levels of complexity by making alterations 
to each of them in order to achieve different goals. Modified basic units can be 
synthesized and lead to higher-order complexity components that can function as de 
novo designed tectons. This can afford building blocks that diverge from Nature, for 
example, the synthesis of unnatural amino acids could provide programmed self-
assembling after insertion in a polypeptide sequence. This would create a new type of 
tectons for synthetic biology. Figure 1.2 shows an adapted scheme from reference 3 
(by E.H.C. Bromley et al.) in which different routes of syntheses of more complex 
systems are placed in the synthetic-biology space according to the degree of 
divergence from Nature within the hierarchical organization of molecular components. 
In this thesis, we are investigating de novo coiled-coil peptide designs. We will 
therefore primarily discuss amino acids and proteins. 
Introduction and background 
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Figure 1.2: Routes for achieving higher-order levels of complexity in the hierarchical organization of 
molecular components encompassing from natural components to completely synthetic components 
(adapted picture from reference 3). 
 
α-Amino acids are the fundamental building blocks of polypeptides. They are small 
biomolecules comprising a central carbon atom, the α-carbon, which bears both the 
amino (-NH2) and the carboxylic groups (-COOH) functionality. The α-carbon has a 
hydrogen and a side chain group referred to as “R” (Figure 1.3). 
 
Figure 1.3: A) General structure of a non-ionized α-amino acid; B) Zwitterionic form of an α-amino acid 
when the pH is in the range of 2.2 to 9.4. 
 
There are 20 different “R” groups found in Nature which constitute the 20 essential α-
amino acids showed in Figure 1.4. The term essential means that they can be found in 
Nature as part of proteins hence the alternative name of proteinogenic amino acids. All 
20 proteinogenic amino acids except Glycine are chiral at the α-carbon. The most 
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common classification of the 20 essential amino acids is carried out according to the 
functionality of the side chains (Figure 1.4). Depending on the pH of the media, either 
the amine or the carboxylic groups can be found in their ionized forms. At pH lower 
than 2.2, the amino group is present as ammonia (+NH3) while the carboxylic group is 
neutral (COOH). At pH higher than 9.4, the carboxylic group is present in its ionized 
state in the form of carboxylate (COO-) whilst the amino group remains neutral (NH2). 
These states have net +1 and -1 charges respectively. When the pH is between 2.2 and 
9.4 both groups can ionize at the same time affording a molecular state known as a 
zwitterion with net zero charge (Figure 1.3B). 
 
Figure 1.4: Classification of the 20 natural α-L-amino acids according to the properties of their side 
chains. 
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When the amino group of one amino acid reacts with the carboxylic group of another 
amino acid through a condensation reaction we have a dipeptide. Both the N-terminus 
and C-terminus of the different amino acids condense to create a new amide bond or 
peptide bond. The lone par of electrons on the nitrogen atom gives the peptide bond a 
resonant structure with a partial double bond character (Figure 1.5). Since double 
bounds disallow rotation, the peptide bond remains in a fixed conformation, being the 
trans conformation the most stable as this allocates both alpha carbons on the 
opposite corners of the peptide group. The alpha carbons allow rotation, hence, 
flexibility to the peptide backbone. If several amino acids are joined together, this 
results in the formation of a polypeptide chain, or a peptide. Consequently, proteins 
are created when the complexity reaches a higher order and the polymerization of 
amino acids extends to a higher number of residues. 
 
Figure 1.5: Resonant structure of the peptide bond. 
 
The way amino acids are joined together in nature is usually linear and can range from 
a few to thousands of amino acids in length. This is known as the primary sequence 
and this contains all the information required for peptide folding, assembly, and 
function. Once a peptide sequence is long enough, it is possible for a local geometry of 
the backbone to arise known as the secondary structure of peptides. The two most 
common secondary structures observed in Nature are the α-helix and the β-strand, 
and they form the basis of most of the building blocks, or tectons, in peptide design. 
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1.2  Secondary structure of proteins: α-helices and β-strands 
The secondary structure of proteins refers to the local geometry of the folded state of 
the polypeptide backbone which is stabilized by the hydrogen bonds between the –CO 
and –NH groups that are part of the peptide bonds. CO acts as hydrogen acceptor 
while NH acts as hydrogen donor. This helps the polypeptide sequences to adopt more 
stable conformations of lower free energy. There are different types of conformational 
structures that can be distinguished for a protein, including: α-helix, 310 helix, π-helix, 
β-strand (both parallel and antiparallel), β-turn, random coil, and collagen. Figure 1.6 
shows cartoons of some of these secondary structures. 
 
Figure 1.6: Representative cartoons of some of the secondary structures known for proteins. The α-helix 
(in dark blue) contains 3.6 residues per turn whilst the 310 helix (in yellow) contains 3 residues per turn, 
and the π-helix (in red) contains 4.4 residues per turn; this provokes more or less hindrance along the 
backbone, hence, differences in length as shown in the picture. 
 
The α-helix is a common secondary structure of proteins. It comprises a polypeptide 
sequence which is wrapped as a right-handed helix where the R groups of the amino 
acids point outwards from the backbone coil. One stabilizing effect of the α-helix is 
given by the hydrogen bonds formed by NH and CO groups of amino acids placed “i + 
4“ positions away. In other words, amino acids use their NH donating-groups for 
hydrogen-boding with residues placed four positions earlier in the sequence: “i + 4  
i“ (see Figure 1.7). This involves 3.6 residues and 13 atoms per turn, hence the α-helix 
is known as the 3.613-helix. 
Introduction and background 
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Figure 1.7: Graphical view of (a) the main backbone of a peptide sequence wound up as an α-helix 
structure with the R groups pointing outwards from the central coil; (b) the same backbone of the 
sequence outside the α-helix cartoon, selecting the 13 atoms of the 3.6 residues of each turn; (c) 
expanded view of the 13 atoms of one α-helical turn with a hydrogen bond formed between the NH 
group of an amino acid placed at an “i” position and the CO group of an amino acid placed “i+4” 
positions away. 
 
In addition to the hydrogen bonding pattern, interactions between the side chains of 
amino acids three and four positions away from each other may favour the formation 
of an α-helix. This spacing leads to one of the key design principles in the higher-order 
assembly of the α-helix which will be discussed in the next section. It has been proven 
that the α-helical structure’s stability will depend on the nature of the amino acids 
forming the peptide sequence. Amino acids such as methionine, alanine, leucine, lysine 
and uncharged glutamate will generally help the formation of an α-helix, whilst proline 
and glycine will disrupt its formation.4-7 
An α-helix has a net charge as a consequence of the aggregate effect of the N- and C-
terminus together with all of the individual ionizable groups present in the peptide. 
The ionizable groups in the peptide are within the side chains of the amino acids, and 
are either COOH or NH2 groups. The pKa of a carboxy-terminal group pKa(COOH) is  
Introduction and background 
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approximately 2.0 and pKa(NH3+) ~ 9.7. This means that at pH 7 both COO- and NH3+ 
groups will be in their ionized form, and hence, have net charges of -1 and +1, 
respectively. At a neutral pH, the net charge of a peptide sequence is therefore null 
without taking into account any other ionizable R groups. To calculate the real net 
charge of a peptide it is necessary to know what the pKa of each of the ionizable 
groups is. In general, at pH < pKa (acidic) all of the protons will be added onto the 
COOH and NH2 groups, and hence they will be in of COOH and NH3+ forms. At pH > pKa 
(basic) all of the protons will be off the COOH and NH2 groups, and hence in the COO- 
and NH2 forms. Figure 1.8 shows the net charges for each end at different pH 
conditions. There are also the dangling O- ions at the C-terminus and dangling H+ ions 
from the N-terminus which would be making hydrogen bonds if they were not at the 
end of helices. This means the charge near the N-terminus is greater than +1 and at C-
terminus is more negative than -1. In addition, having a neutral pH means that the free 
end NH2 is in the NH3+ form and COOH in the COO- form. When interacting two peptide 
sequences in a parallel arrangement to form a more complex structure, such a coiled-
coil, both ends will be either positive or negatively charged. The repulsive interactions 
produced by the charged groups can affect the peptide structure. Stabilization of the 
helix can be accomplished by capping the α-helices, either at the N-terminus with a 
negatively charged group (such as a side chain of glutamate or aspartate, or even a 
phosphate ion), or at the C-terminus with a positively charged amino acid such as 
lysine, although this is less effective. Capping the N-terminus with a positive charged 
group is also possible and can be used to bind negatively charged ligands. 
 
Figure 1.8: Net charge for the N- and C-terminus of a peptide sequence at pH acidic, neutral and basic 
and their overall net charge without taking into account other ionizable groups as a whole. 
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1.3 α-Helical coiled-coils 
Although it can be relatively simple to form peptide sequences which adopt α-helical 
structures, they cannot be considered by themselves as building blocks or tectons as 
they do not include any information about their folding or further assembly with other 
polypeptides. However, the design of α-helical coiled-coils are a starting point to 
synthesize peptidic tectons and self-assembled units. 
α-Helical coiled-coils are an example of higher-order assembly of α-helices and a 
quaternary protein structure. Coiled-coil motifs exhibit a surprising richness and 
diversity in both function and structure of protein-protein interactions in terms of 
number, orientation, and the nature of the interacting elements. They have been 
intensively studied for the last two decades, and due to their abundance in nature 
there are many available and well defined X-ray structures which have been useful to 
establish a number of rules for the successful design of new coiled-coil structures. 
These are called rules-of-thumb and relate protein sequence and structure in coiled-
coil domains.  
In terms of sequence and structure, most coiled-coils domains exhibit a heptad 
sequence repeat pattern, often labelled abcdefg, in which the first and fourth residues 
are hydrophobic (H) and the other positions consist of polar (P) amino acids, 
(HPPHPPP)n, being n = 4, for most coiled-coils. Their structure is based on the “knobs-
into-holes” packing-type layout (KIH) in which the hydrophobic residues of one helix 
act as “knobs” and can be inserted into the “holes” from a different helix (see Figure 
1.9). Positions a, d and e of one peptide sequence provide the “holes” for the “knobs” 
at positions a, d and g of the complementary sequence. 
When two or several α-helices assemble together as a coiled-coil there is a certain 
angle between them leading to a left-handed supercoiling of the helices around each 
other. The angle of assembly is caused by a mismatch between the average spacing of 
the hydrophobic residues in the heptad repeat (which is 3.5) and the α-helix (which is 
3.6). Moreover, this type of assembly results in measurements of ~1nm end-to-end 
length per heptad. 
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The heptad pattern encodes amphiphatic α-helices which assemble into water to bury 
the hydrophobic faces, corresponding to positions a and d of the heptad repeat, 
hence, leaving the hydrophilic face exposed to water. However, although the 
hydrophobic effect is the main driving force for the assembly of coiled-coils, there are 
other effects that can play an important role when defining the structure. Positions e 
and g of the heptad are occupied by amino acids able to provide salt-bridging 
interactions that can help stabilise an α-helical coiled-coil. With respect to the 
remaining positions of the heptad repeat (b, c, f) these are usually kept polar and helix-
favoring – this means, combinations of lysine, glutamate, glutamine, and alanine  – and 
aromatic amino acids such as tryptophan or tyrosine are used as to provide a UV 
chromophore group. Glycine and proline are avoided for disrupting α-helical coiled-
coils as mentioned in the previous section. 
 
Figure 1.9: Different views of a dimeric α-helical coiled coil. (a) Helical wheel diagram for a parallel 
dimeric coiled coil: the hydrophobic residues (at a and d) form the hydrophobic interface, b, c, and f 
form the solvent exposed face (hydrophilic face), and positions e and g are for salt-bridged forming 
residues; (b) KIH packing – the residues forming the hole are green and the knob is occupied by a red 
residue from the other α-helix; (c) A top-down view of a dimeric coiled coil; (d) A side view of the same, 
showing the left-handed supercoil (adapted figure from reference 8). 
 
Despite having clear rules for the design of new α-helical coiled-coil systems, there are 
many important factors to take into consideration. For instance, there are assemblies 
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in which a peptide assembles with itself – called homotopic assemblies – or assemblies 
formed by two or more different peptide sequences – called heterotopic assemblies. In 
addition, different polypeptide sequences can interact to form an α-helical coiled-coil 
structure in an antiparallel arrangement, parallel arrangement, or mixed topologies at 
the same time when more than two α-helices are involved in the assembly. In Nature 
we find α-helical coiled-coil structures with between 2 and 6 helices and these have 
been investigated for the last decades to discover the reasons certain peptides favour 
each specific oligomerization state. Having the key for the design of such structures 
can lead to a new generation of synthetic tectons with important applications for 
bionanotechnology. 
An important contribution to the study of the oligomerization state of α-helical coiled-
coil was first provided by Harbury et al. from investigations on the leuzine-zipper 
peptide (GNC4-p1) from the yeast transcriptional activator.9 It was found that 
attempting to place different combinations of isoleucine (Ile, I) and leucine (Leu, L) in 
positions a and d of the heptad repeat, different oligomerization states could be 
achieved. Thus, when a = I and d = L the structure turned into a dimer; when a = d = I it 
turned into a trimer; and, finally, having a = L and d = I leaded to a tetramer (Figure 
1.10).  
 
Figure 1.10: Representation of the different oligomerization states for the studies within α-helical 
coiled-coil structures after changing Leu and Ile in between positions a and d of the heptad repeat: a 
dimer (light blue), a trimer (light pink) and a tetramer (light brown). 
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However, these combinations of leucine and isoleucine at positions a and d was 
proved not to be completely determining in all cases as demonstrated in de novo 
designs by J.M. Fletcher et al. in 2012.10 An attempt to provide coiled-coil design with a 
robust set of rules for manipulating and predicting the oligomerization state for de 
novo peptide structures was sought in the Woolfson’s lab.10 The aim was to facilitate 
understanding of sequence-to-structure relationships within the set. They focused on 
the most common oligomerization states found in nature – dimers, trimers and 
tetramers – and used the work of Harbury on the leucine-zipper peptide model as a 
starting point.9 Consistent with his results, the trimeric and tetrameric coiled-coil 
models were afforded when using a = d = I and a = L, d = I respectively. However, the 
dimeric coiled-coil was not reproducible when positions a and d were occupied by I 
and L residues respectively. Their further investigations based on negative design 
revealed that having V (valine) and L in position d favored trimers hence concluded 
that for the leuzine-zipper model there are other stronger factors that favor a dimer. 
Fletcher et al. found that incorporating N (Asn, asparagine) in position a, or K (Lys, 
lysine) in positions a or d strongly favored dimers.10 Due to the higher propensity for 
coiled-coil formation of Asn compared with Lys, that N occurs more frequently at 
positions a of coiled-coils, that N is empirically associated with dimeric states when 
placed at a, and that Asn favors trimers when is placed in position d, asparagine was 
proven to be the most suitable residue to place at position a of the heptad, therefore, 
combinations of a = N, d = L confirmed the formation of dimeric coiled-coils in solution. 
In addition, placing the Asn residue at the a site of the third heptad repeat (that is, in 
the middle of the whole sequence) was found to be optimal for the formation of the 
dimeric coiled-coil system, and helped with the rigidity of the structure by means of 
interhelical hydrogen bonds. 
In nature, dimeric and trimeric conformations are predominant, and for the last two 
decades most of the work in coiled-coil de novo design has focused on finding 
stereoselective partners for heterodimeric coiled-coil interactions. These could be very 
useful in conducting de novo protein-protein interactions within large biosynthetic 
structures and for applications in nanotechnology, or even in the submicrometre 
range. 
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A summary of the work developed by Harbury and Fletcher to investigate the different 
oligomerization states of α-helical coiled-coils depending on the residues placed at a 
and d positions can be seen in Table 1.1. 
Harbury  Fletcher 
(GNC4-p1)     (De novo coiled-coil system) 
a = I, d = L Dimer a = N, d = L 
a = I, d = I Trimer a = I, d = I, L 
a = L, d = I Tetramer a = L, d = I 
Table 1.1: Different oligomerization states of α-helical coiled-coils found by Harbury and Fletcher 
depending on the amino acid residues placed at positions a and d of the heptad repeat. 
 
In conclusion, the process by which α-helical coiled-coils are assembled has been 
reasonably well understood and some rules have been established for the design of 
new structures. Studies of, first, small sections of the leuzine-zipper peptide model by 
Harbury,9 and then, de novo designs by Fletcher et al.10 have contributed to our 
understanding of how selecting residues at each different position of the heptad can 
be determining as well as the hydrophobic effects that drive the formation of α-helical 
coiled-coils – by means of charged side chains to help salt-bridging formation.11 
Moreover, the remaining heptad positions can be used for the design of new 
functionalized sequences. 
 
1.4 α-Helical based systems: from naturally occurring blunt-ended 
assembly to programmed self-assembling fibre (SAF) designs 
An important aspect to bear in mind when designing α-helical coiled-coils is the mode 
of association or assembly between sequences. The most common conformation of α-
helical coiled-coil arrangements found in nature is based on the “flush-ends”, or 
“blunt-ends”, conformation and consists of having both hydrophobic surfaces 
completely interacting without having any of their residues free of interaction. Figure 
1.11 shows a designed peptide sequence (PEP1) interacting with another specially 
designed sequence (BEP) as in a blunt-ended fashion.  
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Figure 1.11: Representation of the blunt-ended coiled-coil conformation. At the left-hand side, the 
heptad repeat pattern is written above the PEP1 sequence, and also below the BEP sequence as to 
indicate in which position is placed each residue. Ile and Leu are used, as well as Asn, as to favour 
dimeric coiled-coil formation. Salt-bridging interactions occur between Lys and Glu from positions g and 
e of the complementary sequence. At the right-hand side there is a wheel diagram of this same parallel 
dimeric coiled-coil with the hydrophic residues in blue and the residues for salt-bridging formation in red 
(from PEP1) and in green (from BEP). The arrows indicate where these interactions are happening. 
 
However, another approach developed in Woolfson’s lab is based on the way self-
assembling fibres (SAFs) arrange.12 These polypeptide sequences interact into an offset 
parallel coiled-coil dimer in what it is known as a “sticky-end” tecton for fibre assembly. 
The sticky-ends present complementary charged residues in positions e and g of the 
heptad repeat for salt-bridge formation with their counterparts in the other sequence 
and promote longitudinal association into extended fibres. Figure 1.12 represents the 
concept of a sticky-end tecton. 
As explained in Section 1.3, α-helical coiled-coil structures can be either homotopic or 
heterotopic. In the simplest case where only two polypeptide sequences assemble to 
form a coiled-coil structure, we call them homodimers or heterodimers. Both have 
been considered as tectons for the formation of extended fibres systems in proteins, 
with the heterodimeric type being the best to control self-assembly. Kojima et al. first 
reported the synthesis of homodimeric coiled-coils in which a heptad repeated up to 
three times provided a tetramer that could alter its morphology when the buffer was 
changed. They found larger assemblies that formed fibrils,13 though in a later paper 
the sequence was reversed to render longer fibres which showed an increase in 
stability and in α-helicity.14 Other research groups such as Potekhin’s,15 Conticello’s,16 
or Hartgerink’s17 have also been able to engineer homodimeric coiled-coil systems 
where fibre assembling systems were formed. 
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Figure 1.12: Representation of the sticky-ended coiled-coil arrangement. The heptad repeat pattern is 
written above the PEP1 sequence, and also below the SAF sequence as to indicate in which position is 
placed each residue. Ile and Leu are used, as well as Asn, as to favour dimeric coiled-coil formation. The 
arrows indicate the interactions between the residues for salt-bridging formation. They are Lys and Glu 
residues placed in the g and e positions of the complementary sequences. Hydrogen bonds formed by 
Asn residues from complementary sequences are highlighted in yellow. 
 
However, the heterodimeric coiled-coil structures present advantages for fibre 
formation and control of self-assembling and some examples have been investigated. 
The best studied example of this type of systems comes from Woolfson’s group: the 
“SAFs”.12 The designed has two complementary peptides in which the hydrophobic 
residues at positions a and d promoted parallel dimers, and the charge patterning at 
positions e and g was set for staggered assembly. Though, this was helped by the 
inclusion of offset asparagine residues at positions a to promote hydrogen bonding 
formation between them across the hydrophobic interface. This turned out to be the 
key design feature for promoting sticky ends and then fibre formation. Figure 1.13 
shows the sequences with their salt-bridging interactions and hydrogen-bonding 
between both asparagine residues from complementary sequences. 
 
 
Introduction and background 
17 
 
 
Figure 1.13: Heterodimeric α-helices designed by Woolfson’s group for coiled-coil fibre formation – SAFs 
(adapted figure from reference 12). The hydrogen bonds formed by the Asn residues from the 
complementary sequences are highlighted in yellow. 
 
Investigations on this type of fibre-formation systems demonstrated that replacing 
residues at the polar interface (b, c, and f positions) could promote either interfibre 
hydrophobic interactions or interfibre hydrogen bonding to produce thinner and more-
flexible fibres that form physical hydrogels.18 
 
1.4.1 α-Helical coiled-coil fibrous systems for bionanotechnology 
applications 
The wide variety of α-helical coiled-coil structures inspires the development of new 
self-organizing biomolecular systems as building blocks for biosupramolecular 
chemistry. Synthetic biology can use these structures for a wide variety of potential 
applications in fields such as medicine and biotechnology. Coiled-coil structures can be 
used, for example, as hubs or spacers to bring together bioactive components with 
defined chirality and at set distances with nanometre precision.19 Arndt et al. 
demonstrated that coiled-coils could be used together as hubs to bring together and to 
increase the efficacy of antibodies.20 Moreover, coiled-coil structures have been used 
as linkers to control the aggregation of nanoparticles at set nanometre spacings.21, 22  
However, nature contains many alternative protein-based fibrous materials, such as 
collagen, so it is of interest to use synthetic biology as tool for developing new fibrous-
based materials at the nanometre scale.23 Some examples are given by new designed 
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robust hydrogels by Banwell et al. which support mammalian cell growth and 
differentiation.18 Other studies have developed scaffolds for tissue engineering,24 
smart biomaterials for nanoelectronic devices,25 or fibrous assemblies and materials as 
scaffolds for the adhesion, growth and differentiation of cells.23 Due to the ability of 
self-assembled coiled-coils of fibrous systems to form gels upon high peptide 
concentrations, the applicability as strong fibrous-structures for cell culture and tissue 
engineering shows promising as well as for wound healing and regenerative medicine, 
cosmetics, and personal health.26-29 
 
1.5 Supramolecular chemistry: self-assembly of complex structures 
Bringing two molecules together in space to make a new one implies a chemical 
reaction in which new bonds are formed. The nature of these bonds may vary. 
Traditional chemistry has focused on the study of covalent bonds while supramolecular 
chemistry has tried to investigate other noncovalent forces (which tend to have lower 
energies and may break) that also participate in the process, such as hydrogen bonds, 
metal coordination, van der Waals and hydrophobic forces, π–π interactions, and 
electrostatic effects. 
Supramolecular chemistry started to emerge as an important field of chemistry when 
Latimer and Rodebush gave a better description of how the hydrogen bond must be 
understood – this was useful to demonstrate the real double helical structure of 
DNA.30 However, it is after the Nobel Prize for developing selective “host-guest” 
complexes, awarded to Donald J. Cram, Jean-Marie Lehn, and Charles J. Pedersen in 
1987, when supramolecular chemistry starts to play a more important role in the 
design of new complex structures. After seeing that it was possible to design molecules 
which would only be recognized selectively by a specific partner, new and more 
ambitious complex systems were proposed and achieved. Thus, for example, James 
Fraser Stoddart developed molecular machinery and self-assembled structures,31 as 
well as other researchers contributing other models. 
Since we aim to use molecular components for both generating and controlling 
conformational switching in de novo coiled-coil peptide systems, it is important to 
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understand the way some sequences encode two or more folded states. One protein 
can show activity in one of their conformational states whilst can remain inactive in 
another one. In some cases, this conformational switch may be induced by a 
noncovalent interaction,32 by changes in the pH,33 by different responses to heat,34, 35 
or by other effects such as disulphide-bond reduction.36 Here we focus on metal-
binding and azobenzene photoswitching as modes to control the self-assembling of de 
novo designed peptide systems, and they are discussed next. 
 
1.5.1 Self-assembling systems regulated by metal-binding 
Due to the richness in the properties of the metal ions, supramolecular chemistry 
makes use of coordination chemistry to design novel structures in order to develop 
new functionalized materials for technological applications. Most biological systems 
contain proteins which rely on the effect and properties given by the metal ion to 
which they are bound. The ability of transition metals to form coordination complexes 
can provide us with new systems with well-defined coordination geometries which 
could be used to investigate the relationship between sequence, structure and 
function, but also to control the self-assembly of higher ordered molecular structures. 
The goal is to mimic these natural processes and also to design new metallo-proteins 
which function as building blocks in which different metal ions could favour the 
formation of new functionalized structures.  
It has also been found that metal ions can coordinate ligands, and in such cases the 
affinity of this metal-binding could be enhanced. It is also possible that the production 
of unnatural metal-binding motifs could provide medicinal applications for peptides, as 
well as other different roles in imaging, catalysis, or metal-ion detection.37-43 
An important feature is to select the appropriate ligand to coordinate the metal ion. As 
reported by Imperiali and co-workers,44 there are a limited number of natural amino 
acids capable of binding metals in aqueous media. For this reason, the design of 
synthetic ligands to enhance metal ion selectivities as well as to widen the range of 
metal-binding is an interesting target. 
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Pyridine is one of the most used ligands in coordination chemistry due to the chemical 
nature of nitrogen as electron-donor for bond formation. Pyridylalanine, which is the 
substituted analogue of pyridine is commonly used as part of bioactive compounds 
and as chiral building blocks. These properties make this type of ligands very 
interesting when coordinated to metal ions as the interaction could affect some of 
their physical or chemical properties such as binding angle, coordination geometry, 
and electron donating effects. Moreover, they can be used as part of components of 
antitumour45 and anti-inflammatory46 agents, as well as in pharmaceutical 
applications.47, 48 On this pathway, Imperiali et al. stereoselectively synthesized several 
bipyridine amino acids44, 49, 50 capable of being inserted into polypeptides and studied 
their effects when coordinating to some metal ions such as Co(II), Cd(II), Cu(II), Ni(II) 
and Zn(II).44 When changing the ratio of this amino acid in the presence of a constant 
concentration of the metal ions, the spectroscopic studies showed differences and 
hence the geometry of association could then be examined. 
Kwong and co-workers developed the synthesis of a type of chiral bipyridine ligands 
sensitive to the nature of the coordinated metal ion.51 These bipyridine ligands had an 
axially unfixed bridge that was able to rotate. They complexed the ligand with Ag(I) 
and Cu(I), and ammonium ions and observed different behaviours and geometries of 
association, concluding that these ligands had switchable properties (Figure 1.14). 
 
Figure 1.14: Chemical structure of the rotational conformers of the biphenyl ligand L1 in equilibrium 
(top) and their space filling model (below) developed by Kwong and co-workers (adapted picture from 
reference 51) The structure of the axially unfixed bridge is shown. 
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To date, other examples of polypeptides with novel ligands inserted into their 
sequences by modified amino acids have been reported. There are both examples in 
which the insertion of these novel amino acids takes place in the middle of 
polypeptidic chains or attached in their terminal amino groups.52 Kaiser and Sasaki 
designed the “helichrome” based on a coproporphyrin as a template to control the 
folding of four peptides in a helical-like bundle (Figure 1.15).53 
 
Figure 1.15: Structure of coproporphyrin, and the proposed structure of the helicrome when folding the 
α-helices (adapted figure from reference 53).  
 
Sasaki and Hopkins were also able to achieve metal-binding to peptides by inserting 
unnatural aminodiacetic acid residues in their sequences (Figure 1.16).54, 55 Moreover, 
in order to prove the ability to form a stable bond for the helix, some metal ions were 
tested: Cd(II), Co(II), Cu(II), Ni(II), and Zn(II). Ghadiri’s group designed a peptide in 
which the N-terminus had a pyridyl motif attached.56 The result after complexation 
with Ru(II) was the formation of a four-helix bundle structure which was found to be 
soluble in water (Figure 1.17). 
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Figure 1.16: (a) Structure of the cross-linked peptide in aqueous solution (adapted figure from reference 
55); (b) Chemical structure of the aminodiacetic acid residue responsible for metal binding (adapted 
figure from reference 52).  
 
 
 
Figure 1.17: Four-helix bundle structure produced after coordination of Ru(II) to the pyridyl motifs of a 
pyridyl-functionalized peptide. The functionalized peptide sequence is shown at the bottom of the 
picture (adapted picture from reference 52). 
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Functionalization in the N-terminus with bipyridyl motifs was studied and developed at 
the same time but separately by the research groups of Sasaki and Ghadiri.57, 58 Sasaki 
demonstrated that Fe(II) was able to induce a three-bundle folding when coordinated 
to this bipyridyl motif inserted in a peptide. Ghadiri showed the same folding effect for 
different metal ions such as Ru(II), Co(II) and Ni(II) when coordinated to a peptide 
sequence which included another bipyridyl motif. The two different bipyridyl-ligands 
and the three-bundle structure provided are shown in Figure 1.18. 
 
Figure 1.18: Three-bundle structure produced by the folding of the peptide sequences functionalized 
with the bipyridine ligands developed in Sasaki’s group (represented at the top right), and in Ghadiri’s 
group (represented at the bottom right) after metal-binding (adapted pictures from reference 52). 
 
Ghadiri further incorporated a histidine residue into the bipyridyl-sequences but right 
on the other side of the helix so as to allow an extra metal-binding ligand to coordinate 
from both edges of the helices.59 This new type of metal-binding complexes was 
designed due to some reports which showed the ability of copper to coordinate 
histidine residues in natural proteins.60 The peptide sequence and the folding system 
are shown in Figure 1.19. 
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Figure 1.19: The peptide sequence is shown at the left and the three-helix bundle structure at the right 
(adapted picture from reference 52). 
 
Metal binding not only can provide new functionality but it can also improve the 
activity of the fastest known metalloenzymes, as in the case of the human carbonic 
anhydrase.61 Figure 1.20 shows a ribbon diagram of an artificial metallohydrase that 
Zastrow et al. designed and successfully synthesized. This contained two separate 
metal binding sites able to coordinate both Zn(II), enhancing the nitrogenous catalytic 
activity for either pNPA hydrolysis or CO2 hydration, and Hg(II), which provided 
structural stability. 
 
Figure 1.20: Ribbon diagram of the metalloenzyme synthesized in Pecoraro’s group (adapted picture 
from reference 61). 
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Anna Peacock and co-workers designed a de novo peptide sequence of 30 residues 
capable of binding a therapeutic gold(I) phosphine complex into aqueous solution.62 
Analysis by UV/Vis confirmed metal-binding of Au(I) to the peptide and the CD 
spectrum showed that the coiled coil structure was retained upon coordination with 
the metal ion. A potential application of this type of compound would be to generate a 
new class of gold(I) phosphine peptide therapeutics. In 2014, Peacock’s group designed 
artificial peptide dimers, to which polypyridine switching units were incorporated, to 
demonstrate that biomolecular recognition, and specifically sequence-selective DNA 
binding could be controlled by metal-ion coordination, Cu(II) and Zn(II).63 Their aim was 
to develop a base for a wide range of applications in the future. 
In summary, there is an increasing interest in this field and there are a few examples 
that inspire not only the design of new metal-binding structures to control the 
assembly and folding of polypeptidic structures but also to bring both improved and 
new functionality into these biochemical systems. 
  
1.5.2 Photo-switching molecules to control peptide-assembling 
Nature shows biological systems which are able to control their assembly or 
conformational state through many alternative ways. Photoresponsive systems work 
by irradiating light into a photosensitive element embedded into their matrix which 
after capturing the optical signal transforms it into a physicochemical stimulus. This 
stimulus causes a conformational change in the structure of the biomolecule and may 
provide it with new functionality. These photosensitive elements are called 
chromophores and are responsible for absorbing light to activate the photoswitching 
process which in some cases can be reversibly controlled. 
Using azobenzene derivatives as chromophores is one utilized strategy to 
photoreversibly control the secondary structure of polypeptide sequences or proteins. 
Irradiating light on the azobenzene derivatives at the right wavelength when they are 
attached to peptide sequences may induce a conformational change in the peptides 
secondary structure. The ability to photo-control helical content also offers the 
possibility of photo-controlling protein activity, and hence, protein function. 
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Azobenzene derivatives may vary in their structure and size but the main and common 
feature of these type of molecules is that two phenyl rings are linked by an “azo” N=N 
bond. Figure 1.21 shows the general structure of a trans isomer of an azobenzene 
derivative, having the simplest of them at the left-hand side, and showing the different 
positions for substituents at the right-hand side. 
 
Figure 1.21: General structure of a trans isomer of an azobenzene derivative. At the left-hand side we 
can see the simplest example of these type of compounds at where all the R groups are hydrogens. The 
degree of substitution in the different positions will provide a wide class of this type of molecules.  
 
Azobenzene derivatives can be interconverted from the trans, and most stable isomer, 
to the cis isomer by irradiating with light at the right wavelength (Figure 1.22). Thus, 
UV light will be used for the trans-to-cis isomerization and visible light can be used for 
the cis-to-trans isomerization. Because the cis isomer is thermally disfavored it will 
return to trans slowly by thermal activation. 
 
Figure 1.22: Photoisomerization of an azobenzene by light irradiation. 
 
In general, it has been demonstrated that the trans isomer of an azobenzene 
derivative represents a >99% when the molecule  is in the dark, while the percentage 
of cis isomer that can be achieved after irradiation may vary from 70-90% depending 
on the structure of such derivative, as well as the barrier energy to interconvert both 
isomers. The mechanism through which this isomerization happens is still an object of 
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study and may vary depending on the substituents on the rings, however, there are a 
few proposed mechanisms which are showed in Figure 1.23 adapted from Dhammika 
Bandara’s paper in 2011.64 The characteristic bands of absorption are in the visible and 
UV region, hence, can be monitored by UV/visible absorption spectroscopy. There are 
low lying n → π* bands between 380 and 520 nm, while the π → π* bands appear at 
around 330 nm for the trans isomer and at around 275 nm for the cis isomer.  
Figure 1.23: Proposed mechanisms for the trans-to-cis photoisomerization of an azobenzene molecule. 
The arrows do not indicate electron movement but the movement of the phenyl rings (adapted figure 
from reference 644). 
 
When azobenzene derivatives are incorporated into polypeptide sequences they act as 
the photoswitching element to interconvert the secondary structure of these peptides 
by the effect of light irradiation at the right wavelength. Attachment of azobenzenes to 
polypeptides is done via the reaction of halo-substituted azobenzenes with thiols that 
are part of the peptide sequences. Since the amino acid Cys contains a terminal thiol 
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group, having Cys as part of a polypeptide chain may provide a reactive site to 
incorporate azobenzene derivatives. Thiols, or more specific their conjugate bases, 
thiolates, are readily alkylated to give thioethers when using an adequate base. As an 
azobenzene derivative is attached at two sites, this means that two Cys residues are 
needed within the peptide sequence. However, these thiols can react together to form 
a disulfide bond, -S-S-, and this reaction would block the incorporation of the 
azobenzenes. The way to avoid this unwanted reaction is to control the pH of the 
media. Since pKa(Cys) = 8.35, a pH near 8 is needed to maintain the Cys residues in 
their reduced states and to make possible the reaction with the azobenzene 
derivatives in both reactive sites of these molecules. In addition, as we wish to allow 
the photo-control of the secondary structure of our designed peptide sequences, we 
are interested in the design of simple systems which can operate in water. Therefore, 
having azobenzene derivatives which can be easily dissolved in water will enhance the 
process. 
Woolley et al. have been investigating the distance at which the Cys residues must be 
spaced within the polypeptide sequence so as to be readily cross-linked by the 
azobenzene moiety. In Woolley’s group they designed a few model sequences in which 
the spacing in between Cys residues was: i → i+4, i → i+7, and i → i+11, and used the 
same azobenzene derivative as to find out which spacing could maximize the photo-
switching in the dark-adapted, or inactive, state of the system. They saw that having 
the Cys residues in a spacing at i → i+4 in the dark-adapted state the trans 
conformation leaded to a distorted helicity content.65 However, after photo-irradiation 
to get the cis conformation the helical content increased. For the model at a spacing at 
i → i+7 they found that the azobenzene in its trans conformational state was too long 
to adopt an α-helix conformation, but when the cross-linker was excited with light and 
photo-isomerized to its cis conformation, its length matched the spacing and favored 
an ideal α-helix.66 In contrast with these two models, the spaced at i → i+11 favored 
the formation of an α-helix in the dark-adapted and distorted the α-helix in a high 
degree when the azobenzene moiety was photo-irradiated (Figure 1.24).65  
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Figure 1.24: At the top left, the photo-isomerization of the azobenzene derivative used in reference 65; 
FK-4-X model (i → i+4) at the top right (trans and cis isomers respectively); at the bottom left, JRK 
peptide at a spacing at i → i+7 (trans and cis isomers respectively) and FK-11-X model (i → i+11) at the 
bottom right (trans and cis isomer respectively) (adapted pictures from reference 65). 
 
Once the azobenzene moiety has been incorporated into the polypeptide sequence, 
circular dichroism (CD) is used to demonstrate whether the helix content of such 
peptide can be reversibly photo-controlled when irradiating with the appropriate 
wavelength. Figure 1.25 at the left-hand side shows the typical CD spectra for each of 
the possible conformational structures and, at the right-hand side, an example of the 
spectrum of a polypeptide attached to an azobenzene derivative before and after 
irradiation with light. 
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Figure 1.25: At the left, CD spectra for different conformational structures. This picture was adapted 
from Nature Protocols 2007, 1, 2527 – 2535. At the right, the CD spectra of both trans and cis 
conformational states of a polypeptide sequence when contains an azobenzene moiety attached to it. 
This picture was adapted from PNAS 2000, 97, 3803 – 3808. In this case, the curve a represents the CD 
spectrum of the dark adapted peptide, whereas curve b represents the spectrum obtained after 
exposure of the solution to 380 nm light. Therefore, for this given example, the trans conformation will 
orientate the structure of the peptide in a non-helical conformation while the cis conformation will 
favour an α-helical content. 
 
As seen in Figure 1.25 at the right hand side, for that given example, the trans 
conformational state (curve a) has a lower α-helical content than the peptide structure 
at the cis conformational state (curve b). Since the trans isomer of the azobenzene 
molecule is the most stable, it would be of interest to have the azobenzenes in their 
trans conformational state able to favor an α-helical conformation of the polypeptide 
sequence. 
Depending on the azobenzene derivative and the Ri substituents the cross-linked state 
may couple either the trans or the cis conformation to α-helical content (Figure 
1.26).67  The conformational states of these different linkers can be monitored by 
UV/visible absorption spectroscopy.68 As well as the R groups in an azobenzene 
derivative can affect the conformational state to photo-control polypeptide sequences, 
the position in which these chromophores are placed within the sequences can show 
different effects and efficiency in the photo-regulation of the structures. This was 
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demonstrated in Woolley’s group by synthesizing a polypeptide of 32 residues with a 
determined core structure and inserted their BSBCA derivative at a spacing of i → i + 7 
and, also, at different positions along the helix. Analysis by CD indicated that photo-
control of helix folding or unfolding by BSBCA was most effective when this was 
located in the middle of the sequence, causing the best propagation effect along the 
helix.69 
Figure 1.26: (a) Structure of an azobenzene cross-linker where the cis-β-isomer shows stabilized and 
when switching to trans is disordered. (b) An azobenzene derivative which stabilizes the trans isomer for 
an α-helix sequence and shows a disordered structure when switches to cis (adapted pictures from 
reference 67). 
 
There are many examples of azobenzene derivatives photo-regulating polypeptidic 
structures within proteins. For example, Rudolf K. Allemann et al. used azobenzene 
cross-linkers to control α-helical peptides within MyoD.70 MyoD is a human protein 
with a key role in regulating muscle differentiation. When an azobenzene unit binds 
the DNA-recognition helix of MyoD, this protein shows photo-control of its activity 
(Figure 1.27). 
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Figure 1.27: (a) Photo-isomerization of photoMyoD; (b) schematic representation of the MyoD and 
photoMyoD structures showing the primary peptide sequence of their basic regions; (c) model of the 
DNA complex of photoMyoD with the cross-linker in its cis configuration complexed by recognition 
helices of two bHLH subunits of the dimeric protein (adapted figure from reference 70). 
 
Although azobenzene derivatives have the ability to photoisomerize from trans-to-cis 
and viceversa, some of the experiments with polypeptides that were investigated 
showed incomplete reversibility due to the fact that the chromophore became trapped 
in one photo-isomeric state. Woolley and co-workers designed a modified GCN4-bZIP 
protein which utilizes an azobenzene motif to enhance the DNA-binding ability in a 
fully thermally reversible process.71 
Wanting to show the versatility of the azobenzene derivatives, Woolley’s group 
designed longer azobenzene cross-linkers to allow photo-isomerization of peptides 
when the Cys residues were located in a spacing of 12, 15 and 16 residues away.72 The 
azobenzene derivative which they used for this purpose is shown in Figure 1.28a. 
However, in an attempt to expand this scope they designed a bis-azobenzene 
derivative Figure 1.28b which showed to stabilize structures at much longer spaced 
relationships.73 
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Figure 1.28: Structure of longer azobenzene-like chromophores to photo-control peptide folding at a 
higher spacing relationship. 
 
Rener and Moroder also described azobenzenes as chromophores able to photo-
regulate the structures in which peptides were folded.74 Schultz et al. incorporated an 
azobenzene into proteins in E. coli in order to control enzyme activity.75 Woolley also 
tested azobenzenes as photoregulators of the activity in ion channels.76 In 2010, the 
work developed by Woolley’s group shown that coiled-coils of proteins within living 
cells could also been controlled by light irradiation.77 Again, in 2011, Woolley et al. 
attached a fluorescent dye near the azobenzene in order to test whether the intensity 
in fluorescence emission changed when conformational isomerization occurred (Figure 
1.29).78  
Woolley’s group have also found an alternative to switching by UV, using visible light 
(red-shifted) in biological systems. They find successful results with new synthesized 
azobenzene derivatives in which their four ortho positions to the azo group were 
substituted with bulky, polar and electron-rich substituents, such as methoxy (or even 
with chloro),79 S-ethyl groups,80 and also using a longer bisazobenzene cross-linker 
which contained a central piperazine unit linking both azobenzene chromophores in 
para position.81 
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Figure 1.29: Above, the representation of the photo-isomerization of the azobenzene motif. Below this, 
the peptide sequence is shown as well as the dye, or fluorescent reporter. The structure when the cross-
linker is attached to the peptide and its photo-isomerization is shown below (Adapted picture from 
reference 78). 
 
Since azobenzene derivatives have a wide range of applicability, there is a growing 
interest in designing new types of azo-switches to develop new enhanced applications 
such as molecular motors82, 83 and molecular electronic devices,84 smart polymers for 
optical data storage,85 conformational switches in cyclic peptides,86 design of light-
activated proteins within complex biochemical systems,71 chromopeptide74 and 
carbohydrate applications,87 molecular sensors of plasmonic nanoantennas,88 
regulation of porous hybrid materials,89 for energy-storage of solar thermal fuels with 
functionalized carbon nanotubes,90 as potential substitute for conventional metallic 
paints,91 enhance gene delivery and contributing to more exposure of genes for 
transcription,92 and as pH indicators,93 in between some of them. In this project we 
aim to use an azobenzene derivatives as molecular switch to reversibly photo-control 
and trigger peptide assembly and folding. 
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1.6   Project aims 
Having a clear concept of what an amino acid is, how amino acids are brought together 
to form peptide sequences through amide bonds, and how these peptide sequences 
can interact and assemble with other peptide sequences to form higher order 
structures is the starting point of this research project. Here we focus on α-helical 
coiled-coils as the elements of higher order peptide structures. 
We can say that peptide chemistry is the base of this thesis and we use solid-phase 
peptide-synthesis (SPPS) strategies to synthesize the designed self-assembling peptide 
systems. However, this project is described as interdisciplinary due to the use of both 
organic chemistry (that we make use to synthesize small organic molecules) and 
inorganic chemistry (through the use of metal-binding), but also spectroscopy (that we 
use for analysis). 
As seen in Nature, biomolecules containing a metal ion within their structure provide 
different functionality within living organisms (structural, electron transfer, catalytic 
functionality, etc.). It has also been demonstrated that de novo metalloproteins can be 
built from scratch and can also be competitive with known natural metalloenzymes.94   
Therefore, we aim to use novel molecular components to generate conformational 
switching in de novo coiled-coil peptide designs. This includes both the synthesis of 
synthetic amino acids analogues for metal-binding and the synthesis of azobenzene 
derivatives for photoisomerization. 
By incorporating synthesized novel amino acids into self-assembling peptide system 
we aim to form both novel chiral metal-based biocatalysts but also to investigate to 
what extent the self-assembly can control metal-binding and to what extent the metal-
binding can control self-assembly. Moreover, the geometry of association between 
polypeptides and metal ion may vary depending on the metal ion (size, oxidation state, 
reactivity properties). In this case we say that metal binding is a tool to trigger or 
suppress assembling. 
By using azobenzene derivatives, which can be photoswitched between cis and trans 
isomers, we can induce conformational changes in the secondary structure of coiled-
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coil peptide designs. The success of this effect in simple systems could encourage to 
test it in larger systems which would add a whole extra layer of complexity to the 
assemblies. The use of azobenzene derivatives for photo-regulation of peptide 
sequences may provide a potential power source for protein motors, e.g. in a motor 
hub to influence the direction and efficiency of stepping.95, 96 
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Chapter 2 
Synthesis of molecular components to 
generate conformational switching in 
coiled-coil structures 
2.1 Background 
As previously discussed in Section 1.5, it is possible to control the self-assembly of 
polypeptide sequences that encode two or more folded states in different ways.1-4 
However, here we focus on metal-binding and azobenzene-photoswitching as tools to 
reversibly control the different conformational states of de novo designed α-coiled-coil 
and fibrous systems. We aim to design synthetic amino acids which can act as ligands 
for metal-binding. Incorporating these unnatural amino acids into our peptide designs 
should allow a reasonable degree of control of both peptide folding and self-assembly 
leading to a generation of protein nanostructures that have a highly defined 3D 
architecture. On the other hand, azobenzene linkers have been proven to act as 
photoswitches to reversibly control protein functions by means of their trans-to-cis 
photoisomerization effect when attached to them.5, 6 We aim to design an azobenzene 
moiety which after cross-linking two side chains in our peptide sequences will 
represent a potential alternative to metal-binding as method to control the self-
assembly as well as for applications in protein motors. 
 
 
 
Synthesis of molecular components to generate conformational switching in coiled-coil structures 
42 
 
2.1.1 Metal-binding 
Metal-binding has been extensively used from the late 80’s as a tool to control the self-
assembly of relatively small peptides7 and, more recently, to control the folding of 
proteins.8 Binding a metal ion to a polypeptide sequence can either enhance or 
provide metalloproteins with different functionality and/or activity. Some of these are 
related to fundamental biological processes such as respiration, metabolism, nitrogen 
fixation, and signal transduction.9 Moreover, new types of metalloprotein-based 
therapeutics, and medical biosensors or screening agents can be developed.10 
To achieve metal-binding with polypeptides we need to have an amino acid within the 
sequence capable of offering a binding site to the metal ion. Ogawa and co-workers 
designed and synthesized a 30-residue polypeptide in which a histidine residue was 
placed in position 21 (H21). The peptide self-assembled in a two-stranded coiled-coil 
(Figure 2.1.a). Upon complexation with Ru(II), the metalloprotein serves as a scaffold 
to incorporate electron-transfer (ET) functionality (Figure 2.1.b).11 With the same aim 
of incorporating ET functionality into synthetic metalloproteins, Ogawa’s group 
synthesized a polypeptide sequence in which two Cys residues were placed at 
positions 16 and 19 (allocated within the hydrophobic core) capable to bind both Cd(II) 
and Cu(I) ions providing the polypeptide with different conformational changes, being 
a two-stranded coiled-coil when Cd(II) was bound (Figure 2.1.c) and a four-stranded 
coiled-coil with Cu(I) (Figure 2.1.d).12 
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Figure 2.1: (a) Schematic representation of the third heptad repeat of the ET metalloheterodimer; (b) 
Computer-generated model of the heterodimer ET metalloprotein; (c) Energy-minimized computer 
model of the Cd-bridged C16C19 peptide dimer in which Cys residues located at positions 16 and 19 of 
each peptide chain bind the Cd center in a tetrahedral geometry; and (d) Computer-generated model of 
the tetrameric CuI-C16C19-GGY metalloprotein. (Pictures taken and described as in references 11 and 
12) 
 
Although there are a few examples where histidine or cysteine have been used for this 
aim, we are interested in the design and synthesis of polypeptide sequences bearing 
unnatural amino acids with metal-binding properties. Incorporation of either one or 
several of these unnatural amino acids within the sequences could make the peptides 
adopt a previously designed and desired conformation. As mentioned in Section 1.5.1, 
ligands including nitrogen atoms are ideal for coordinating amino acids with metal ions 
due to the chemical nature of nitrogen in coordination chemistry. Section 1.5.1 
showed a few examples where pyridine- and bipyridine-based derivatives were used to 
control the conformation of α-helical peptide sequences. Hence, pyridylalanine 
derivatives represent our target amino acids for this project. 
Mikhail V. Tsurkan and Michael Y. Ogawa combined the principles of supramolecular 
coordination chemistry with those of de novo protein design to lead to a new class of 
metal-peptide nanoassemblies.13-15 We looked into their work as the unnatural amino 
Synthesis of molecular components to generate conformational switching in coiled-coil structures 
44 
 
acid for metal-binding that they were using was a 4-pyridylalanine derivative (Pal, 38), 
the same type of ligand that we decided to use for incorporation in our designs. 
Tsurkan and Ogawa started these type of experiments by turning one of their previous 
sequences used for generating α-helical coiled-coils into a metal binding sequence. 
This consisted of a 30-residue polypeptide sequence (containing 4 heptads) in which 
the unnatural amino acid Pal was placed in position f of the third heptad, which is the 
most solvent exposed, and a Cys was placed in position d of the second heptad, that is 
in the hydrophobic face (Figure 2.2.a). Upon oxidation of the Cys residues, a disulphide 
covalent bond was internally formed to help the construction of dimeric coiled-coils 
and the Pal residue coordinated a Re(III) complex to form short metal-peptide 
oligomers (Figure 2.2.a).13 Modification of the initial peptide sequence again, this time 
inserting two metal-binding Pal residues at positions f of the second and third heptads, 
favored the formation of a stable two-stranded α-helical coiled-coil structure which 
after complexation with a Pt(II) complex, discrete four-helix bundles were observed 
(Figure 2.2.b).14 In an attempt to form a more conformationally flexible peptide than 
before and to compare the conformational properties of the assemblies, a new 
modification to the initial sequence was made. This time only one Pal unnatural amino 
acid was inserted at position f of the third-heptad (without that Cys residue which 
favored an internal covalent disulphide bond in the previous model). The result was 
the formation of nanospheres and fibrils upon coordination with a Pt(II) complex 
(Figure 2.2.c).15 Further investigations on this last system showed that the 
oligomerization state was buffer-dependent and could afford either nanometer-scale 
globular materials or millimiter-scale rod-like materials depending on the conditions 
used, suggesting that different driving forces dictated the final structures, such as the 
structure of the peptide sequence and/or the ligand-ions interactions when the metal-
peptide complex is formed.16 This matches with our idea of investigating to what 
extent our ligands can determine the oligomerization state or assembly of the peptide 
sequences, and the way our peptide designs may have bigger influence than metal-
binding on self-assembly. 
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Figure 2.2: Schematic representation of (a) the short metal-peptide oligomers formed when coordinated 
to a Re(III) complex; (b) two-stranded α-helical coiled-coil of AQ-PAL14PAL21 coordinating to a Pt(II) 
complex to form discrete four-helix bundles; and (c) two-stranded α-helical coiled-coil of AQ-PAL14 that 
coordinates to a Pt(II) complex to form nanospheres and fibrils (adapted pictures from references 13, 15 
and 16). 
 
2.2 Synthesis of pyridylalanine (Pal) derivatives. 
The initial target amino acids of our study were the 2- and 3-pyridylalanine derivatives 
and they were synthesized in the form of Fmoc- and Boc-protected pyridylalanine 
amino acids 1 to 4 (Figure 2.3). 
 
Figure 2.3: Structures of the initial target ligands pyridylalanine amino acids 1 to 4. 
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The retrosynthetic analysis to make 1 and 2 (Fmoc-protected amino acids), and 3 and 4 
(Boc-protected amino acids) are given in Scheme 2.1 and Scheme 2.2 respectively. In 
both synthetic routes the key intermediates were the orthogonally protected 
iodoalanine derivatives 7 and 10. The iodoalanine compounds were reacted with 
different halopyridines via a palladium-catalysed Negishi cross-coupling reaction to 
access the corresponding orthogonally protected pyridylalanine amino acids.17 The 
Negishi methodology had already been used in the Cobb group to synthesize a library 
of novel phenylalanine and tyrosine analogues.18 Finally, removal of the protecting 
groups at the carboxylic groups afforded the target compounds 1 to 4. Acid-labile 
protecting groups (-tBu) were used in the case of the Fmoc-protected amino acids and 
benzyl-groups in the Boc-protected derivatives, which could be removed by H2/Pd in a 
weak acidic media. 
 
Scheme 2.1: Retrosynthetic pathway for the synthesis of the Fmoc-protected pyridylalanine amino acids 
1 and 2. 
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Scheme 2.2: Retrosynthetic pathway for the synthesis of the Boc-protected pyridylalanine amino acids 3 
and 4. The Boc-protected iodoalanine benzyl ester 10 is already available in our research group. 
 
As outlined in Scheme 2.1, the first step in the synthesis of the unnatural Fmoc-
protected pyridylalanine amino acid derivatives 1 and 2 consisted of a reaction to 
prepare an orthogonally-protected serine derivative, Fmoc-Ser-OtBu (6). As the amino 
terminus was protected with an Fmoc group (required for SPPS), which could be 
cleaved under basic conditions, we used an acid-labile protecting group for the 
carboxylic terminus. The reagent tert-butyl trichloroacetimidate (TBTA) could be used 
as a protecting group for a carboxylic acid in the presence of an alcohol,19 and this was 
used as shown in Scheme 2.3. Fmoc-Ser (5) was reacted with TBTA in EtOAc to give 6 in 
a 65% yield.  
Although 65% is a good yield, different reaction conditions were used in an attempt to 
try to increase it, but also to minimise unwanted side products. When EtOAc was the 
solvent of reaction, we found higher yields when working at higher scales of reagents. 
Thus, the lowest yield (53%) was achieved when starting from 3.05 mmol of 5, and the 
highest (94%) when starting from 15.27 mmol of 5. A different solvent system for this 
same reaction consisting of a mixture of ethyl acetate and cyclohexane was found in 
the literature to afford a 90% yield.20 However, we were not able to reproduce the 
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same results and only achieved a maximum yield of 46% under those conditions. A 
summary of the conditions used are given in Table 2.1. 
 
Scheme 2.3: Synthesis of Fmoc-Ser-OtBu 6. See Table 2.1 for reagents and conditions. 
 
Solvent system eq. of amino acid 
(5) 
eq. of TBTA Yield (%) 
(6) 
EtOAc 1.0 1.5 53 - 94 
EtOAc/cycloexane 1.0 4.0 46 
Table 2.1: Effect of solvent for the synthesis of compound 6.  
 
After purification by column chromatography of the crude of reaction, compound 6 
was not the only product of this reaction but a by-product (13) was observed to form 
in all these set of reactions. The 1H NMR signals of 6 (in black) and 13 (in red) showed 
great similarities (Figure 2.4): the shifts of both their Fmoc-aromatic and aliphatic 
protons remained the same and so did the corresponding signals of the NH protons 
next to the Fmoc-group. However, a few differences in the shifts of the proton signals 
were observed: this was the case of the signal of the α-H in 13 which got mixed with 
the signals of the CH2-Fmoc protons whilst these two different group of signals could 
be seen individually in the 1H NMR spectrum of 6; the β-protons of the CH2 group next 
to the OH in 6 that were seen as a singlet, split into two different double doublets in 
the spectrum of 13 and shifted to a higher field. This indicated that a chiral component 
had attached to the oxygen next to this CH2 group, hence removing the alcoholic 
functionality. In addition, the new singlet observed in the spectrum of 13 at 1.06 ppm 
integrating at 9 protons – that matched the number of protons of a tert-butyl group – 
was indicative of the formation of a terminal tert-butyl ester group. As this tert-butyl 
group was linked to an aliphatic CH2 and this is less electro-releasing than a C=O group, 
it showed a shift to a lower frequency than the existing tert-butyl group directly 
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attached to the carbonyl group. The mass analysis by ESI-MS of compound 13 
confirmed the formation of the double tert-butyl protected amino ester: (ES+) m/z 
462.4 [M+Na]+. ESI-MS analysis of compound 6 showed (ES+) m/z 407.2 [M+Na]+ as 
expected. 
 
Figure 2.4: 1H NMR spectra of compounds 6 (in black) and 13 (in red). The two peaks integrating near 9 
protons and the slight shift in the other proton signals suggest the formation of a di-tert-butyl protected 
amino ester (13). 
 
As previously reported in our research group, easily accessible N-protected iodoalanine 
derivatives as starting materials for the coupling reaction with haloaromatic reagents 
were needed for the synthesis of novel amino acids containing both homo- and 
heteroaromatic molecules of interest, such as pyridylalanines. The iodoalanine 
protected amino ester could be achieved by following the known methodology to form 
alkyl iodides.21 The alkyl-iodide compound was prepared by a first reaction of 
triphenylphosphine and elemental iodine in situ. The alcohol 6 and the weak organic 
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base, imidazole, were then added. The overall result was the conversion of the alcohol 
into Fmoc-Ala(I)-OtBu (7) (Scheme 2.4). 
 
Scheme 2.4: Synthesis of Fmoc-Ala(I)-OtBu (7). 
 
The β-OH group of 6 was substituted and an alkyl-iodide compound 7 was formed. ESI-
MS analysis of the crude showed: (ES+) m/z 516.2 [M+Na]+, as expected for the 
formation of compound 7. The 1H NMR spectrum of the crude of reaction supported 
this information by showing a shift in the signal of the CH2 protons next to the OH 
group, indicating the conversion of -CH2-OH (at 3.87 ppm) into -CH2-I (at 3.60 ppm) 
(Figure 2.5). Due to the lower electronegativity of iodine compared to that of the OH 
group, this CH2 signal was shifted to a lower frequency. As seen in the previous stage 
where the yield of compound 6 was higher when working at higher scale, a set of 
reactions to make 7 were also prepared at different scales from 3.5 to 13.5 mmol, 
however, similar yields were obtained in all cases with the best recorded yield being 
54%. All reactions were carried out at room temperature and, after 24 hours, the 
crude product was purified via column chromatography on SiO2. Compound 7 was 
achieved as a sticky yellow oil that became a solid at low temperature. The reason for 
the low yield could be due to the formation of side products such as Ph3P=O species 
which were difficult to remove from the products during purification. 
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Figure 2.5: 1H NMR spectra of compounds 6 (in black) and 7 (in green). The shift in the CH2 signals 
corresponding to the groups where OH and I exchange indicate the formation of compound 7. 
 
The syntheses of both Fmoc- and Boc-protected pyridylalanine amino acids 1 to 4 
(Figure 2.4) were achieved by following the general procedure of protecting groups 
cleavage in SPPS (by either acid or basic wash depending on the protecting groups) of 
the amino esters 8, 9, 11, and 12 (see Scheme 2.1 and 2.2). We then carried out 
synthesis of the Fmoc- and Boc-protected amino esters 8, 9, 11 and 12 using 
palladium-catalysed cross-coupling reactions. 
There exist several types of cross-coupling reactions. These involve reactions between 
two different reagents aided by a metal catalyst to make a new bond that “couples” 
them. Initially, the use of Ni, Cu or Fe as metal catalysts was generalized for this type of 
reactions, however, the palladium-catalysed cross-coupling of an organometallic 
compound with an organic electrophile appeared to be superior when stereo-, regio-, 
and chemoselectivities were required.22 Many examples of the advantages of Pd over 
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Ni had been reported, e.g., superior stereospecificity.23 Most palladium catalysed 
reactions are believed to follow a similar catalytic cycle. The concept of double metal 
catalysis and the favourable effects of additives on the Pd-catalysed cross-coupling 
reactions were first demonstrated by Negishi in 1978.24 Negishi chemistry can make 
use of Zn, Al and Zr as the second metal catalyst, however, we used Zn due to the 
favourable results achieved in our group in previous work.18 Moreover, there are 
several advantages to using supported catalysis in organic synthesis and these include 
reagent stability, suitability for automation, ease of work-up, recyclability, and lower 
Pd contamination in the final product.  
Thus, amongst all the Pd-catalysed cross-coupling methodologies, we chose the 
Negishi reaction to synthesize the Fmoc- and Boc-protected amino esters 8, 9, 11 and 
12 as this has been proven to lead to the direct formation of new C-C single bonds and 
it has shown extremely robust for couplings when using aryl iodide derivatives. In 
addition, Negishi chemistry is tolerant to a wide variety of functional groups such as 
aldehydes, esters, alcohols, amines and phosphonates,25,26,27 and enables the integrity 
of the α-carbon to be unaffected by the coupling conditions so that the enantiomeric 
excess of the final product is only dependent on the initial starting material. 
Zinc was acid washed since a proper activation of zinc dust was essential for good zinc 
insertion. Although two procedures had been reported for the activation of zinc dust, 
the methodology using a catalytic amount of elemental iodine was found to be 
favoured over the Knochel procedure.28 . Anhydrous DMF was used as solvent due to 
the sensitivity of organozincs to both moisture and air. Therefore, the Negishi coupling must 
be performed in an oxygen and water free environment. Despite a wide range of Pd(0) and 
Pd(II) catalysts being used in this type of reaction, we used the commercially available 
Pd(dba)2 since this had been previously tested in our group and had achieved good 
results. With respect to the ligand and co-ligands, their choice determined the 
mechanism by which the oxidative addition occurred.29 The elimination step was 
accelerated by the use of bulky ligands.30 
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In order to investigate which co-ligand produced a more reactive specie of Pd(0), both 
tri-(o-tolyl)phosphine and Sphos were tried and compared in the coupling reactions of 
the Fmoc-protected amino esters, whilst Sphos and Xantphos were used and 
compared in the synthesis of Boc-protected amino esters. As coupling reagents, 
different halo-pyridines were used in order to investigate the effects of the leaving 
groups. For a given R group, the normal order of reactivity of halogens should be I > Br 
> Cl. Unfortunately, the least expensive, and hence most desirable, Cl-containing 
pyridine was the least reactive. The different halo-pyridines tested in our set of 
experiments were: 2-bromopyridine, 3-bromopyridine, 2-iodopyridine and 3-
iodopyridine, and the results are discussed.  
The general coupling conditions used for the Negishi methodology used to synthesize 
compounds 8, 9, 11, and 12 are shown in Scheme 2.5 and consisted of several steps: 
firstly, Zn dust (acid wash) (4.00 eq.) was placed in the reaction vessel under vacuum at 
100 °C and for 30 min; secondly, I2 in DMF under argon was added dropwise at 70 °C; 
after decreasing the temperature to 50 °C, the protected iodo-alanine reagent P1HN-
Ala(I)-OP2 (1.00 eq.) together with the catalyst Pd(dba)2 (0.03 eq.) and the 
corresponding co-ligand (0.09 eq.) dissolved in DMF were added under argon. The 
coupling reagent (1.00 eq.) was then added and the reaction mixture stirred for 6 h. 
The mixture was cooled down to room temperature and stirred overnight (for a 
minimum of 15 hours) before purification by column chromatography.  
 
Scheme 2.5: General conditions for the cross-coupling reactions between the protected iodoalanine 
amino esters 7 and 10 and the pyridyl halides using the Negishi methodology. Co-ligands can be: P(o-
tol)3, Sphos and Xantphos; pyridyl halides can be: 2- and 3-bromopyridine, and 2- and 3-iodopyridine; P1 
can be Fmoc- and Boc-; and P2 can be tBu and Bn respectively. 
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The proposed mechanism for the Negishi cross-coupling reaction of this set of 
experiments is shown in Figure 2.6. The first step consists of an oxidative addition of 
the Pd(0) catalyst. The addition of the halopyridine to the Pd atom increases the 
number of ligands changing its oxidation state to Pd(II). The second step is the 
transmetallation step. An alkylzinc specie, formed by the insertion of the activated Zn 
into the side chain and the iodine atom of the protected amino ester, proceeds to 
exchange the ligands with the palladium centre. Finally, the last step of the reaction 
consists of an eliminative reduction. This proceeds with the elimination of the cross-
coupled product and the regeneration of the Pd(0) catalyst.  
 
Figure 2.6: Mechanism for the Negishi cross-coupling reaction. 
 
Scheme 2.6 shows the general scheme for the Negishi cross-coupling reactions to 
synthesize the Fmoc/tert-butyl protected amino esters 8 and 9. 
 
Scheme 2.6: General scheme for the Negishi cross-coupling reactions to synthesize the new Fmoc-
protected pyridylalanine amino esters 8 and 9. Compound 8 is afforded due to using 2-halopyridine 
derivatives as coupling reagents, and 9 uses 3-halopyridine derivatives (Table 2.2). 
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Table 2.2 shows the results for the set of reactions prepared to synthesize compounds 
8 and 9. The reaction did not work as desired when using P(o-tol)3 as a ligand with 
either 2- or 3-bromopyridine as coupling reagents. However, it worked well with Sphos 
acting as ligand and 2- or 3-bromopyridine as coupling reagents, affording yields of 
60% and 55% respectively. We believed that despite Sphos being larger ligand, its two 
cyclohexyl rings allowed flexibility, hence best addition to the intermediate and also 
elimination from the final product. As the normal order of reactivity of halogens is I > 
Br, we attempted to optimize the reaction yield by using 2- and 3-iodopyridine as 
coupling reagents. Nonetheless, lower yields of 8 and 9 were obtained, probably due 
to the formation of side products favoured by the higher reactivity of I. 
Entry Ligand Coupling reagent Yield (%) 
   8        /       9 
2a  /  2b P(o-tol)3 2-bromopyridine / 3-bromopyridine -                - 
2c  / 2d Sphos 2-bromopyridine / 3-bromopyridine 60               55 
2e  /  2f Sphos 2-iodopyridine / 3-iodopyiridine 40               34 
Table 2.2: Different reagents, such as ligand and coupling reagents, utilized to optimize the yield in the 
synthesis of 8 and 9. 
 
Figure 2.7 shows the 1H NMR spectra of compounds 8 and 9 compared to the starting 
reagent 7 and shows evidence for the successful formation of the Fmoc-pyridylalanine 
tert-butyl ester compounds. The proton shifts of both the NH and tBu signals in the 1H 
NMR of 8 and 9 indicated the formation of new species starting from 7, which were 
probably caused by internal hydrogen bonds. The shift of the CH2 protons signal 
attached to the iodine in 7 moved when substituted by 2-pyridyl and 3-pyridyl motifs. 
Due to the distancing of the electronegative atom from the CH2 group, the frequency 
decreased from I>2-pyridyl>3-pyridyl and the proton signals shifted upfield. The 
protons in the region of 4.75 to 4.00 ppm contained the α-proton together with the 
aliphatic protons of the Fmoc group. 
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Figure 2.7: 1H NMR spectra of 7 (in blue) compared to 8 (in black) and 9 (in red). 
 
An expansion of the aromatic region (Figure 2.8) provided enough detail to confirm the 
formation of both 8 and 9 by 1H NMR taking into account that we started from 
compound 7 with certainty. The aromatic protons of the Fmoc group are enclosed into 
blue squares and each of the pyridyl protons are assigned on the spectrum. Single 
mass analysis (TOF ESI-MS) supported the information provided by NMR that 
confirmed the formation of compounds 8 and 9: for compound 8 (ES+) m/z 445.3 
[M+H]+, 467.7 [M+Na]+, 468.2 [M+H+Na]+; for compound 9 (ES+) m/z 445.4 [M+H]+. 
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Figure 2.8: 1H NMR spectra of the aromatic region of 7 (in blue) compared to 8 (in black) and 9 (in red). 
 
Due to the fact that the achieved yields of 8 and 9 (these are the Fmoc-protected 
pyridylalanine amino esters) ranged from 34% to 60% and we aimed to obtain higher 
yields, we decided to follow a different strategy. Previously synthesized in our research 
group, the Boc-protected iodoalanine derivative 10 was available to be used. Thus, we 
decided to synthesize the Boc-protected pyridylalanine amino esters 11 and 12 to 
check if an increase in the yield was possible. Scheme 2.7 shows the general scheme 
for the Negishi cross-coupling reactions to synthesize 11 and 12. 
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Scheme 2.7: General scheme for the Negishi cross-coupling reactions to synthesize the new Boc-
protected pyridylalanine amino esters 11 and 12. Compound 11 is afforded due to using 2-halopyridine 
derivatives as coupling reagents, and 12 uses 3-halopyridine derivatives (Table 2.3). 
 
Table 2.3 shows the results for the synthesis of 11 and 12. As P(o-tol)3 did not work as 
desired when synthesising the Fmoc-pyridylalanine derivatives 8 and 9, we decided to 
use Sphos as ligand for this set of reactions. When using 2- and 3-bromopyridine as 
coupling reagents we produced 11 and 12 in 48% and 30% yields respectively which 
were lower yields than the obtained in the synthesis of the Fmoc-analogues. However, 
it provided higher yields than for the Fmoc-analogues when 2- and 3-iodopyridine 
were used as coupling reagents, producing compounds 11 and 12 in 51% and 45% 
yields respectively. As Xantphos is a more hindered ligand, we thought that using it 
could provide a higher selectivity in the synthesis of the final product. Hence, a final 
attempt to optimize the yields of 11 and 12 was made using the ligand Xantphos 
instead of Sphos. This was first used with 2-bromopyridine and a very low yield of 11 
was achieved (9%). We then decided to try with 3-iodopyridine since the iodo-
derivative should be more reactive than bromo-derivative for these type of 
compounds. However, a low yield of 12 was achieved (13%). Xantphos may turn into a 
highly hindered ligand which does not favour the formation of the pyridylalanine 
derivative but a different side product. We did not investigate this effect in detail or 
attempted to optimize the synthesis when using Xantphos since Sphos provided better 
yields in this set of experiments. 
Entry Ligand Coupling reagent Yield (%) 
   11       /       12 
3a  /  3b Sphos 2-bromopyridine / 3-bromopyridine 48               30 
3c  / 3d Sphos 2-iodopyridine / 3-iodopyiridine 51               45 
3e  /  3f Xantphos 2-bromopyridine / 3-iodopyiridine 9                13 
Table 2.3: Different reagents (ligand and coupling reagents) used to optimize the yield of 11 and 12. 
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Figure 2.9 shows the 1H NMR spectra of compounds 11 and 12 compared to the 
starting reagent 10 and shows evidences for the successful formation of the Boc-
pyridylalanine O-benzyl ester compounds. The proton signals of the tBu groups in the 
1H NMR of 11 and 12 were at the same shift as 10. The shift of the CH2 protons signal 
next to the iodine in 10, moved when substituted by 2-pyridyl and 3-pyridyl motifs as 
seen for the Fmoc-analogues. Due to the distancing of the electronegative atom from 
the CH2 group, the frequency decreased from I>2-pyridyl>3-pyridyl and the proton 
signals shifted upfield. The protons in the region of 5.25 to 4.50 ppm contained the α-
proton together with the protons of the CH2 of the benzyl group of compound 12. 
 
Figure 2.9: 1H NMR spectra of 10 (in blue) compared to 11 (in black) and 12 (in red). 
 
An expansion of the aromatic region (Figure 2.10) provided enough detail to confirm 
the formation of compounds 11 and 12 by 1H NMR taking into account that we started 
from compound 10 with certainty. The aromatic protons of the benzyl group were 
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together under the same signal, and each of the pyridyl protons are assigned in the 
spectrum. Single mass analysis (TOF ESI-MS) of compounds 11 and 12 supported the 
information provided by NMR: for compound 11 (ES+) m/z 380.3 [M+H+Na]+; for 
compound 12 (ES+) m/z 357.3 [M+H]+. 
 
Figure 2.10: 1H NMR spectra of the aromatic region of 10 (in blue) compared to 11 (in black) and 12 (in 
red). 
 
2.3 Photoswitching as a method to generate conformational changes 
in peptide assemblies 
As alternative to metal-binding as a method to generate conformational switching in 
our peptide designs, we decided to make use of light as energy source to induce 
conformational changes. In particular, we focused on azobenzenes since these 
molecules can be photoswitched between their trans and cis isomers, and this 
switching can be amplified up by attaching the azobenzenes onto the polypeptide 
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sequences on the verge of triggering. This may as well provide a potential power 
source for protein motors. 
 
2.3.1 Synthesis of an azobenzene derivative to photo-control α-helical 
coiled-coil structures 
The initial target compound was 3,3’-bis(sulfonato)-4,4’-bis(chloroacetamido)-
azobenzene (BSBCA, 19), previously designed and synthesized in Woolley’s lab.31 
Scheme 2.8 shows the procedure for the synthesis of 19.  
 
Scheme 2.8: Published synthesis of BSBCA.31 
 
Following this procedure, the first step in the synthesis to afford 19 consisted of a 
selective protection step in which the amine group in position ortho to the sulfonic 
group from compound 15 reacted selectively with acetic anhydride in acetic glacial 
acid under reflux conditions. The resulting compound 16a should be a mono-
acetylated amino benzene sulfonic acid, however, we never achieved this step as a 
clean reaction. 1H NMR and ESI-MS analysis of our crude of reaction showed a mixture 
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of products that indicated difficulties for selective protection of the amine group ortho 
to the sulfonic group. Figure 2.11 shows the negative-ion mode electrospray ESI-MS 
spectrum of the crude of reaction. The detection of three different low-molecular-
weight molecules is discussed and assigned as follows: compound 15 which is the 
starting material shows an (ES)- m/z 187.4 [M]; compound 16a shows an (ES)- m/z 
229.4 [M]; finally, compound 16b shows an (ES)- m/z 271.5 [M]. 
 
Figure 2.11: ESI-MS (negative-ion mode) of the crude in the first step for the synthesis of compound 19. 
 
NMR analysis of the crude product (Figures 2.12 and 2.13) was consistent with the ESI-
MS analysis and confirmed a mixture of compounds: 15, 16a and 16b. The 1H NMR 
spectrum of the crude also showed a peak at 1.91 ppm from unreacted acetic acid, and 
a peak at 2.51 ppm from the solvent (DMSO-d6).  Scheme 2.9 shows an overall view of 
the molecules involved in this first step of reaction: 15 is the starting reagent, 16b is a 
by-product, and 16a is the major component of this crude product (as confirmed by 
NMR, Figure 2.13) and the product of interest to carry on with the synthesis of 19. 
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Scheme 2.9: Reaction scheme after the first step in the synthesis of BSBCA (19).  
 
The 1H NMR spectra shown in Figure 2.12 shows the shifts for the NH and CH3 protons 
of the products in the crude of reaction: 16a showed a singlet at 10.34 ppm 
corresponding to the proton of the NH in the acetyl group, and a singlet at 2.09 ppm 
from the protons of the CH3 group; 16b showed two different singlets at 10.23 and 
9.93 ppm from their two NH group protons, and two different singlets at 2.03 and 2.01 
ppm from the CH3 protons on the acetyl groups. The nearer these protons were to the 
sulfonic group (-SO3H), the more shifted to low field (or high frequency) they appeared 
in the spectrum. 
 
Figure 2.12: Assignment of the NH and CH3 protons for compounds 16a and 16b by 1H NMR. 
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Figure 2.13 shows an expansion of the 1H NMR spectrum of the aromatic region and 
the assignment for each of the proton shifts: 16a showed a doublet at 8.40 ppm (Hc), a 
doublet at 7.72 ppm (Ha) and a doublet of doublets at 7.33 ppm (Hb); 16b was 
identified by a doublet at 8.17 ppm (Hc), a doublet at 7.86 ppm (Ha) and a doublet of 
doublets at 7.59 ppm (Hb). Finally, 15 (starting material) was identified by a doublet at 
7.56 ppm (Hc), a doublet of doublets at 7.15 ppm (Hb) and a doublet at 7.06 ppm (Ha). 
 
Figure 2.13: 1H NMR spectrum of the crude of reaction from the aromatic region. All compounds from 
the crude of reaction were successfully assigned as showed. The ratio of compounds was assigned by 
NMR as follows: 15/16a/16b (1:3:1), being 16a the major product in a 59% as maximum yield. 
 
Although we were able to identify all compounds from this first step, we never 
succeeded in synthesizing compound 17 by following the next step in the procedure. 
Initially, we started the second step of the synthesis from the crude mixture containing 
compounds 15, 16a and 16b since we thought that an attempt to separate these 
products would mean a big loss of starting material. However, we also thought that 
having this mixture of compounds as starting material could affect the reaction 
conditions by not achieving the right pH conditions for compound 16a to react as 
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expected, hence, not favoring the formation of 17. Since this seemed to be the case, 
we decided to separate compounds 15, 16a and 16b from the crude mixture of step 1 
before starting step 2 by using RP-HPLC semi-preparative C18.  
Figure 2.14 shows the chromatogram of this separation together with the ESI-MS 
analysis (positive-ion mode) of fractions 2 and 3, corresponding to compounds 16a and 
16b respectively. Fraction 1 contained compound 15: (ES) m/z 187.36 [M]+; 16b was 
found within fraction 3: (ES) m/z 270.9 [M]+; finally, fraction 2 contained compound 
16a (ES) m/z 230.8 [M]+; together with some residual 16b (m/z 272.9 [M+H]+).  
 
Figure 2.14: HPLC chromatogram of the mixture from step 1 of the procedure to make 19. Fractions 2 
and 3 show their ESI-MS spectra to identify compounds 16a and 16b.  
 
Separate 1H NMR analysis of fractions 2 and 3 collected from the RP-HPLC separation 
helped to confirm what observed by ESI-MS (Figures 2.15 and 2.16). However, the 
residual traces of 16b observed in fraction 2 by ESI-MS were not detected by 1H NMR 
as seen in the spectrum in Figure 2.15, with 16a being the only compound detected. 
Compound 16b was perfectly identified as shown in Figure 2.16. 
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Figure 2.15: 1H NMR spectrum in DMSO-d6 of fraction 2 after HPLC separation of the crude of reaction 
from step 1 to synthesize 19. Compound 16a is identified and the proton signals assigned as shown: 2.06 
ppm (CH3), 7.27 ppm (CHbAr), 7.69 ppm (CHaAr), 8.38 ppm (CHcAr), and 10.35 ppm (NH). Chapter 7 
provides 13C NMR data and supports this information. 
 
 
Figure 2.16: 1H NMR spectrum in DMSO-d6 of fraction 2 after HPLC separation of the crude of reaction 
from step 1 to synthesize 19. Compound 16b is identified and the proton signals assigned as shown: 2.01 
ppm (CH3), 2.03 ppm (CH3), 7.57 ppm (CHbAr), 7.86 ppm (CHaAr), 8.16 ppm (CHcAr), 9.92 ppm (NH), and 
10.35 ppm (NH). Chapter 7 provides 13C NMR data and supports this information. 
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Using compound 16a as showed in Figure 2.15 to continue with the next step of the 
synthesis of 19 never produced 17. Thus, we decided to find an alternative and 
synthesize an azobenzene derivative similar to compound 19. Since we thought that 
we could be having issues in the synthesis of 17 due to the reactivity of the sulfonic 
groups which was not completely understood, we decided to synthesize an 
azobenzene analogue in which the sulfonic groups were not part of the molecule. The 
sulfonic groups provide higher solubility to the peptide sequences when they are in 
solution and that was the reason to try to make 19 in first instance. However, our final 
cross-linked peptides were found to be very soluble in aqueous conditions and we 
therefore did not find the loss of the water soluble groups to be an obstacle. 
Our target compound then became 4,4’-dichloroacetamido-azobenzene (24). 
Fortunately, we saw in the literature that an analogue of this compound had already 
been made.32 And, although this was taken into account, some modifications were 
applied to the original procedure to achieve higher yields. Scheme 2.10 shows the 
synthetic route to produce 24. 
 
Scheme 2.10: Synthetic route to afford 24. Procedures A and B are detailed in Scheme 2.12. 
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The synthesis of 24 was successful and achieved in three steps. The first step of the 
synthesis consisted of a partial oxidation of 20 in the presence of hydrogen peroxide 
and simultaneous coupling of the in situ formed 4-nitroso acetanilide (21) to unreacted 
4-aminoacetanilide (20) in acetic acid (Scheme 2.11). This afforded 22 in a 13% yield. 
 
Scheme 2.11: Synthesis of 4,4’-diacetylamino azobenzene (22), followed as described in reference 32. 
 
Figure 2.17 shows the 1H NMR spectrum of 22 in DMSO-d6. Since 22 is a symmetric 
molecule, the spectrum only shows half of the molecule. The NH protons were seen as 
a singlet at 10.28 ppm, the aromatic CH protons as two doublets between 7.85 and 
7.78 ppm, the CH3 protons from the acetyl groups as a singlet at 2.10 ppm, and H2O 
from the DMSO-d6 was seen at 3.35 ppm. ESI-MS (negative-mode ion) supported the 
1H NMR data: (ES-) m/z 295.20 [M]. 
 
Figure 2.17: 1H NMR spectrum of 22 and assignation of the proton signals. 
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Step two to synthesize compound 23 was achieved by following two different 
procedures found in the literature.32, 33 We referred to them as procedure A and 
procedure B as detailed in the general synthetic route shown in Scheme 2.10. 
Procedure A afforded a 73% yield and consisted of removal of the N-acetyl groups by 
dissolving 22 in H2O and refluxing it in concentrated hydrochloric acid (conc.HCl) for 3 
hours. Procedure B increased the yield up to 84% when dissolving 22 in MeOH and 
refluxing it into conc.HCl for 1.5 hours until complete removal of the acetyl groups 
(Scheme 2.12). 
 
Scheme 2.12: Synthesis of 23: procedure A: (22 in H2O)/conc.HCl/reflux 3 hours; procedure B: (22 in 
MeOH)/conc.HCl/reflux 3 hours 
 
Figure 2.18 shows the 1H NMR spectrum of 23, which was also a symmetric compound 
as 22, thus, the NMR only showed half of the molecule in the spectrum. The signal of 
the aromatic CH protons appeared as two doublets at 7.52 ppm and 6.63 ppm and the 
NH2 protons as a singlet at 5.74 ppm. The spectrum was run in DMSO-d6 which 
appeared at 2.51 ppm, and contained traces of H2O that were seen at 3.35 ppm. ESI-
MS (positive-mode ion) analysis was consistent with the 1H NMR data and confirmed 
the formation of 23: (ES+) m/z 213.08 [M+H]+. 
 
Synthesis of molecular components to generate conformational switching in coiled-coil structures 
70 
 
 
Figure 2.18: 1H NMR spectrum of 23 and assignation of the proton signals. 
 
The last step of the synthesis to finally produce 4,4’-dichloroacetamido azobenzene 
(24) consisted of suspending 23 in acetonitrile and the addition of chloroacetyl 
chloride at room temperature in the presence of a base (potassium carbonate) 
(Scheme 2.13). 
 
Scheme 2.13: Synthesis of 4,4’-dichloroacetamido azobenzene, 24. 
 
Compound 24 was obtained in a 96% yield and both 1H NMR and ESI-MS data were 
consistent with the structure of the molecule. Figure 2.19 shows the 1H NMR spectrum 
of 24, which was also a symmetric compound and only showed half of the molecule in 
the spectrum. The signal of the NH protons appeared as a singlet at 10.66 ppm which 
was consistent if compared with 22 as the chlorine atom is more electronegative and 
shifted the NH proton to lower field (higher frequency); the aromatic CH protons 
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appeared as two doublets at 7.89 ppm and 7.82 ppm which was also consistent if 
compared with 22 due to the similarity of their chemical environment; the CH2 protons 
attached to the chlorine atoms appeared as a singlet at 4.33 ppm, which was expected 
due to the deshielding provoked by the high electronegativity of the chlorine. The 
spectrum was run in DMSO-d6 which appeared at 2.51 ppm, and traces of H2O were 
seen at 3.35 ppm as part of the solvent. ESI-MS (negative-mode ion) analysis of 24 
showed m/z 362.9 [M]. The isotopic effects of the chlorine atom was indicative that 
the azobenzene 24 had the chlorine attached to the molecule and showed the highest 
intensity at the 35Cl-35Cl peak (Figure 2.20). 
 
Figure 2.19: 1H NMR spectrum of 24 and assignation of the proton signals. 
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Figure 2.20: Expansion of the ESI-MS (negative-mode ion) spectrum of 24 where the isotopic effects 
caused by the chlorine atom show different ratio according to the abundance of the isotopes in nature 
35Cl (75.8%) and 37Cl (24.2%). 
 
Figure 2.21 shows the overlayed 1H NMR spectra of 22 (black), 23 (red) and 24 (blue) 
for direct visual comparison of the proton signals of the different chemical groups in 
the molecules. There was clear evidence of some transformations from 22 to 24. For 
instance, the CH3 signal in 22 shifted to a higher frequency when converted into CH2Cl 
in 24. As previously explained, this was caused by the deshield effect of the CH2 group 
due to the high electronegativity of the chlorine atom. This effect extended to the NH 
protons when going from 22 to 24, however it was not as strong since the spacing 
between NH and Cl was bigger than the spacing between CH2 and Cl. When comparing 
22 and 24 with 23, the aromatic protons shifted to a lower frequency. Again, the 
effects of the substituents directly attached to the phenyl rings were responsible for 
these changes. Whilst the acetyl or chloroacetyl groups are electron-releasing groups, 
hence the deshield effect shifted the aromatic protons to higher frequency, the amine 
groups are electron-donor and shifted the protons closer to them to a much lower 
frequency. The aromatic protons near the azo group were less affected by these 
changes. 
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Figure 2.21: Overlayed 1H NMR spectra of 22, 23 and 24 and assignation of the proton signals. 
 
2.3.2 UV/Vis spectroscopy for photoisomerization testing 
As previously discussed in Section 1.5.2, the trans isomers of azobenzene derivatives 
are their most stable conformation and can photoisomerize to their cis isomers upon 
UV irradiation. Therefore, a UV/Vis analysis of 24 would be useful to confirm the 
presence of the azo bond in the molecule. Figure 2.22 represents both trans and cis 
isomers of 24 upon UV-Vis radiation. Both conformational structures should switch 
from trans-to-cis upon irradiation with UV light (380 nm), and should return to the 
trans isomer upon irradiation with visible light (450 nm) or by thermal heating.  
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Figure 2.22: Photoisomerization of 24 by irradiation with UV/Vis light. 
 
Figure 2.23 shows the UV/Vis spectra recorded after irradiating compound 24 (in 
DMSO) at both 380 nm and 450 nm. The initial UV/Vis spectrum, prior to any 
irradiation, showed the characteristic bands of absorption of an azobenzene derivative 
in its trans isomer (blue line). As discussed in Section 1.5.2 these bands are low lying n 
→ π* bands between 380 and 520 nm, while the π → π* bands appear at around 330 
nm for the trans isomer and at around 275 nm for the cis isomer. Our azobenzene 24 
showed a maximum of absorption, corresponding to a π → π* band, at 367 nm in the 
trans isomer. After irradiating 24 at 380 nm for 10 min, another UV/Vis measurement 
was recorded (red line). The band at 367 nm disappeared and seemed to be decreased 
and shifted to 330 nm, making 270 nm the maximum of absorbance for the cis isomer 
as previously described. This was a clear sign of the photoisomerization of our 
azobenzene derivative 24. Irradiation of the cis isomer with 450 nm light for another 
10 min returned cis-(24) to the trans conformational state (green line), however this 
was insufficient to return most of the molecules to the trans conformational state. 
Thus, irradiation at 450 nm for another 20 min was done and another spectrum 
recorded (purple line). As seen in Figure 2.23, this last irradiation was enough to return 
most of the molecules to the initial trans-conformational state. 
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Figure 2.23: Overlayed UV/Vis spectra of the conformational switching (trans-to-cis and cis-to-trans 
isomerization) of 4,4’-dichloroacetamido azobenzene (24) 0.05 mM in DMSO. 
 
2.4 Summary 
We successfully synthesized unnatural amino acids for metal-binding investigations: 
Fmoc-2-Pal-OtBu (8), Fmoc-3-Pal-OtBu (9), Boc-2-Pal-OBn (11) and Boc-3-Pal-OBn (12). 
These will be incorporated into our designed self-assembling peptide sequences by 
SPPS methods. They will provide binding sites for metal-binding and will test the ability 
of a metal complex to modify the initial conformations of the peptide assemblies. On 
the other side, we were also able to synthesize an azobenzene derivative (4,4’-
dichloroacetamido azobenzene, 24) for photoswitching investigations, representing an 
alternative to metal-binding as a tool to generate conformational switch within 
peptide structures. The azobenzene derivative will be attached to our peptide designs 
through the thiol groups of Cys residues. This will help to investigate whether the 
photoisomerization of this switch, when attached to the peptide structure, can 
generate conformational changes to the structure of different peptide assemblies. 
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Chapter 3 
Development of a chassis for de novo 
coiled-coil self-assembling peptide 
systems 
3.1 Overview 
As shown in Section 1.3, there is enough information for the design and construction 
of α-helical coiled-coil structures based on the rules-of-thumb which relate protein 
sequence and structure in coiled-coil domains. When considering the chemical 
synthesis of a peptide, we should aim for an approach which gives speed and simplicity 
for the synthesis. A linear stepwise synthesis – that is, one which the target is built one 
amino acid at a time as a single peptide strand – is conceptually simple and affords 
control over the incorporation of modifications within the sequence. Solid phase 
peptide synthesis (SPPS) is the methodology followed for the successful synthesis of 
our designed peptides and involves the appropriate choice of a solid support on to 
which the peptide sequence is going to be built (see Section 3.2). 
 
3.2 Introduction to Solid Phase Peptide Synthesis (SPPS) 
SPPS is the standard strategy used for the chemical synthesis of peptide sequences. A 
stepwise approach utilizing solid-phase Fmoc chemistry was adopted to proceed with 
the chemical transformations which were carried out on a solid support. SPPS presents 
advantages over solution-phase peptide synthesis, in particular in longer sequences 
where repetition of coupling and deprotections cycles are labour intensive, and often 
require purification of the intermediates. In addition, the use of a solid support in SPPS 
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allows the individual peptide coupling reactions to be pushed to completion through 
the use of excess reagents and multiple couplings. 
SPPS proceeds via repeating cycle of coupling and deprotections steps which are 
assisted by microwave (MW) energy as this decreases reaction times and improves on 
the crude product yield and purity (Scheme 3.1). These reaction steps proceed inside a 
PTFE reaction vessel where the resin is left to swell in the appropriate solvent 
(dichloromethane, DCM, or dimethylformamide, DMF, in our synthesis) for a minimum 
time of 2 hours prior to any amino acid additions. A solution of the amino acid to be 
coupled together with an activating agent is then added and coupled with MW heating 
and agitation by bubbling nitrogen gas. Unreacted amino acids are removed by 
draining the solution-phase from the reaction vessel. The coupled amino acids are 
Fmoc-deprotected by addition of base – this is a 20% (v/v) solution of piperidine in 
DMF – and the subsequent amino acid is added to the growing peptide sequence. 
Upon completion of the sequence, the cleavage of the peptide from resin is achieved 
by treating the acid-labile peptide-resin with a trifluoro acetic (TFA) solution (in our 
case, with triisopropylsilane, TIPS, as scavenger to avoid undesirable acid-catalysed side 
reactions of the peptide) and this solution is shaken for a minimum of 3 hours at room 
temperature. The TFA solution also serves to remove side chain protecting groups 
present on amino acid side chains. For N-acetylation when capping peptides, the 
peptide-resin is suspended in a 20% (v/v) solution of acetic anhydride in DMF and 
shaken for 30 min before rinsing, DMF washing and rinsing again before TFA cleavage. 
All steps of the synthesis were run on a CEM Liberty1 automated peptide synthesizer 
equipped with a Discover microwave. Single couplings were carried out with activation 
using 5 equivalents of Fmoc amino acid under the default conditions (75 ˚C, 10 min). 
Removal of the Fmoc group was effected via treatment with 20% piperidine for 3 min 
with microwave assistance (75 ˚C) (see Section 7.2.2 for experimental details of SPPS). 
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Scheme 3.1: Outline of the general procedure for Fmoc-SPPS. 
 
The solid support 
Careful selection of both the resin polymer and the linker type is crucial for an efficient 
peptide synthesis. The most common used polymers are polystyrene, poly(ethylene 
glycol) (PEG), PEG hybrid polystyrene, and polyamide (PA), each with different swelling 
properties in various solvents.1 For the linkers (Figure 3.1) either a hydroxyl group (for 
an “acid resin”) or amine group (“amide resin”) on the linker is used to anchor the C-
terminal amino acid onto the resin via an esterification or amide bond formation 
respectively during the initial resin loading. After elongation the peptide is cleaved 
from resin using 95% TFA (Section 7.2.2) to give either a peptide acid or peptide amide 
(depending on whether an acid or amide resin is used). 
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Figure 3.1: Commonly used linkers for Fmoc SPPS. For Rink amide the C-terminal amino acid is attached 
via coupling to an amine, for Wang a hydroxyl group is used. 
 
3.3 Synthesis of peptide sequences and discussion 
3.3.1 Introduction to the design of coiled-coil systems 
We aim to synthesize peptides with reasonable stability to produce a range of 
potential variants: (i) a blunt-ended coiled-coil; (ii) a sticky-ended fibre assembly 
similar to the SAF peptides to examine whether metal-binding can affect the 
morphology of the fibres; and (iii) a sticky ended assembly in the manner of the 
peptide nanostructures. The design principles are as follows: 
a) We need a specifying polar residue to promote parallel dimer formation and to 
produce the sticky-ended coiled-coils (for enthalpic reasons the blunt-ended 
coiled-coil is always favourable unless the structure is heavily biased). 
b) We need to use charge repulsion to prevent the formation of homo dimers 
(entropically favourable unless designed against). 
c) We need four heptads of coiled-coil at least in order to provide reasonable 
stability particularly in the case of sticky-ended fibre assembly in the manner of 
SAF peptides. 
d) At least two locations for metal binding amino acids must be found and be 
separate from the functional areas of the coiled-coil (including core residues, 
charged residues and chromophores). 
e) Each peptide should have a net charge (to help solubility) and the complex 
should have an overall charge of +1 (to mimic the SAF system). 
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3.3.2 Synthesis of peptide sequences for coiled-coil formation 
With all these requirements, the initial designed sequence Peptide1 (PEP1, 25), its 
blunt-ended partner (BEP, 26) and sticky-end partner (SAF, 27) are as indicated in 
Figure 3.2, and their interaction mode is represented in Figure 3.3 for (PEP1+BEP) – 
taken from Section 1.4, Figure 1.10 – and Figure 3.4 for (PEP1+SAF). 
                 gabcdefgabcdefgabcdefgabcdef 
PEP1  KIAALKQKNAALKQEIAALEYEIEALEQ 
BEP  EIAALEYENAALEQKIKALKQKIKALKQ 
SAF  KIKALKQKIKALKQEIAALEYENAALEQ 
 
Figure 3.2: Sequences of PEP1, BEP and SAF. In PEP1, amino acids for salt-bridging formation are 
highlighted in red, while in green for BEP and SAF. Positions a to f of the heptads are showed above the 
sequences and different tones of colour are used to highlight different heptads (4 heptads in total). Asn 
is placed in positions a of the third heptad to favor dimeric coiled-coil formation as explained in Section 
1.3. 
 
 
 
Figure 3.3: Interaction of sequences PEP1 and BEP for dimeric coiled-coil formation. Amino acids for 
salt-bridging formation are highlighted in red in PEP1 while in green in BEP and the red arrows indicate 
at where this happens – which is between positions e and g of complementary peptide sequences. 
Positions a to f of the heptads are showed above and below the sequences. Asn interactions is indicated 
in yellow. A wheel diagram of the heptads with both complementary sequences interacting is 
represented at the right-hand side of the figure with the hydrophobic residues (a and d) depicted in blue 
and the solvent-exposed residues (b, c and f) in grey. 
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Figure 3.4: Interaction of sequences PEP1 and SAF for dimeric coiled-coil fibre formation. Amino acids 
for salt-bridging formation are highlighted in red in PEP1 while in green in SAF and the red arrows 
indicate at where this happens between positions e and g of complementary peptide sequences. 
Positions a to f of the heptads are showed above and below the sequences. Asn interactions are 
indicated in yellow. 
 
The synthesis of peptides 25, 26 and 27 was successfully accomplished by automated 
Fmoc-MW-SPPS and purification by RP-HPLC afforded all the peptides with high purity 
as shown by MALDI-MS analysis. PEP1 (25) was first synthesized on low loaded Fmoc-
Gln(Trt)-wang resin (0.59 mmol/g substitution) at a 0.05 mmol scale following peptide 
synthesis – procedure 1 (Section 7.2.3) to afford 78 mg of crude peptide (50%). When 
25 was synthesized at a 0.10 mmol scale, following peptide synthesis – procedure 2 
(Section 7.2.3), the crude yield increased to 75% affording 235 mg of crude peptide. 
RP-HPLC of the crude peptide affords the pure peptide highly pure as determined by 
HRMS analysis (HRMS values are shown in Section 7.5). Figure 3.5 shows the MALDI 
spectrum of the crude PEP1 at the left and the MALDI spectrum of the pure PEP1 after 
RP-HPLC purification at the right. 
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Figure 3.5: MALDI-TOF MS spectra of PEP1 (25) before HPLC purification (at the left side) and after RP-
HPLC purification (at the right). 
 
Figure 3.6 shows the MALDI spectrum of PEP1 after RP-HPLC purification, indicating 
the peaks found to confirm the presence of 25: MALDI-TOF MS m/z 3127.5 [M]+, 
3128.5 [M+H]+, 3149.6 [M+Na]+, 3151.5 [M+H+Na]+. 
 
Figure 3.6: MALDI-TOF MS spectrum of PEP1 (25). The molecular weight and different ions for the 
possible detectable species is at the top right corner. On the spectrum, detected ions are indicated. 
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Analytical RP-HPLC of the pure peptide 25 using a linear gradient of 0-100% of solvent 
B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in Section 7.1.4 – 
over 30 min was useful to confirm the presence of a single peptide sequence, and 
showed a retention time at 15.18 min (Figure 3.7). 
 
Figure 3.7: Analytical RP-HPLC chromatogram of PEP1 (25) at 280 nm. 
 
BEP (26) was synthesized on low loaded Fmoc-Gln(Trt)-wang resin (0.59 mmol/g 
substitution) at a 0.05 mmol scale following peptide synthesis – procedure 1 (Section 
7.2.3) affording 90 mg of crude peptide (57%). Figure 3.8 shows the MALDI spectrum 
of BEP after RP-HPLC purification: MALDI-TOF MS m/z 3183.5 [M]+, 3184.5 [M+H]+. 
 
Figure 3.8: MALDI-TOF MS spectrum of BEP (26). The molecular weight and different ions for the 
possible detectable species is at the top right corner. On the spectrum, detected ions are indicated. 
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As for peptide 25, analytical RP-HPLC of the pure peptide 26 using a linear gradient of 
0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained 
in Section 7.1.4 – over 30 min was also useful to confirm the presence of a single 
peptide sequence, showing a retention time at 13.86 min (Figure 3.9). Since PEP1 (25) 
showed a retention time at 15.18 min using the same linear gradient, we conclude that 
peptide 25 is more hydrophobic than 26. 
 
Figure 3.9: Analytical RP-HPLC chromatogram of BEP (26) at 280 nm. 
 
SAF (27) was initially synthesized on low loaded Fmoc-Gln(Trt)-wang resin (0.59 
mmol/g substitution) at a 0.05 mmol scale, using peptide synthesis – procedure 1 
(Section 7.2.3) to afford 72 mg of crude peptide (45%). When synthesising 27 at a 0.10 
mmol scale, following peptide synthesis – procedure 4 (Section 7.2.3) the crude yield 
increased to give 235 mg of crude peptide (74%). Figure 3.10 shows the MALDI 
spectrum of SAF after RP-HPLC: MALDI-TOF MS m/z 3183.3 [M]+, 3184.3 [M+H]+, 
3206.4 [M+Na]+. 
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Figure 3.10: MALDI-TOF MS spectrum of SAF (27). The molecular weight and different ions for the 
possible detectable species is at the top right corner. On the spectrum, detected ions are indicated. 
 
Analytical RP-HPLC of the pure peptide 27 using a linear gradient of 0-100% of solvent 
B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in Section 7.1.4 – 
over 30 min (as used for 25 and 26), confirmed the presence of a single peptide 
sequence, showing a retention time at 13.50 min (Figure 3.11). Since PEP1 (25) 
showed a retention time at 15.18 min, and BEP (26) at 13.86 min using the same linear 
gradient, we conclude that SAF (27) is the most hydrophobic of all these three 
peptides. 
 
Figure 3.11: Analytical RP-HPLC chromatogram of SAF (27) at 280 nm. 
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CD analysis of the mixtures (PEP1+BEP) and (PEP1+SAF) at equal concentrations of 
each peptide provided information about the α-helical folding state of both systems. 
Measurements of both the single peptides 25, 26 and 27, and their mixtures (25+26) 
and (25+27) were carried out in PBS buffer at pH 7.4 at different concentrations of 20, 
50, 100 and 200 µM to investigate if the self-assembly of the peptides and peptide 
systems depended on the concentration. However, all results at all concentrations for 
all these experiments indicated that both the single peptides and their corresponding 
mixtures were insensitive to concentration when promoting α-helical conformations. 
In this section, we only show the results of the CD spectra at 100 µM of peptides 25, 
26, 27 and the CD spectra at 100 µM of their corresponding mixtures (25+26) and 
(25+27). We used room temperature (21 ˚C) as we had troubles with the temperature 
controller regulator and 21 ˚C was the temperature found in the room and read by the 
instrument. All the CD spectra at different concentrations can be found in the 
Appendices.  
Figure 3.12 shows the CD spectra at room temperature (21 ˚C) of PEP1 (25) in blue, 
BEP (26) in orange and their (1:1) mixture (PEP1+BEP) in green for coiled-coil 
formation, each of them at a concentration of 100 µM. The dotted green line shows an 
average of the single CD spectra of PEP1 and BEP as a prediction for no interaction 
between these peptides. PEP1 alone shows a minimum at 198 nm which is indicative 
that it does not predominantly have an α-helical but a random conformation. BEP 
alone shows two negative bands at 203 nm and 222 nm, intermediate between helical 
and disordered forms of the peptide. Upon mixture of both peptides, a clear 
interaction is denoted since two negative bands at 208 nm and 222 nm appear in the 
spectrum. These correspond with the same wavelength as for the typical CD spectrum 
of a coiled-coil structure. However, the θ222nm (ellipticity at 222 nm) should have a 
similar or higher absolute value than the θ208nm (ellipticity at 208 nm) in a fully folded 
α-helical coiled-coil structure. Thus, this indicates that the structure formed in the 
mixture (25+26) is not 100 % α-helical (only a 37.1 %) but contains other secondary 
structure elements.  
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Figure 3.12: CD spectra of 100 µM solutions of PEP1 (25), BEP (26) and (PEP1+BEP) (25+26) in PBS buffer 
at pH 7.4 at 21 ˚C.  
 
Figure 3.13 shows the CD spectra at room temperature (21 ˚C) in PBS at pH 7.4 of PEP1 
(25) in blue, SAF (27) in orange and their (1:1) mixture (PEP1+SAF) in green for coiled-
coil formation, each of them at a concentration of 100 µM. The dotted green line 
shows an average of the single CD spectra of PEP1 and BEP as a prediction for no 
interaction between these peptides. As in the previous case, PEP1 alone shows a 
minimum at 198 nm indicating that does not fold as an α-helix. SAF alone also shows a 
negative bands at 200 nm denoting the lack of an α-helical structure. When PEP1 and 
SAF are mixed together, an interaction is observed as the negative band shifts to 202 
nm. However, this is a clear evidence that a full α-helical conformation is not achieved. 
We conclude that the mixture of (PEP1+SAF) only forms a random coil and it is unable 
to form an α-helical coiled-coil as required. 
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Figure 3.13: CD spectra of 100 µM solutions PEP1 (25), SAF (27) and (PEP1+SAF) (25+27) in PBS buffer at 
pH 7.4 at 21 ˚C. 
 
Table 3.1 summarises different data obtained at pH 7.4 from peptides 25, 26 and 27 
and their mixtures (25+26) and (25+27) at 100 µM in PBS at 21 °C. The helical contents 
of each peptide were calculated using the assumption that 100% helix gives a value of 
(-40000)*[(n-4)/n] where n is the number of residues in the peptide.2 The percentage 
of helicity were calculated by using θ222 / [100% helix x (1-(2.57/n))].3 The same type of 
data obtained at different concentrations for each one of the peptides and peptide 
mixtures can be found in the Appendices. 
100 µM, pH 7.4 θ222nm(deg mol-1 cm2) θ222nm/ θ208nm % helicity 
PEP1 (25) -2292.99 0.31 7.4 
BEP (26) -8213.04 0.67 26.4 
SAF (27) -3122.39 0.46 10.0 
PEP1 + BEP (25+26) -13132.60 0.83 37.1 
PEP1 + SAF (25+27) -2556.91 0.41 7.2 
Table 3.1: Summarised data obtained at pH 7.4 from peptides 25, 26 and 27 and the mixtures (25+26) 
and (25+27) at 100 µM in PBS at 21 °C. 
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When looking at our peptide sequences and comparing them to the coiled-coil fibrous 
systems reviewed in the literature,4,5,6 we found that these were double capped – this 
means N-terminal acetylated and C-terminal amidated. Since our peptide sequences 
have free both N- and C-terminus – this means in the form –NH3+ and –OH- at pH 7.4 – 
we attribute our results to the lack of both chemical groups (acetyl and amide) at the 
end of the sequences as they could provide a higher and more stable interaction 
between sequences for dimeric coiled-coil formation. As discussed in Section 1.2, the 
charged free ends may cause repulsive interactions between the sequences that avoid 
α-helical coiled-coil formation. Therefore, we decided to double capping both PEP1 
and BEP sequences – renaming them as c-PEP1 (28) and c-BEP (29) – and leave SAF as 
firstly designed as we believed that 28 and 29 would provide enough stability for 
interaction and for coiled-coil formation when mixed with SAF. In addition, we thought 
that PBS might have a high percentage of salts that were interacting with our peptide 
sequences and could hinder the formation of coiled-coils. Thus, having a buffer 
solution with less salts than PBS could facilitate the formation of α-helical coiled-coil 
structures and also fibres for the (PEP1+SAF) mixture. As MOPS had been successfully 
utilized for the systems reviewed in the literature (references 4-6), a 10 mM solution of 
MOPS buffer at pH 8.5 was prepared and used in the CD measurements of these new 
peptides and peptide combinations. 
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Figure 3.14 shows the MALDI spectrum of c-PEP1 (28) after RP-HPLC purification: 
MALDI-TOF MS m/z 3191.5 [M+Na]+, 3207.4 [M+K]+.  
 
Figure 3.14: MALDI-TOF MS spectrum of c-PEP1 (28): CH3O-KIAALKQKNAALKQEIAALEYEIEALEQ-NH2. The 
molecular weight and different ions for the possible detectable species is at the top right corner. On the 
spectrum, detected ions are indicated. 
 
As previously, analytical RP-HPLC of the pure peptide 28 using a linear gradient of 0-
100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in 
Section 7.1.4 – over 30 min was useful to confirm the presence of a single peptide 
sequence, and showed a retention time at 15.86 min (Figure 3.15). If we compare 28 
to its analogue 25 (retention time at 15.18), we observe that double capping the 
peptide sequence provokes a small increase in the hydrophobicity of the peptide. 
 
Figure 3.15: Analytical RP-HPLC chromatogram of c-PEP1 (28) at 280 nm. 
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Figure 3.16 shows the MALDI spectrum of c-BEP after RP-HPLC purification: MALDI-
TOF MS m/z 3224.7 [M]+, 3225.7 [M+H]+, 3246.7 [M+Na]+. 
 
Figure 3.16: MALDI-TOF MS spectrum of c-BEP (29): CH3O-EIAALEYENAALEQKIKALKQKIKALKQ-NH2. The 
molecular weight and different ions for the possible detectable species is at the top right corner. On the 
spectrum, detected ions are indicated. 
 
The analytical RP-HPLC of the pure peptide 29 using a linear gradient of 0-100% of 
solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in Section 
7.1.4 – over 30 min was also used to confirm the presence of a single peptide 
sequence, and showed a retention time at 14.68 min (Figure 3.17). As when comparing 
25 and 28, capping the initial 26 to convert it into 29 also makes the hydrophobicity 
slightly higher. However, as when comparing 25 and 26, their analogues 28 and 29 also 
show the same tendency and 29 remains slightly more hydrophilic than 28. 
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Figure 3.17: Analytical RP-HPLC chromatogram of c-BEP (29) at 280 nm. 
 
CD analysis of the mixtures (c-PEP1+c-BEP) and (c-PEP1+SAF) showed more folding as 
anticipated. Measurements at 100 µM and 200 µM of the single peptides were carried 
out in MOPS buffer (10 mM) at pH 8.5 as to investigate the effect of the concentration 
on the self-assembly. However, no signs of dependence on the concentration were 
seen. The peptide mixtures were measured at 100 µM under the same conditions. As 
previously mentioned, in this section, we only show the CD spectra for 100 µM 
solutions of peptides 28, 29, 27 and their corresponding mixtures. As we chose 21 °C as 
the temperature conditions for our measurements, this is the temperature shown in 
our results. The CD spectra of the single peptides at 200 µM at pH 8.5 and 21 °C can be 
found in the Appendices together with the CD measurements of the single peptides 
and their mixtures at 100 µM in 10 mM MOPS at pH 8.5 and at 10 °C since coiled-coils 
are generally more folded at this temperature. 
Figure 3.18 shows the CD spectra at room temperature (21 ˚C) of 28, 29 and their 
mixture for coiled-coil formation, each of them at a concentration of 100 µM. In this 
case, c-PEP1 (blue line) shows two negative bands at 208 nm and 222 nm typical of an 
α-helical peptide structure, with the absolute value at 208 nm slightly higher than the 
one at 222 nm. The same effect is observed in the CD spectrum of c-BEP (orange line). 
The dotted green line represents the average of the CD spectra of both peptides alone 
as a prediction for no interaction between them. When observing the CD signal of their 
mixture (green line), there exists a clear evidence of interaction between both of them. 
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The absolute value of θ222nm becomes slightly higher than the one at θ208nm this being a 
sign of α-helical coiled-coil formation. 
 
Figure 3.18: CD spectra of 100 µM solutions of c-PEP1 (28), c-BEP (29) and (c-PEP1+c-BEP) (28+29) in 10 
mM MOPS buffer at pH 8.5 and at 21 ˚C. 
 
Thermal denaturation experiments were carried out to investigate the degree of 
thermal stability reached after coiled-coil formation. Figure 3.19 shows an increase in 
the melting temperature (TM) after mixing peptides 28 (blue line) and 29 (orange line). 
While TM (c-PEP1) = 48.7 ˚C and TM (c-BEP) = 49.4 ˚C, their mixture (green line) 
exhibited a TM (c-PEP1+c-BEP) = 74.8 ˚C, which was a sign of higher thermal stability 
with coiled-coil formation. When looking at the curve, we found that the majority of 
this transition in which the initial helical structure was being disrupted happened in the 
range of 60 to 80 ˚C. 
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Figure 3.19: Thermal denaturation curves of 100 µM solutions of c-PEP1 (28), c-BEP (29) and their 
mixture (c-PEP1+c-BEP) (28+29) in 10 mM MOPS buffer at pH 8.5. 
 
Figure 3.20 shows the CD spectra at room temperature (21 ˚C) of 28, 27 and their 
mixture for coiled-coil and fibre formation, each of them at individual concentrations 
of 100 µM. As previously seen, c-PEP1 (blue line) showed two negative bands at 208 
nm and 222 nm typical of a peptide structure with a high degree of α-helical content, 
with the absolute value at 208 nm slightly higher than the one at 222 nm. As we 
explained before, the CD spectrum of SAF (orange line) exhibited a negative band at 
202 nm corresponding to the typical spectrum of a disordered structure. The dotted 
green line represents the average of the CD spectra of both peptides alone as a 
prediction for no interaction between them. Though, when observing the CD signal of 
the mixture (28+27) a clear evidence of interaction was seen. The association of both 
peptides (green line) exhibited an increase in the magnitude of the θ222nm minimum in 
a larger magnitude that the one at θ208nm.  This provides a value of θ222nm/θ208nm = 1.29, 
which is indicative of the promotion of α-helical coiled-coil and fibre formation. In 
addition, the θ222nm minimum showed a slight red-shift. This effect was noted in 
Bromley et al. and assigned to the chiral scattering provoked by the elongated α-
helices into bundled fibres.6 Moreover, this fibre formation was proved and supported 
by transmission electron microscopy (TEM) as showed in Figure 3.22. 
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Figure 3.20: CD spectra of 100 µM solutions of c-PEP1 (28), SAF (27) and (c-PEP1+SAF) (28+27) in 10 mM 
MOPS buffer at pH 8.5 and at 21 ˚C. 
 
Figure 3.21 shows the thermal denaturation curves of 100 µM solutions of 29 (blue 
line), 27 (orange line) and their mixture (27+29) (green line) in 10 mM MOPS at pH 8.5. 
While TM (c-PEP1) = 48.7 ˚C and TM (SAF) = 19.7 ˚C, their mixture exhibited a slightly 
higher thermal stability than the individual peptides: TM (c-PEP1+SAF) = 52.1 ˚C. The 
curve exhibited the largest change of this transition in the range of 35 to 55 ˚C.  
 
Figure 3.21: Thermal denaturation curves of 100 µM solutions of c-PEP1 (28), SAF (27) and their mixture 
(c-PEP1+SAF) (28+27) in 10 mM MOPS buffer at pH 8.5. 
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Figure 3.22 shows different views and scales of the TEM spectra of (c-PEP1+SAF): 
Image A shows an overall view of the fibres longitudinally associated on the grid at a 
10 µm scale. They look stiff thickened fibres between 6 to 36 µm length, and image B is 
a closer view from the fibres, at a 1 µm scale. Image C shows several of these fibres 
bending alongside their peptide chains at a 0.5 µm scale. Image D shows what it looks 
a longitudinally dimeric coiled-coil next to a higher order of fibre association which 
associate longitudinally (0.5 µm scale). Image E (at a 20 nm scale) shows the regular 
striation patterns seen for fibre formation previously reported by the Woolfson’s lab,5 
which are indicative of internal organization and ultrastructure, in addition to 
providing information about the width of these fibres (~ 90nm). Finally, image F (at a 
50 nm scale) shows the same pattern in multiple fibres that associate longitudinally. 
 
Figure 3.22: TEM spectra of (c-PEP1+SAF) (28+27) at different scales, in 10mM MOPS buffer at pH 8.5 at 
21 ˚C. The image’s scales range from 10 µm (in image A) to 50 nm (in image F).  
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Table 3.2 summarises different data obtained at pH 8.5 from peptides 28, 29 and 27 
and their mixtures (28+29) and (28+27) at 100 µM in MOPS at 21 °C. As explained, the 
helical contents of each peptide were calculated using the assumption that 100% helix 
gives a value of (-40000)*[(n-4)/n] where n is the number of residues in the peptide.2 
The percentage of helicity were calculated by using θ222 / [100% helix x (1-(2.57/n))].3  
100 µM, pH 8.5 θ222nm(deg mol-1 cm2) θ222nm/ θ208nm % helicity TM (°C) 
c-PEP1 (28) -19975.2 0.93 64.1 48.7 
c-BEP (29) -23545.9 1.00 75.6 49.4 
SAF (27) -7460.8 0.67 24.0 19.7 
(28+29) -27534.7 1.02 77.7 74.8 
(28+27) -8919.9 1.29 25.2 52.1 
Table 3.2: Summarised data obtained at pH 8.5 from peptides 28, 29 and 27 and the mixtures (28+29) 
and (28+27) at 100 µM in MOPS at 21 °C. 
 
Table 3.3 shows evidences of a higher folding of the peptides and peptide systems at 
10 °C compared to the folding showed at 21 °C. As anticipated, the CD spectra at 10 °C 
can be found in the Appendices. 
100 µM, pH 8.5 θ222nm (deg mol-1 cm2) 
10 °C vs. 21°C 
θ222nm/ θ208nm 
10 °C vs. 21°C 
% helicity 
10 °C vs. 21°C 
c-PEP1 (28) -21815.0 vs. (-19975.2) 0.96 vs. 0.93 70.1 vs. 64.1 
c-BEP (29) -25155.4 vs. (-23545.9) 1.03 vs. 1.00 80.8 vs. 75.6 
SAF (27) -9348.7 vs. (-7460.8) 0.74 vs. 0.67 30.0 vs. 24.0 
(28+29) -28827.7 vs. (-27534.7) 1.04 vs. 1.02 81.3 vs. 77.7 
(28+27) -10853.7 vs. (-8919.9) 1.18 vs. 1.29 30.6 vs. 25.2 
Table 3.3: Comparison of the data obtained at pH 8.5 from peptides 28, 29 and 27 and the mixtures 
(28+29) and (28+27) at 100 µM in MOPS at both 10 °C and at 21 °C to show the higher folding of the 
structures at the lower temperature. 
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3.4 Summary 
In this chapter we hence demonstrated the synthesis of the chassis for that our next 
experiments would be based on. We designed, synthesized and characterized the 
necessary peptide building blocks – c-PEP1 (28), c-BEP (29) and SAF (27) – and 
successfully tested our initial aims described in Section 3.3.1: the formation of a blunt-
ended α-helical coiled-coil from two individual peptides – (c-PEP1+c-BEP) or (28+29) – 
as well as the formation of a sticky-ended fibre assembly similar to the SAF peptides to 
examine whether metal-binding will affect the morphology of these fibres – this being 
(c-PEP1+SAF) or (28+27). 
Table 3.4 summarises all the θ222nm/ θ208nm data and percentage of helicity obtained for 
the peptides and peptide systems at different conditions of buffer solution, pH and 
temperature made in this Chapter for a quicker comparison of results. 
Peptide system Buffer and pH T (°C) θ222nm/ θ208nm % helicity 
PEP1 PBS pH 7.4 21 0.31 7.4 
c-PEP1 MOPS pH 8.5 10 0.96 70.1 
  21 0.93 64.1 
BEP PBS pH 7.4 21 0.67 26.4 
c-BEP MOPS pH 8.5 10 1.03 80.8 
  21 1.00 75.6 
 PBS pH 7.4 21 0.46 10.0 
SAF MOPS pH 8.5 10 0.74 30.0 
  21 0.67 24.0 
(PEP1+BEP) PBS pH 7.4 21 0.83 37.1 
(c-PEP1+c-BEP) MOPS pH 8.5 10 1.04 81.3 
  21 1.02 77.7 
(PEP1+SAF) PBS pH 7.4 21 0.41 7.2 
(c-PEP1+SAF) MOPS pH 8.5 10 1.18 30.6 
  21 1.29 25.2 
Table 3.4: Summary of all the peptide data obtained in this Chapter at different conditions of buffer 
solution, pH and temperature. 
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Chapter 4 
Coiled-coil self-assembling peptide 
systems susceptible to conformational 
changes upon metal-binding 
4.1 Design of coiled-coil assemblies susceptible to metal-binding 
Our discussion in Section 1.5.1 explained the possibility of controlling the self-
assembly of peptide systems by introducing motifs within the polypeptide chains with 
the ability to coordinate metal ions that would bring a conformational change in the 
secondary structure of the system. The synthesis of pyridylalanine derivatives as 
unnatural amino acids (compounds 1 to 4 from Section 2.3) would provide a reacting 
site for metal-binding. We also mentioned that one of our aims is to investigate which 
of the effects are more important in determining the final structure: the peptide 
system itself (in our case, a designed α-helical coiled-coil structure) or the metal ion 
bound to the peptide system. 
Although we successfully synthesized amino acids 1 to 4, due to requiring a bigger 
mass of unnatural amino acid for automated SPPS and the laborious synthesis and 
work up of the products for high purity, we also obtained commercially: Fmoc-3-
pyridylalanine (2) and Fmoc-4-pyridylalanine (38) amino acids (Figure 4.1). 
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Figure 4.1: Structures of the unnatural Fmoc-pyridylalanine amino acids purchased for automated SPPS 
use. 
 
When designing the initial chassis peptide sequence PEP1 (25), positions susceptible 
for conformational changes upon external stimulus were underlined (Figure 3.2 and 
Figure 4.2). These correspond to positions b, c and f of the third and fourth heptad 
repeats, which are located at the hydrophilic face of the α-helical coiled-coil peptide 
structures. Since we aim to construct both blunt-ended heterodimers and sticky-end 
partners for fibre formation upon metal-binding and to compare these results with the 
initial peptide systems showed in Section 3.3.2, PEP1 (25) is used as a template to 
swap either one or several of the underlined amino acids with one or several 
pyridylalanine amino acid derivatives. As PEP1 did not provide stable self-assembly 
with BEP and/or SAF when lacking the N-acetyl and C-amide groups at the end of their 
peptide sequences, c-PEP1 was used as the template instead. 
Figure 4.2 shows the template or chassis sequence c-PEP1 from which the subsequent 
peptide sequences susceptible for metal binding were synthesized. The names and 
compound numbers of these labelled peptides are shown next to the sequences, with 
the positions a to f of the heptads. Peptides 30 to 32 are labelled with unnatural amino 
acids at the indicated X positions. X = Pal = Pyridylalanine amino acid, being 3-Pal for 
peptides 30 to 32 and 4-Pal for peptide 33. Their partners 29 (blunt-ended) and 27 
(sticky-ended) for coiled-coil and fibre formation are also included for reference. 
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Figure 4.2: Peptide sequences for the study of metal-binding when coiled-coil formation with X being a 
pyridylalanine residue. 
 
4.2 Synthesis of peptides labelled with pyridylalanine amino acids  
The synthesis of all the pyridylalanine labelled peptides 30 to 33 was fully 
accomplished by automated Fmoc-MW-SPPS using rink amide MBHA resin at a 0.10 
mmol scale following the peptide synthesis procedure 5 from Section 7.2.3. Table 4.1 
shows all peaks found in the MALDI-TOF spectra of each of the pure peptides after RP-
HPLC purification and the retention times found in the analytical RP-HPLC injections of 
the pure peptides using a linear gradient of 0-100% of solvent B (Section 7.1.4) over 30 
min. These retention times are all slightly lower than the “template” peptide c-PEP1 
(28) which showed a retention time of 15.86 min. This indicates that all labelled 
peptides 30 to 33 are slightly more hydrophilic than 28. The similar retention times of 
the labelled peptides is a sign of their similar hydrophobicity, 33 being the most 
hydrophobic peptide followed by 30, then 32, and finally 31. From these observations 
we can conclude that insertion of a 4-pyridylalanine residue provokes a smaller effect 
with respect to decreasing the hydrophobicity of the chassis peptide (28) while 
insertion of 3-pyridylalanine residues induces a higher increase in the hydrophylicity of 
the peptides with respect to the original peptide sequence (28). 
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Peptide name 
and compound 
number 
c-3PAL14 
(30) 
c-3PAL10PAL14 
(31) 
c-3PAL7PAL14 
(32) 
c-4PAL14 
(33) 
Molecular weight 
(mw) 
3188.7 3265.9 3208.8 3188.7 
MALDI-TOF MS 
(m/z) [M]+ 
  3208.3  
MALDI-TOF MS 
(m/z) [M+Na]+ 
3211.8 3288.8 3231.2 3211.9 
MALDI-TOF MS 
(m/z) [M+H+Na]+ 
  3232.2  
MALDI-TOF MS 
(m/z) [M+2Na]+ 
3233.7  3254.3  
MALDI-TOF MS 
(m/z) [M+K]+ 
   3227.4 
Retention time 
(min) 
15.56 15.19 15.35 15.72 
Table 4.1: Peaks found in the MALDI spectra of the pure peptides 30 to 33 after RP-HPLC purification 
together with their retention times after analytical RP-HPLC injections. 
 
4.3 Formation of blunt-ended coiled-coil heterodimers 
The mixture of peptides c-PEP1 and c-BEP (28+29) produced blunt-ended coiled-coil 
heterodimers at a concentration of 100 µM in 10 mM MOPS at pH 8.5 at 21 °C. We 
expected to achieve the same results when mixing c-BEP with each one of the pyridyl-
labelled peptides 30 to 33 under the same conditions. Thus, solutions of both the 
single peptides 29 and 30 to 33, and their mixtures (29+30), (29+31), (29+32) and 
(29+33) were prepared and analysed by CD spectroscopy – and at room temperature 
(21 °C) as explained in Section 3.3.2 (page 88). These results are shown and discussed 
next. We did not measure the CD spectra of these peptides and peptide systems at 10 
°C as our measuring conditions were always room temperature because of the initial 
trouble we had with the temperature controller. However, as seen in Table 3.4 from 
Chapter 3, we thought that the chassis peptides showed enough helicity at 21 °C 
compared to the one obtained at 10°C and this would provide reliable results. 
Figure 4.3 shows the CD spectra of 100 µM solutions of c-BEP (29), c-3PAL14 (30), and 
their mixture (29+30) in 10 mM MOPS at pH 8.5 at 21 °C. As expected, and previously 
seen (Section 3.3.2), c-BEP (29) (blue line) exhibited two negative bands at 208 nm and 
222 nm. The magnitudes of their θ222nm and θ208nm values were very similar, producing 
a θ222nm/θ208nm = 1.00, indicative of an α-helical conformation. The CD spectrum of 30 
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(orange line) showed two negative bands at 208 nm and 222 nm with the absolute 
value of θ222nm slightly smaller than θ208nm and producing a θ222nm/θ208nm = 0.91. This 
indicated that peptide 30 did not have a fully folded α-helical structure (39.2 %) but 
contained some degree of disordered forms of the peptide. The dotted green line 
represents the average of the CD spectra of both peptides alone as a prediction for no 
interaction. This line compared to the CD spectrum of the mixture (29+30) (green line) 
evidences signs of interaction between peptides 29 and 30. An increase in the 
magnitude of the θ222nm minimum produced a θ222nm/θ208nm = 1.07, indicative of an 
increase in the α-helical content of the peptide structure (84.0 %) compared to the 
individual structures that 29 and 30 exhibited when alone. Therefore, we proved that 
the mixture (29+30) promoted the formation of α-helical coiled-coil heterodimers 
under these conditions. 
 
Figure 4.3: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL14 (30) and (c-BEP+c-3PAL14) (29+30) in 
10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-pyridylalanine (3-Pal) 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
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Figure 4.4 shows the thermal denaturation spectra recorded for the single peptides 29 
and 30, and their mixture (29+30) at a concentration of 100 µM in 10 mM MOPS at pH 
8.5. Whilst peptide 29 (blue line) shows a melting temperature (TM) of 50.6 ˚C and 
peptide 30 (orange line) shows a TM (30) = 36.8 ˚C, the mixture of both peptides (green 
line) shows an important increase in this temperature (TM = 69.1 ˚C). The melting point 
of the coiled-coil formed is about 20 ˚C higher than the most thermally stable of the 
single peptide components. We understand this effect as an increase of the thermal 
stability of the coiled-coil that has been formed compared to the ones for the single 
peptides. 
  
Figure 4.4: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL14 (30) and (c-BEP+c-
3PAL14) (29+30) in 10 mM MOPS buffer at pH 8.5. TM (c-BEP) = 50.6 ˚C; TM (c-3PAL14) = 36.8 ˚C; TM (c-
BEP+c-3PAL14) = 69.1 ˚C. 
 
We then prepared 100 µM solutions of c-BEP (29), c-3PAL10PAL14 (31), and their 
mixture (29+31) in 10 mM MOPS at pH 8.5. Figure 4.5 shows the CD spectra of these 
solutions at room temperature. As previously, 29 (blue line) exhibited two negative 
bands at θ222nm and θ208nm typical of an α-helical conformation. The CD spectrum of 31 
(orange line) showed two negative bands at 205 nm and 221 nm, being the absolute 
value of θ221nm smaller than θ205nm. The observed value of θ222nm/θ208nm for 31 was 
0.79, indicating that the structure of 31 had some degree of α-helical content (26.0 %) 
together with disordered forms of the peptide.  
As previously, the dotted green line represents the average of the CD spectra of both 
peptides alone as a prediction for no interaction and the green line represents the CD 
spectrum of the mixture (29+31). The CD spectrum of the mixture evidenced signs of 
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interaction between peptides as an increase in the magnitude of the θ222nm minimum 
was observed. This became slightly bigger than the magnitude of the θ208nm minimum, 
producing a θ222nm/θ208nm = 1.06, which was indicative of an increase in the α-helical 
content of the coiled-coil (67.2 %). As for the previous mixture (29+30), (29+31) was 
also able to promote the formation of α-helical coiled-coil under these conditions. 
 
Figure 4.5: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL10PAL14 (31) and (c-BEP+c-
3PAL10PAL14) (29+31) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 
3-Pal: 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
 
The thermal denaturation curve of (29+31) (Figure 4.6) demonstrated an increase in 
the thermal stability of the peptide mixture compared to the ones exhibited by the 
individual peptides. The recorded melting temperatures were: TM (29) = 50.6 ˚C (blue 
line); TM (31) = 29.2 ˚C (orange line); and TM (29+31) = 66.6 ˚C (green line). This 
indicated a large increase in the thermal stability of the peptide structure after coiled-
coil formation compared to the thermal stability shown by the individual peptides. 
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Figure 4.6: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL10PAL4 (31) and (c-
BEP+c-3PAL10PAL14) (29+31) in 10 mM MOPS buffer at pH 8.5. TM (c-BEP) = 50.6 ˚C; TM (c-
3PAL10PAL14) = 29.2 ˚C; TM (c-BEP+c-3PAL10PAL14) = 66.6 ˚C. 
 
The CD analysis at room temperature of 100 µM solutions of c-BEP (29), c-3PAL7PAL14 
(32), and their mixture (29+32) in 10 mM MOPS at pH 8.5 is shown in Figure 4.7. From 
the previous experiments, we knew that 29 (blue line) was α-helical. The CD spectrum 
of 32 (orange line) showed two negative bands at 205 nm and 222 nm, very similar to 
the CD spectrum of peptide 31. Though, these bands produced a smaller θ222nm/θ208nm 
(0.72) than the observed for 31. This indicated a decrease in the α-helical content of 32 
compared to 30 and 31. From this observations, we concluded that the insertion of 
two pyridylalanine residues within the sequence decreased the α-helical content (17.2 
%) with respect to the original peptide 28 (64.1 %). Moreover, the longer the distance 
between the unnatural amino acids in the sequence (i  i+7 in this case), the higher 
the decrease of α-helicity in the peptide structure. However, this was found for the 
single peptides and we were investigating the interaction with the blunt-ended partner 
to form α-helical coiled-coils.  
The dotted green line represents the average of the CD spectrum of 29 and 32 as a 
prediction for no interaction whilst the green line represents the CD spectrum of the 
interaction produced by the mixture (29+32). When observing the CD spectrum of the 
mixture, signs of interaction were identified by an increase in the magnitude of the 
θ222nm minimum becoming this slightly bigger than the magnitude of θ208nm. The 
formation of the coiled-coil produced a θ222nm/θ208nm = 1.09 (77.7 % helicity), indicating 
that the interaction between 29 and 32 promoted α-helical coiled-coil formation. 
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Figure 4.7: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL7PAL14 (32) and (c-BEP+c-3PAL7PAL14) 
(29+32) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-Pal 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.8 shows the thermal denaturation of 29 (blue line), 32 (orange line), and their 
mixture (29+32) (green line) at a concentration of 100 µM in MOPS (10 mM) at pH 8.5. 
As previously, TM (29) = 50.6 ˚C. The software used to obtain the TM of each of our 
peptides or peptide mixtures was unable to provide us with a TM value for 32 due to 
the shape of its melting curve. Thus, we estimated a value lower than 25 ˚C since we 
guessed a transitional change between 10 ˚C and 35 ˚C (orange line). This temperature 
was lower than the one found for peptide 31: TM (31) = 29.2 ˚C. When comparing 
peptides 31 and 32, we found that the thermal stability of 31 was higher than the one 
of 32: TM (31) > TM (32). We also saw that the secondary structure of 32 was slightly 
less α-helical than the found for 31 (17.2% vs. 26.0%). From these observations, we 
concluded that the higher degree of α-helicity in a single peptide the higher their 
thermal stability. For the mixture (29+32) we found a TM = 66.8 ˚C, being this value very 
similar to the TM obtained for the mixture (29+31) (66.6 ˚C). This evidenced an 
important increase in the melting point with respect to the structure shown by the 
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individual peptides, indicating a large increase of the thermal stability after coiled-coil 
formation. 
  
Figure 4.8: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL7PAL4 (32) and (c-
BEP+c-3PAL7PAL14) (29+32) in 10 mM MOPS buffer at pH 8.5. TM (c-BEP) = 50.6 ˚C; TM (c-3PAL7PAL14) < 
25 ˚C; TM (c-BEP+c-3PAL7PAL14) = 66.8 ˚C. 
 
Figure 4.9 shows the CD analysis at room temperature of 100 µM solutions of c-BEP 
(29), c-4PAL14 (33), and their mixture (29+33) in 10 mM MOPS at pH 8.5. Peptide 29 
(blue line) was α-helical. The CD spectrum of 33 (orange line) showed two negative 
bands at 205 nm and 222 nm, with the absolute value of θ222nm smaller than θ205nm. 
This indicated that 33 could have some α-helical content (32.3 %) together with a 
random conformation structure. The dotted green line represents the average of the 
CD spectra of both peptides alone as a prediction for no interaction between them. 
When we measured the CD spectrum of the mixture (29+33) (green line), signs of 
interaction between both peptides were observed. The absolute value of θ222nm 
became slightly bigger than the corresponding at θ208nm. This produced a θ222nm/θ208nm 
= 1.04, a sign of α-helical coiled-coil formation. 
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Figure 4.9: CD spectra of 100 µM solutions of c-BEP (29), c-4PAL14 (33) and (c-BEP+c-4PAL14) (29+33) in 
10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 4-Pal 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.10 shows the thermal denaturation spectra recorded for 29 (blue line), 33 
(orange line), and their mixture (29+33) (green line) at a concentration of 100 µM in 10 
mM MOPS 10 mM at pH 8.5. We knew that TM (c-BEP) = 50.6 ˚C. Peptide 33 showed a 
TM of 31.1 ˚C which was slightly lower than the analogous peptide 30. In principle, and 
from this data, we could say that our labelled peptide including 3-pyridylalanine was 
more thermally stable than when including 4-pyridylalanine. The mixture of 29 and 33 
recorded a TM (29+33) = 68.0 ˚C. This indicated that there was an increase of the 
thermal stability after coiled-coil formation. Thought, TM (29+30) = 69.1 showed a 
slightly higher melting point than the mixture formed by 29 and 33. From this fact we 
believed that the insertion of the unnatural amino acid 3-pyridylalanine within the 
peptide sequence produced a slightly higher thermal stability than when inserting the 
4-pyridylalanine analogue. 
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Figure 4.10: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-4PAL4 (33) and (c-BEP+c-
4PAL14) (29+33) in 10 mM MOPS buffer at pH 8.5. TM (c-BEP) = 50.6 ˚C; TM (c-4PAL14) = 31.1 ˚C; TM (c-
BEP+c-4PAL14) = 68.0 ˚C. 
 
All combinations of c-BEP (29) with each of the pyridyl-labelled peptides (30 to 33) 
exhibited signs of coiled-coil formation (Figures 4.3, 4.5, 4.7 and 4.9). In all cases, the 
magnitude of their θ222nm minimums in the mixtures increased, becoming slightly 
bigger than the magnitudes at θ208nm. This produced values of θ222nm/θ208nm higher than 
1.00 in all cases, evidencing an increase in the α-helical content – with respect to the 
individual peptides – and promoting coiled-coil formation. When observing the 
thermal denaturation curves of each of the mixtures in Figures 4.4, 4.6, 4.8 and 4.10, 
signs of interaction between the individual peptides to form self-assembled systems 
were observed by an increase of their TM. These temperatures increased in about 20 ˚C 
compared to the most thermally stable peptide component (c-BEP in all cases), and 
between 30 ˚C and 40 ˚C compared to the least thermally stable peptide component 
(the pyridyl-labelled peptides in all cases). 
Despite achieving what we considered good results as to carry on with our research, 
we wondered whether these peptide mixtures would be able to form blunt-ended 
coiled-coils at a near-physiological pH. Therefore, we prepared the same peptide 
solutions at 100 µM in 10 mM MOPS at pH 7.2 and observed their CD spectra at room 
temperature (21 °C). We saw that coiled-coils were also able to form at this pH. The 
values produced for the θ222nm/θ282nm coefficients were always equal or higher than 
1.00 as a sign of α-helical content. When running thermal denaturation experiments of 
the mixtures at this pH, evidences of interaction between peptides were observed by 
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an increase in the thermal stability of each of the peptide mixtures. Their TM values 
increased in about 30 ˚C with respect to the TM that the individual peptides exhibited. 
These spectra and the data obtained with these peptide systems are shown in the 
Appendices in Figures A4.1 to A4.8 together with a table (Table A4.1) summarising 
some peptide data obtained at these conditions at pH (7.2) compared to the same type 
of peptide data obtained at pH 8.5. 
Table 4.2 shows the obtained data of 100 µM solutions of all the individual peptides 
and peptide systems of this Section 4.3 at pH 8.5 and at 21 °C. These data consists of: 
ellipticity at 222 nm (θ222), the ellipticity ratio between 222 nm and 208 nm (θ222/θ208), 
the percentage of helicity, and the melting temperature (TM). 
Peptide or peptide 
systems 
θ222 (deg mol-1 cm2) θ222nm/θ208nm % helicity TM (°C) 
c-BEP (29) -20860.2 1.00 67.0 50.6 
c-3PAL14 (30) -12216.4 0.91 39.2 36.8 
c-3PAL10PAL14 (31) -8107.6 0.79 26.0 29.2 
c-3PAL7PAL14 (32) -5356.7 0.72 17.2 < 25 
c-4PAL14 (33) -10045.1 0.80 32.3 31.1 
(29+30) -29760.4 1.07 84.0 69.1 
(29+31) -23813.6 1.06 67.2 66.6 
(29+32) -27542.0 1.09 77.7 66.8 
(29+33) -26179.5 1.04 73.9 68.0 
Table 4.2: Peptide data obtained for 100 µM solutions of c-BEP (29), the labelled peptides (30 to 33) and 
the peptide mixtures of 29 with each one of the labelled peptides in 10 mM MOPS at pH 8.5 at 21 °C. 
 
4.3.1 Metal-binding experiments on the blunt-ended peptide systems 
After examining the effects of the interaction between the pyridyl-labelled peptides 30 
to 33 and the blunt-ended partner 29, we wanted to investigate whether the addition 
of a metal complex to the blunt-ended coiled-coil peptide systems from Section 4.3 
could provide any conformational changes in their secondary structures. Since the 
pyridyl groups are soft ligands, we needed to find a soft metal to match, as described 
by the soft-hard theory of ligand-metal coordination: soft ligands (e.g. pyridyl or thiol 
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groups) bind relatively strongly to soft metals (e.g. Pt, Au, etc). We also saw how 
Mikhail Tsurkan had successfully used platinum complexes to bind pyridyl amino acids 
in previous investigations.1,2,3 Thus, we decided to use a Pt(II) complex (K2PtCl4) in 
order to check the effects in the α-helical coiled-coil structures that we had formed. 
The platinum complex was completely soluble in the buffer solution used to record all 
the CD measurements, this is 10 mM MOPS at pH 8.5. 
We then prepared 100 µM solutions of 29 to 33 and the corresponding mixtures of 29 
with each one of them in 10 mM MOPS at pH 8.5. Several CD measurements of these 
peptide mixtures were recorded for a period of time where no spectral changes were 
observed after 48 hours. Thus, after incubation of the peptide systems for this period 
of time, volumes of 100 µL of a 100 µM solution of the metal complex were added into 
each one of the peptide mixtures, producing a total concentration of 66.7 µM. An 
initial CD measurement of the metal-peptide system was recorded and the evolution 
of these metal-peptide mixtures was monitored. Since we did not observe significant 
conformational changes in the CD spectra after 40 to 45 hours, 45 hours was the final 
recorded time. We thought that evaporation effects on the metal-peptide mixture 
provoked smooth differences in the CD signals. Thermal denaturation experiments of 
the metal-peptide systems were recorded and their thermal stability compared with 
the peptide systems without the metal additions. 
Figure 4.11 shows the CD spectrum of the mixture (29+30) 48 hours later of being 
prepared (red line). The interaction between peptides exhibited a coiled-coil structure 
with certain degree of α-helical content as determined by their θ222nm/θ208nm = 1.07 in 
this case. Upon the addition of the Pt(II) complex, no significant changes in the CD 
spectra were observed. An initial measurement showed a θ222nm/θ208nm = 1.08, 
indicating that the degree of α-helical content in the type of structure generated 
remained similar (purple line). We did not observe significant conformational changes 
after 45 hours (green line). The addition of the metal complex to the peptide structure 
did not trigger any conformational change in the secondary structure, indicating that 
metal-binding is compatible with coiled-coil formation. We thought, therefore, that 
the peptide system was energetically more favourable in the initial conformation and 
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that the peptide assembly was the driving force to dictate the conformation of the 
system. 
  
Figure 4.11: CD measurements of 100 µM (c-BEP+c-3PAL14) (29+30) in 10 mM MOPS at pH 8.5 at 21 ˚C 
and the metal-binding effects after addition of K2PtCl4. 
 
Figure 4.12 shows the thermal denaturation curves 100 µM solutions of 29 (blue line), 
30 (orange line), (29+30) (green line) and the metal-peptide mixture (29+30+Pt(II) 
(yellow line) in 10 mM MOPS at pH 8.5. The melting points seemed to be similar for 
the peptide mixtures before and after the addition of the metal complex, with TM 
(29+30+Pt(II)) = 70.2 ˚C, this being indicative that metal-binding did not create 
conformational changes as previously mentioned. 
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Figure 4.12: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL14 (30), their 
mixture (29+30) and the mixture with K2PtCl4 (29+30+Pt(II)) in 10 mM MOPS buffer at pH 8.5. TM (29) = 
50.6 ˚C; TM (30) = 36.8 ˚C; TM (29+30) = 69.1 ˚C; TM (29+30+Pt(II)) = 70.2 ˚C. 
 
Figure 4.13 shows the CD spectra of the metal-binding experiments of the remaining 
100 µM peptide mixtures of 29 with 31, 32 and 33. This exhibited the same tendency 
as the mixture (29+30) upon metal-binding with the Pt(II) complex: no significant 
conformational changes were observed. These spectra together with their thermal 
denaturation experiments can be found in the Appendices (Figures A4.9 to A4.14). 
 
Figure 4.13: CD spectra of 100 µM solutions in 10 mM MOPS at pH 8.5 and at 21 ˚C of (A) (29+31); (B) 
(29+32); and (C) (29+33), and their metal-binding experiments with K2PtCl4. The red lines represent the 
first CD measurement of the peptide mixtures after being incubated for 48 hours. The purple lines 
represent the CD measurements in the initial time of the Pt(II) addition, the blue lines after 15 hours, 
the yellow lines after 20 hours, and the green lines after 45 hours. 
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Table 4.3 shows the TM of the 100 µM solutions of the metal-peptide systems in 10 
mM MOPS at pH 8.5 before and after the addition of the metal complex to 
demonstrate that metal-binding did not create conformational changes that affected 
their thermal stability. 
Peptide 
system 
TM (˚C) Peptide system 
(metal-binding) 
TM (˚C) 
(29+30) 69.1 (29+30+Pt) 70.2 
(29+31) 66.6 (29+31+Pt) 65.0 
(29+32) 66.8 (29+32+Pt) 70.7 
(29+33) 68.0 (29+33+Pt) 68.5 
Table 4.3: TM 100 µM solutions in MOPS at pH 8.5 of each one of the peptide systems of c-BEP (29) with 
the pyridyl labelled peptides (30 to 33) before and after metal-binding the Pt(II) complex. 
 
The metal-peptide mixtures were also prepared at a concentration of 50 µM in 10 mM 
MOPS at pH 8.5 and their CD spectra recorded at 21 ˚C. This was measured only to test 
whether the concentration could affect the metal-binding in these type of peptide 
structures. However, the same behaviour as for the samples at 100 µM was found and 
no signs of concentration dependency was observed. Since the CD spectra recorded for 
the last hours did not show any significant conformational changes, the incubating 
times for these peptide mixtures was reduced. These CD spectra can be found in the 
Appendices (Figures A4.15 to A4.18) and the incubating times indicated. 
As a conclusion from all these set of metal-binding experiments with the blunt-ended 
coiled-coil heterodimers, we found that the peptide assemblies dictated the final 
structure of the peptide system and the addition of the Pt-complex did not appear to 
trigger any conformational change. The assembly provided by the association between 
peptides may be more energetically favourable than the possible structure produced 
by a conformational switch induced by the metal ion. All the peptide systems were 
more thermally stable after coiled-coil formation than the individual peptides as 
indicated by their TM. In addition, the TM of the metal-peptide structures exhibited a 
similar value to the one shown by the peptide structures without the metal additions. 
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4.4 Formation of sticky-ended coiled-coils 
Similar to what we achieved in Section 4.3, we wanted to test whether the pyridyl-
labelled peptides 30 to 33 – which were modifications of the c-PEP1 (28) sequence – 
were able to interact with SAF (27) as sticky-ends heterodimers and form fibres in the 
same mode as the mixture (28+27) was able to achieve it. The peptide mixtures to test 
for fibre formation were as follows: (27+30), (27+31), (27+32) and (27+33). These were 
prepared at a concentration of 100 µM in 10 mM MOPS at pH 8.5 and at 21 °C (room 
temperature) and their CD spectra are discussed next. However, to avoid having many 
spectra lines within the same figures, here we only show the CD spectra of the peptide 
mixtures and their evolution with the time. The last recorded time was 24 hours in all 
cases as this was the time when the peptide mixtures stopped exhibiting significant 
conformational changes. The CD spectra of the individual peptides prior to the mixture 
and after being mixed at both the initial time and after incubation for 24 hours are 
shown in the Appendices in Figures A4.19 to A4.22. 
Figure 4.14 shows the CD measurements of a 100 µM solution of (27+30) in 10 mM 
MOPS at pH 8.5 at different intervals of time for 24 hours. The evolution of the CD 
signal obtained over time is prominent. From these results, we concluded that the 
fibrillogenesis process was time dependent. Thus, when observing the CD spectrum of 
the mixture at an initial time (red line), the magnitude of the θ222nm and θ208nm 
minimums indicated the formation of a partially folded α-helical structure together 
with some degree of random coiled-coil. Within the first two hours (yellow line) the CD 
spectrum became completely α-helical, showing a θ222nm/θ208nm = 1.17, typical of an α-
helical coiled-coil structure with promotion to form fibres. After 8 hours (blue line), the 
tendency continued exhibiting a larger decrease in the magnitude of the θ208nm 
minimum and a red shift of the band at θ222nm. As previously discussed in Section 3.3.2, 
this effect had already been visualized by Bromley et al.4 and was assigned to the chiral 
scattering provoked by the helices bundling in the fibres. After 20 hours, the change in 
spectrum became less noteworthy, with 24 hours being the last measurement time 
(green line) (θ222nm/θ208nm = 1.40). 
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After leaving the mixture (27+30) to mature the fibres for 24 hours, they had thicken 
and lengthen enough to be clearly detected by CD spectroscopy. We were also able to 
see by eye the formation of a blurred white precipitated within the cuvette. The 
appearance of these aggregates were not visible in the initial solution mixtures which 
appeared to be transparent. Figure 4.15 shows a fresh prepared mixture of (27+30) at 
100 µM in MOPS at pH 8.5 compared to a three days old mixture of a 100 µM mixture 
of (27+30) at the same conditions of pH. 
  
Figure 4.14: CD measurements at different times for a period of 24 hours of 100 µM (SAF+c-3PAL14) 
(27+30) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-Pal 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
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Figure 4.15: Visual comparison of 100 µM solutions of (SAF+c-3PAL14) (27+30) in 10 mM MOPS buffer 
at pH 8.5 at 21 ˚C at different times of their maturing process: just prepared sample at the left hand side 
vs a three-days old sample. 
 
We found that incubating a 100 µM solution of the mixture (27+30) for 24 hours was 
enough to observe the formation of both α-helical coiled-coils and fibrous structures 
that could be detected by CD spectroscopy. Thus, we decided to use the same 
conditions in each of the remaining mixtures of the pyridyl-labelled peptides (31, 32 
and 33) with the SAF partner (27) and check whether they were also able to provide 
similar results. 
Figure 4.16 shows the CD measurements of a 100 µM solution of (27+31) in MOPS at 
pH 8.5 recorded at different times for 24 hours. The mixture (27+31) did not show a 
fully folded α-helical coiled-coil pattern. The magnitude of the θ222nm minimum was 
never able to reach the same or a higher value than the negative band at θ208nm. 
Neither the freshly prepared sample (red line) nor the incubated sample after one day 
(green line) exhibited signs of α-helical coiled-coil formation or fibre formation by CD 
spectroscopy. However, as in the previous mixture of (27+30), a slightly blurred 
aggregation was observed within the cuvette after one day. Though, this was a tiny 
part of the total volume of the cuvette and stayed at the edge. We believed that this 
could be due to evaporation and the loss of this tiny volume from solution produced a 
reduction in the absolute signal of the CD spectrum. 
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Figure 4.16: CD measurements at different times for a period of 24 hours of a 100 µM solution of 
(SAF+c-3PAL10PAL14) (27+31) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are 
shown. X = 3-Pal 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
 
We next prepared and investigated the mixture (27+32) at a concentration of 100 µM 
in 10 mM MOPS at pH 8.5. The results obtained by CD spectroscopy are shown in 
Figure 4.17. In this case, the initial sample recorded a spectrum that was not fully 
folded as an α-helical coiled-coil structure (red line). The magnitude of the negative 
band at θ222nm was of a lower absolute value than the one at θ208nm, showing an initial 
θ222nm/θ208nm = 0.91. However, different measurements at different times in a total 
time of 24 hours exhibited a conformational change in the peptide structure by CD 
spectroscopy. As time increased, we believed that the peptide system was evolving to 
the formation of both α-helical coiled-coils and fibres. The green line shows the CD 
spectrum recorded 24 hours later than having prepared the peptide mixture. The 
negative band at 222 nm was then of a higher magnitude than the band at 208 nm, 
producing a θ222nm/θ208nm = 1.11. We did not see any red-shift of the θ208nm, however, 
we believed that the kinetics of this system might be slower than for the previous 
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peptide mixture (27+30). Since an increase in the α-helical content was observed, we 
supposed that the mixture (27+32) would be able to promote both α-helical coiled-coil 
formation and fibre formation at longer times than 24 hours. 
  
Figure 4.17: CD measurements at different times for a period of 24 hours of a 100 µM solution of 
(SAF+c-3PAL7PAL14) (27+32) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are 
shown. X = 3-Pal 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
The last of our peptide mixtures to test for α-helical coiled-coil and fibre formation was 
(27+33). Figure 4.18 shows the CD measurements of a 100 µM solution in 10 mM 
MOPS at pH 8.5 recorded at different times for a period of one day. An initial 
measurement of the just prepared mixture exhibited a CD spectrum of a structure 
which was not fully folded as an α-helical coiled-coil (red line). The negative bands at 
208 nm and 222 nm were of different magnitudes showing a θ222nm/θ208nm = 0.79. 
Monitoring the evolution of the peptide mixture by CD spectroscopy did not show any 
conformational changes in the secondary structure after 24 hours. The magnitude of 
θ222nm remained at a similar value as well as the magnitude at θ208nm, producing a value 
of θ222nm/θ208nm = 0.80 in the last measurement recorded (green line). This peptide 
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mixture did not show evidences for the formation of fully folded α-helical coiled-coil 
structures nor fibre formation. In addition, no visual signs of any blurred precipitate at 
the bottom or at the sides of the cuvette was detected. 
  
Figure 4.18: CD measurements at different times for a period of 24 hours of 100 µM (SAF+c-4PAL14) 
(27+33) in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 4-Pal 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
As observed, not all combinations of SAF (27) with the pyridyl-labelled peptides 30 to 
33 exhibited signs of α-helical coiled-coil and fibre formation by CD spectroscopy. In 
addition, the magnitude of the minimums in the CD spectra appeared to be lower than 
what expected for these type of conformations (around -25,000 to -30,000 mdeg mol-1 
cm2). We believed that the insertion of the unnatural amino acids within the peptide 
sequences caused this effect since it was a common feature in the CD spectra of all 
these peptide mixtures. The combinations of (27+30) and (27+32) (Figures 4.14 and 
4.17) showed the typical CD spectra pattern for α-helical coiled-coils and fibrous 
structures – although of a lower magnitude as just mentioned. In these two cases, the 
magnitudes of their θ222nm minimums increased with respect to the magnitude of the 
negative bands at θ208nm, which decreased and red-shifted as for the mixture (27+30). 
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From what we observed in the mixture (27+32) we also thought that higher 
concentrations of the peptide mixtures might show better and faster results of fibre 
formation, given that the kinetics of these processes are an important issue to take 
into account. On the other hand, when observing the CD spectra of the mixtures 
(27+31) and (27+33) a different behaviour was seen. These peptide mixtures did not 
exhibit a conformational change by CD spectroscopy that could indicate promotion of 
α-helical coiled-coil or fibre formation.  
From these results and from a direct comparison of the mixtures (27+30) and (27+33), 
we could say that the insertion of a 3-pyridylalanine motif promoted α-helical coiled-
coil and fibre formation whilst 4-pyridylalanine was unable to produce the same effect. 
We believed that the distancing from the nitrogen atom of the 3-pyridylalanine residue 
to the coiled-coil backbone could favor stabilizing interactions – such as hydrogen 
bonds – to promote the required structure. However, due to the distancing of the 
nitrogen atom in the 4-pyridylalanine residue together with the electronic effects of a 
para-substituted pyridyl ring did not produce the same effect. In the same way, when 
comparing (27+31) with (27+32), we observed that the assembly of 27 with 32 
promoted α-helical coiled-coil and fibre formation in a way 31 was unable to achieve 
it. The different spacing of the two pyridylalanine motifs inserted within the sequences 
may be the cause of different effects: i  i+4 for peptide 31 and i  i+7 for peptide 
32. Perhaps, having both residues in 32 located on the same positions of the heptad (f 
and f) provided better stabilizing effects – hydrogen bonds – to favour the required 
structure whilst in peptide 31 (f and b) the stabilizing effects for this type of structure 
were lower than the hindrance caused by the pyridyl rings at different positions of the 
heptad repeat, producing a higher constrain, thus avoiding α-helical coiled-coil and 
fibre formation. 
Table 4.4 shows the obtained data of ellipticity at 222 nm (θ222) and the ratio θ222/θ208 
for each one of the 100 µM solutions of all the individual peptides and peptide systems 
of this Section 4.4 at pH 8.5 and at 21 °C. 
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Peptide or peptide systems θ222 (deg mol-1 cm2) θ222nm/θ208nm 
SAF (27) -13764.8 0.84 
c-3PAL14 (30) -11990.5 0.86 
(27+30) t0 -13956.4 0.91 
(27+30) t24h -13256.3 1.40 
c-3PAL10PAL14 (31) -5064.6 0.65 
(27+31) t0 -10306.3 0.83 
(27+31) t24h -7102.2 0.84 
c-3PAL7PAL14 (32) -7431.8 0.78 
(27+32) t0 -12601.9 0.91 
(27+32) t24h -8613.5 1.11 
c-4PAL14 (33) -5904.1 0.61 
(27+33) t0 -8192.4 0.80 
(27+33) t24h -8139.8 0.80 
Table 4.4: Peptide data obtained for 100 µM solutions of SAF (27), the labelled peptides (30 to 33) and 
the peptide mixtures of 27 with each one of the labelled peptides in 10 mM MOPS at pH 8.5 at 21 °C; t0 
means the CD spectra recorded at the initial time of the mixture; t24h means the CD spectra recorded 
after incubating the peptide mixture for 24 hours. 
 
To complete this section, we were curious to find out whether the formation of fibres 
of these peptide-mixtures were concentration dependent. Since the peptide mixture 
(27+30) exhibited the biggest changes by CD spectroscopy after 8 hours, we prepared a 
50 µM solution of (27+30) in 10 mM MOPS at pH 8.5 and monitored the evolution by 
CD spectra for 12 hours (Figure 4.19). As no changes in the secondary structure were 
observed, we thought that the process of fibre formation for these peptide mixtures 
was also concentration-dependent. 
Coiled-coil self-assembling peptide systems susceptible to conformational changes upon metal-binding 
127 
 
 
Figure 4.19: CD spectra at different intervals of time for 12 hours of 50 µM (SAF+c-3PAL14) (27+30) in 
10 mM MOPS buffer at pH 8.5 at 21 ˚C. 
 
4.4.1 Metal-binding experiments on the sticky-ended peptide systems 
Once we were able to demonstrate that some of our pyridyl-labelled peptides (30 and 
32) were able to promote α-helical coiled-coil and fibre formation upon their mixture 
with the SAF peptide (27), we wanted to test whether the addition of a metal complex 
would promote any conformational changes to the peptide structures. As mentioned 
in Section 4.3.1, pyridyl groups (soft ligands) bind relatively strong to soft metals, thus, 
we decided to use the Pt(II) complex K2PtCl4. We then proceeded to add aliquots of a 1 
mM solution of K2PtCl4 to each of the peptide mixtures from Section 4.4 – these were 
100 µM solutions in MOPS at pH 8.5 of (27+30), (27+31), (27+32) and (27+33) – and 
observed the results by CD spectroscopy at different times for 24 hours. 
Figure 4.20 shows the CD measurements of the metal-binding experiments of (27+30) 
with Pt(II). The red line shows the CD spectrum of the initial peptide mixture and the 
green line is the CD spectrum after 24 hours. These spectra match with Figure 4.14. As 
we discussed, for a 100 µM solution of (27+30), an increase in the magnitude in the 
θ222nm minimum evidenced the promotion of fibre formation after 24 hours with a 
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θ222nm/θ208nm of 1.40. The addition of 5 µL of a 1 mM solution of K2PtCl4 produced a 
total concentration of the metal-peptide system of 97.96 µM. An initial CD 
measurement exhibited a change in the response in the CD spectrum (purple line). The 
magnitude of the θ222nm minimum increased producing a θ222nm/θ208nm of 1.64. This 
effect remained after 24 hours (yellow line), producing a very similar θ222nm/θ208nm of 
1.61. In this particular case, we concluded that the addition of the platinum complex 
K2PtCl4 to the incubated peptide mixture accentuated the process of fibre formation 
and increased the degree of chiral scattering of the final coiled-coil structure. 
  
Figure 4.20: CD measurements of the metal-binding experiments of 100 µM (SAF+c-3PAL14) (27+30) 
with the Pt(II) complex in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 
3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.21 shows the CD measurements of the metal-binding experiments of (27+31) 
with K2PtCl4. In this case, 25 µL of a 1 mM solution of K2PtCl4 were added to 240 µL of a 
100 µM solution of (27+31) producing a final concentration of 90.57 µM, being this 
slightly lower than the starting concentration. The red line shows the CD spectrum of 
the initial peptide mixture and the green line after 24 hours. As we showed in Figure 
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4.16, the peptide mixture (27+31) prepared at a concentration of 100 µM in MOPS (pH 
8.5) did not form fully folded α-helical coiled-coil structures nor promoted fibre 
formation. However, the addition of the Pt(II) complex showed to be crucial in causing 
conformational changes with respect to the initial structure. The purple line shows the 
CD spectrum of the mixture (27+31) right after the addition of Pt(II). The magnitude of 
θ222nm increased compared to the negative band at θ208nm indicating that coiled-coil 
formation was being promoted. Upon the addition of the Pt(II) complex, the 
θ222nm/θ208nm value increased from 0.83 in the initial peptide mixture (27+31) to 0.97 in 
(27+30+Pt-complex). We recorded another CD spectrum after incubating the metal-
peptide sample for 24 (yellow line). This showed a higher θ222nm/θ208nm = 1.06, this 
being an evidence of promotion of α-helical coiled-coil. However, no evidences of fibre 
formation were observed. 
 
Figure 4.21: CD measurements of the metal-binding experiments of 100 µM (SAF+c-3PAL10PAL14) 
(27+31) with the Pt(II) complex in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are 
shown. X = 3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
 
-15000
-13000
-11000
-9000
-7000
-5000
-3000
-1000
1000
3000
5000
190 200 210 220 230 240 250 260
M
R
E 
(d
eg
 m
o
l-1
cm
2 )
wavelength (nm)
(27+31) t=0
(27+31) t=24h
(27+31) t=24h + Pt(II) t=0
(27+31) t=24h + Pt(II) t=24h
Coiled-coil self-assembling peptide systems susceptible to conformational changes upon metal-binding 
130 
 
In this particular case (27+31+Pt-complex), we thought that the kinetics might be slow 
and longer times might be needed to produce higher values of θ222nm/θ208nm that 
would evidence proof of fibre formation. Therefore, we concluded that the addition of 
the platinum complex K2PtCl4 to the peptide mixture produced a conformational 
change that increased the α-helicity in the final structure. 
Figure 4.22 shows the CD measurements of the metal-binding experiments of (27+32) 
with Pt(II). Again, 25 µL of a 1 mM solution of K2PtCl4 were added to 240 µL of a 100 
µM solution of (27+32) producing a final concentration of 90.57 µM, being this lower 
than the starting concentration. The red line shows the CD spectrum of the initial 
peptide mixture. As we showed in Figure 4.17, a 100 µM solution of (27+32) in 10 mM 
MOPS at pH 8.5 promoted α-helical coiled-coil and fibre formation after 24 hours 
(green line). The addition of the Pt(II) complex exhibited conformational changes 
increasing the propensity for fibre formation. The purple line shows the CD spectrum 
of the mixture (27+32) right after the addition of Pt(II). An increase in the magnitude of 
the θ222nm minimum produced a higher value of θ222nm/θ208nm. This increased from 1.11 
in the initial peptide mixture to 1.26 upon the addition of Pt(II). After incubating the 
sample for 24 hours, we recorded one last CD measurement (yellow line). The CD 
spectrum looked very similar to the one obtained right after the addition of the Pt(II) 
complex, producing a θ222nm/θ208nm = 1.24. For this particular metal-peptide system, we 
concluded that the addition of the platinum complex K2PtCl4 to the peptide mixture 
provoked a morphological change in the final structure since an increase in the chiral 
scattering could be observed by the θ222nm/θ208nm coefficient. 
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Figure 4.22: CD measurements of the metal-binding experiments of 100 µM (SAF+c-3PAL7PAL14) 
(27+32) with the Pt(II) complex in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are 
shown. X = 3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.23 shows the CD measurements of the metal-binding experiments of (27+33) 
with Pt(II). Also in this case, 25 µL of a 1 mM solution of K2PtCl4 were added to 240 µL 
of a 100 µM solution of (27+33) producing a final concentration of 90.57 µM. The red 
line shows the CD spectrum of the initial peptide mixture. As we showed in Figure 
4.18, a 100 µM solution of (27+33) in MOPS at pH 8.5 did not produce a fully folded α-
helical coiled-coil structure after one day (green line). The CD spectrum recorded 
during the first minute after the addition of the Pt(II) complex did not show 
conformational changes to the initial structure of the peptide mixture (purple line). A 
remarkable conformational change was observed after 24 hours (yellow line). The 
magnitude of the θ222nm minimum increased compared to the one at θ208nm which 
slightly red-shifted. This change in magnitudes produced an increase in the 
θ222nm/θ208nm coefficients from 0.83 to 0.99. Thus, for this particular peptide mixture, 
we concluded that the addition of K2PtCl4 provoked conformational changes helping to 
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increase the α-helical content of the coiled-coil. The metal complex may be folding up 
the N-terminal region of the peptide 33, which may therefore have been unfolded in 
the assembly prior to metal addition. Though, we could not detect the formation of 
fibres by CD spectroscopy since the CD spectra did not match the patterns for this type 
of structure. This could be due to the slow kinetics of the system and leaving it for 
longer times might promote fibre formation. 
  
Figure 4.23: CD measurements of the metal-binding experiments of 100 µM (SAF+c-4PAL14) (27+33) 
with the Pt(II) complex in 10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 
4-pyridylalanine (4-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Table 4.5 shows the obtained data of ellipticity at 222 nm (θ222) and the ratio θ222/θ208 
for each one of the 100 µM solutions of all the individual peptides and peptide systems 
of this first part of Section 4.4.1 at pH 8.5 and at 21 °C and complements the obtained 
data from Table 4.4 (which are written in grey). 
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Peptide or peptide systems θ222 (deg mol-1 cm2) θ222nm/θ208nm 
(27+30) t0 -13956.4 0.91 
(27+30) t24h -13256.3 1.40 
[(27+30) t24h + Pt(II)] t0 -15670.9 1.64 
[(27+30) t24h + Pt(II)] t24h -15783.2 1.61 
(27+31) t0 -10306.3 0.83 
(27+31) t24h -7102.2 0.84 
[(27+30) t24h + Pt(II)] t0 -9114.1 0.97 
[(27+30) t24h + Pt(II)] t24h -10523.0 1.06 
(27+32) t0 -12601.9 0.91 
(27+32) t24h -8613.5 1.11 
[(27+30) t24h + Pt(II)] t0 -10900.9 1.26 
[(27+30) t24h + Pt(II)] t24h -10779.9 1.24 
(27+33) t0 -8192.4 0.80 
(27+33) t24h -8139.8 0.80 
[(27+30) t24h + Pt(II)] t0 -9640.3 0.83 
[(27+30) t24h + Pt(II)] t24h -9030.8 0.99 
Table 4.5: Peptide data obtained for the peptide mixtures of SAF (27) with each one of the labelled 
peptides (30 to 33) after complexation with the platinum complex K2PtCl4 (Pt(II)) in 10 mM MOPS at pH 
8.5 at 21 °C; t0 is the CD spectra recorded at the initial time of the mixture; t24h is the CD spectra 
recorded after incubating the mixture for 24 hours. Data from Table 4.4 (in grey ink) shows the results 
prior to the addition of the platinum complex to compare the evolution after metal-binding. 
 
We were also interested in investigating the effect that the single pyridyl-labelled 
peptides 30 to 33 would have upon interaction with the metal complex K2PtCl4 prior to 
be mixed with the SAF partner (27). Since none of the individual pyridyl-labelled 
peptides had a fully folded α-helical conformation, we thought that adding the Pt(II) 
complex could modify their structure rearranging them to be more or less α-helical. In 
addition, peptides 31 and 32 had two potential binding sites that could be used by the 
Pt(II) ion promoting changes in either the oxidation state or the coordination sphere of 
the metal centre. Thus, we prepared solutions in 10 mM MOPS at pH 8.5 of 
(30+K2PtCl4), (31+K2PtCl4), (32+K2PtCl4) and (33+K2PtCl4) and monitored the sample 
mixtures for one day. These samples were prepared as follows: aliquots of 100 µL of 
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K2PtCl4 200 µM were added to 200 µL of each of the pyridyl-labelled peptides at 200 
µM, producing a peptide concentration of 133 µM. After this period of time 20 µL of 
the SAF peptide (27) at 2000 µM were added – producing a final concentration of 125 
µM in the peptide mixture  – to see if the metal ion was able to affect the interaction 
mode that the peptides had previously shown in Section 4.4.  
The results obtained for all the metal-peptide mixtures exhibited the same tendency in 
this type of experiments. Figure 4.24 shows the CD measurements of a freshly 
prepared solution of 30 (in orange), its mixture with the Pt(II) complex right after being 
mixed (purple line) and 24 hours later (yellow line), and the subsequent addition of 
SAF (27) right after being mixed (red line) and 28 hours later (green line). As explained, 
the final concentration of this sample was 125 µM in 10 mM MOPS at pH 8.5. The 
dotted green line represents the mixture of (27+30) incubated for 24 hours and then 
mixed with the Pt(II) complex and left for another 24 hours matching the yellow line 
from Figure 4.20. This allowed us to compare the difference in the CD spectra taking 
into account the order in which the components of the system were mixed. As 
previously seen, the CD spectrum of 30 (orange line) indicated that this did not have a 
fully folded α-helical conformation. An initial CD measurement right after addition of 
the Pt(II) complex did not exhibit any conformational change (purple line) and the 
same was observed after 24 hours (yellow line). We proceeded then to add SAF (27) 
and an initial CD measurement showed changes in the secondary structure (red line). 
The negative band at 208 nm had red-shifted and the magnitude of the θ222nm 
minimum had increased producing a θ222nm/θ208nm = 0.97. This effect remained after 28 
hours where the spectrum did not show large conformational changes (green line).  
When comparing the green line and the dotted green line we observed how the order 
in which the components were mixed caused different structures. We also noticed the 
formation of a slightly blurred precipitated at the bottom of the cuvette which made 
us wonder whether some percentage of the fibrous structures were being formed. 
Perhaps, the kinetics of this type of structure were much slower due to the hindrance 
that the Pt(II) complex could cause on 30 prior to the addition of 27. 
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Figure 4.24: CD measurements at 21 ˚C of the metal-binding experiments in 10 mM MOPS buffer at pH 
8.5 where the Pt(II) complex was first added to 30 and after a period of 24 hours, the SAF partner (27) 
was added to the mixture and monitored for another 28 hours. The peptide sequences are shown. X = 3-
pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.25 shows the CD measurements of a 200 µM solution of 31 freshly prepared 
(in orange), the mixture with the Pt(II) complex at different times (at a total 
concentration of 133.3 µM), and then the subsequent addition of SAF (27) (at a final 
concentration of 125 µM). The dotted green line represents the mixture of (27+31) 
incubated for 24 hours and then mixed with the Pt(II) complex and left for another 24 
hours matching the yellow line from Figure 4.21. The CD spectrum of 31 (orange line) 
did not show the structure of a fully folded α-helical conformation but a structure that 
also contained some disordered forms of the peptide. After the addition of the Pt(II) 
complex, some structural changes could be seen by CD spectroscopy. A measurement 
at the initial time of the mixture (purple line) showed a red-shift in the negative band 
at 208 nm, and a similar structure was observed after 24 hours (yellow line). When 27 
was added, conformational changes could be detected by CD spectroscopy. The 
negative band at 208 nm continued red-shifting and the magnitude of the θ222nm 
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increased compared to the one at θ208nm producing higher value of the θ222nm/θ208nm 
coefficient (0.86) (red line). After 28 hours, the CD spectrum showed a θ222nm/θ208nm = 
0.92, indicating that the addition of the SAF partner was promoting an increase in the 
α-helicity of the structure (green line). However, this was not enough as to observe 
either a fully folded α-helical coiled-coil conformation or a fibrous structure. 
We thought that the structure was evolving to a more α-helical structure but the 
kinetics were too slow to promote fibre formation in the period of time of our study. 
Again, when comparing the green line with the dotted green line we concluded that 
the addition of the Pt(II) complex K2PtCl4 to 31 and incubation for 24 hours prior to the 
addition of the SAF partner was hindering the interaction of both peptides, hence, not 
favoring the promotion of fully folded α-helical coiled-coils nor fibres.  
   
Figure 4.25: CD measurements at 21 ˚C of the metal-binding experiments in 10 mM MOPS buffer at pH 
8.5 where the Pt(II) complex was first added to 31 and after a period of 24 hours, the SAF partner (27) 
was added to the mixture and monitored for another 28 hours. The peptide sequences are shown. X = 3-
pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
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Figure 4.26 shows the CD measurements of a 200 µM solution of 32 freshly prepared 
(in orange), the mixture with the Pt(II) complex at different times (at a total 
concentration of 133.3 µM), and then the subsequent addition of the SAF partner (27) 
(at a final concentration of 125 µM). The dotted green line represents the mixture of 
(27+32) incubated for 24 hours and then mixed with the Pt(II) complex and left for 
another 24 hours, matching the yellow line from Figure 4.22. The CD spectrum of 32 
(orange line), as we already knew from previous discussions, did not show the 
structure of a fully folded α-helical conformation. After addition of Pt(II) and measuring 
the initial time of the mixture (purple line), the same type of structure was observed 
without any significant change for 24 hours (yellow line). After the addition of the SAF 
partner (27), the negative band at 208 nm red-shifted showing, in this case, a similar 
magnitude to the band at 222 nm. An increase in the magnitude of the θ222nm 
minimum compared to θ208nm produced a θ222nm/ θ208nm = 0.94 (yellow line). This was 
indicative that the interaction with SAF was promoting an increase in the α-helical 
content of the system. The same effect remained after 28 hours (green line). The 
system seemed to evolve towards a more α-helical structure upon addition of 27, 
however, this was insufficient to generate a fully folded α-helical coiled-coil 
conformation or to promote fibre formation. Again, the addition of the Pt(II) complex 
to the pyridyl-labelled peptide (32) and incubation for 24 hours prior to the addition of 
the SAF partner hindered the association of both peptides avoiding the promotion of a 
fully folded α-helical coiled-coil and fibrous structure. 
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Figure 4.26: CD measurements at 21 ˚C of the metal-binding experiments in 10 mM MOPS buffer at pH 
8.5 where the Pt(II) complex was first added to 32 and after a period of 24 hours, the SAF partner (27) 
was added to the mixture and monitored for another 28 hours. The peptide sequences are shown. X = 3-
pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
Figure 4.27 shows the CD measurements of a 200 µM solution of 33 freshly prepared 
(in orange), the mixture with the Pt(II) complex at different times (at a total 
concentration of 133.3 µM), and then the subsequent addition of the SAF partner (27) 
(at a final concentration of 125 µM). The dotted green line represents the mixture of 
(27+33) incubated for 24 hours and then mixed with the Pt(II) complex and left for 
another 24 hours, matching the yellow line from Figure 4.23. Peptide 33 (orange line) 
did not have a fully folded α-helical conformation as previously seen. After the 
addition of Pt(II) and measuring the initial time of the mixture (purple line), a similar 
type of structure was observed without any changes after 24 hours (yellow line). 
Moreover, the θ222nm/ θ208nm value remained similar (0.61 vs. 0.65). When the SAF 
partner (27) was added, structural changes were observed. At the initial time of the 
mixture, the negative band at 208 nm had red-shifted although it did not show a 
similar magnitude as the band at 222 nm (red line). Though, these negative minimums 
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became closer in magnitude than in the absence of 27 after 28 hours, producing a 
θ222nm/ θ208nm = 0.91 (green line). The CD spectrum did not show a fully folded α-helical 
coiled-coil conformation nor fibre formation. The addition of SAF increased the α-
helical content in the metal-peptide structure. However, when comparing the green 
line with the dotted green line, we could see that the addition of the Pt(II) complex to 
the pyridyl-labelled peptide 33 and incubation for 24 hours prior to the addition of SAF 
was hindering the association of both peptides avoiding the promotion of any type of 
fully folded α-helical coiled-coil or fibrous structures. 
  
Figure 4.27: CD measurements at 21 ˚C of the metal-binding experiments in 10 mM MOPS buffer at pH 
8.5 where the Pt(II) complex was first added to 33 and after a period of 24 hours, the SAF partner (27) 
was added to the mixture and monitored for another 28 hours. The peptide sequences are shown. X = 4-
pyridylalanine (4-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
From these set of experiments we could see that the addition of the Pt(II) complex to 
the pyridyl-labelled peptides (30 to 33) showed a similar response by CD spectroscopy  
as for the individual peptides. The addition of the SAF partner (27) promoted structural 
changes as seen by CD spectroscopy increasing their degree of α-helicity in all the 
mixtures. However, this was never enough to produce fully folded α-helical coiled-coils 
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or fibres. Perhaps, the addition of the Pt(II) complex prior to the addition of SAF 
slowed the kinetics of the peptide system to avoid the formation of fibrous structures 
or the metal ion hindered an efficient folding between peptide partners. From these 
results, we concluded that the order in which the pyridyl-labelled peptides 30 to 33 
were mixed either with 27 or the Pt(II) complex was important since both ways 
produced different results. Table 4.6 summarises the peptide data of θ222 and θ222/θ208 
obtained for the peptide mixtures of this last set of experiments. 
Peptide or peptide systems θ222 (deg mol-1 cm2) θ222nm/θ208nm 
c-3PAL14 (30) -12794.9 0.90 
(30+Pt(II)) t0 -10973.2 0.88 
(30+Pt(II)) t24h -11253.6 0.88 
[(30+Pt(II)) t24h + SAF] t0 -12456.9 0.97 
[(30+Pt(II)) t24h + SAF] t24h -11420.0 0.94 
c-3PAL10PAL14 (31) -2532.3 0.65 
(31+Pt(II)) t0 -8076.8 0.72 
(31+Pt(II)) t24h -6688.0 0.73 
[(31+Pt(II)) t24h + SAF] t0 -9609.9 0.86 
[(31+Pt(II)) t24h + SAF] t24h -11676.4 0.92 
c-3PAL7PAL14 (32) -3715.9 0.78 
(32+Pt(II)) t0 -7397.2 0.80 
(32+Pt(II)) t24h -6915.9 0.78 
[(32+Pt(II)) t24h + SAF] t0 -10186.4 0.94 
[(32+Pt(II)) t24h + SAF] t24h -12158.5 0.93 
c-4PAL14 (33) -2952.0 0.61 
(33+Pt(II)) t0 -5492.7 0.65 
(33+Pt(II)) t24h -5464.9 0.63 
[(33+Pt(II)) t24h + SAF] t0 -12897.3 0.85 
[(33+Pt(II)) t24h + SAF] t24h -12266.8 0.91 
Table 4.6: Summarised peptide data of θ222 and θ222/θ208 obtained for the peptide mixtures of SAF (27) 
with each one of the previously incubated mixtures of the labelled peptides with the platinum complex 
Pt(II) in 10 mM MOPS at pH 8.5 and 21 °C. The obtained data for the individual labelled peptides 30 to 
33 is also included to compare with their following mixtures. t0 is the CD measurement at the initial time 
of the mixture and t24h is the CD measurement obtained after incubation of the mixture for 24 hours. 
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4.5 Summary 
Some differences were observed when comparing the metal-binding experiments of c-
BEP (29) and/or SAF (27) with the pyridyl-labelled peptides 30 to 33. The first obvious 
thing was a decrease in the magnitude of the spectra when peptides 30 to 33 were 
mixed with 27. We thought that the insertion of the unnatural amino acids within 
these peptide structures caused that effect by CD spectroscopy. Upon the addition of 
the Pt(II) complex to the peptide mixtures, the blunt-ended coiled-coil structures did 
not seem to exhibit any change in their secondary structure, indicating that metal-
binding did not cause any conformational switch. We also thought that the peptide 
system was energetically stable and that was the reason to avoid conformational 
changes that the metal-binding could generate. However, after doing the same type of 
experiments with 27, we found evidences of conformational switching by metal-
binding. Either when we mixed both peptide partners and continued with the addition 
of the Pt(II) complex or when incubated the pyridyl-labelled peptides with the Pt(II) 
complex prior to the addition of their SAF partner, structural changes were observed. 
In this first case, the addition of Pt(II) to the peptide mixtures helped to increase their 
α-helical content and to promote fibre formation. In the second, we thought that the 
addition of the Pt(II) complex to the pyridyl-labelled peptides might slow the kinetics of 
the system towards the interaction with SAF and subsequent rearrangement. 
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Chapter 5 
Photoswitching investigations in de novo 
coiled-coil peptide systems 
5.1 Design of a peptide sequence to incorporate an azobenzene 
derivative for photoisomerization 
As previously discussed in Section 1.5.2 and Section 2.3, for proteins that present 
several folding states, it is possible to reversibly photo-control the isomerization states 
by irradiating light of a determined wavelength on a chromophore group within the 
protein structure. Here we design a peptide sequence with two binding sites for the 
attachment of an azobenzene derivative (4,4’-dichloroacetamide azobenzene, 24) and 
to take advantage of the trans-to-cis isomerization switch (and viceversa) of these 
compounds for photoisomerization of its folding states when forming an α-helical 
coiled-coil. We still follow the same principles for peptide design explained in Section 
3.3, hence, the design of a peptide partner of PEP1 (25) for blunt-ended coiled-coil 
formation but with the ability of incorporating an azobenzene. 
Since BEP (26) was designed to form an α-helical coiled-coil structure upon interaction 
with PEP1 (25), we use peptide 26 as a template for the design and construction of a 
peptide partner for 25 with the addition of two binding sites for the attachment of the 
azobenzene unit are arranged. As we explained in Section 1.5.2, thiols can easily react 
with halo-compounds under the right conditions of pH. Cys residues contain thiol 
groups as side chains than can react with the halo-azobenzene (4,4’-dichloroacetamide 
azobenzene, 24) synthesized for this purpose. As the design of these peptides is to 
form an α-helical coiled-coil in its native state, a spacing of i  i+11 is selected for the 
incorporation of the Cys residues. This decision was made based on the information 
provided by Wooley where models placed at this spacing favoured the formation of an 
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α-helix in the dark adapted state when attached to an azobenzene derivative of similar 
structure to the one synthesized in this thesis.1  
As α-helical coiled-coils are designed to assemble to bury their hydrophobic faces and 
these are positions a and d of the heptad, and positions e and g are used for salt-
bridging interactions, the remaining heptad positions to allocate the Cys residues are 
b, c or f, which are in the hydrophilic face, hence designing a water-soluble azobenzene 
derivative (Section 2.3). Due to the greater effect that an azobenzene derivative has on 
a peptide when placed at the middle of the sequence, we decided to design a Cys-
containing peptide that could achieve this, hence, suitably finding positions in the 
second and third heptad of the sequence to accommodate this. We decided to replace 
the Gln residue of position f of the second heptad and the corresponding amino acid at 
a spacing of i  i+11 which was an Ala residue in position b of the third heptad, which 
matched our planned requirements.  
This new designed peptide, CYS (34), can then react with the azobenzene derivative 
(4,4’-dichloroacetamide azobenzene, 24) to form a cross-linked peptide, CL (35), for 
heterodimer coiled-coil formation and for photoisomerization investigations. Figure 
5.1 illustrates a summary of what has been explained in the paragraphs before about 
the steps for the design of 34, 35 and the coiled-coil dimer for photoisomerization. 
 
Figure 5.1: Steps for the design of CYS and CL from BEP and representation of the heterodimer design 
for coiled-coil formation and photoisomerization investigations. 
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Taking into consideration that our first designs in Section 3.3 gave good results when 
the sequences were double capped – this is N-acetylated and C-amidated – we decided 
to synthesize the Cys-containing peptide also as a double capped peptide, c-CYS (36), 
and its cross-linking reaction with 4,4’-dichloroacetamide azobenzene (24) would 
provide c-CL (37) for heterodimer coiled-coil formation with c-PEP1 (28) and 
subsequent photoisomerization investigations. Nevertheless, as we have PEP1, c-PEP1, 
CL and c-CL, it would be interesting to prepare all the possible combinations for coiled-
coil formation to gain a better understanding of the photoisomerization effects on 
each type of structure. Figure 5.2 shows the target heterodimer coiled-coil structures 
for photoisomerization investigations. 
 
Figure 5.2: Potential combinations of coiled-coil heterodimers for photoisomerization investigations: (1) 
(PEP1+CL); (2) (PEP1+c-CL); (3) (c-PEP1+CL); and (4) (c-PEP1+c-CL). 
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5.2 Synthesis, characterization and discussion 
5.2.1 Peptide synthesis 
The synthesis of the Cys-containing peptides 34 and 36 was successfully accomplished 
by automated Fmoc-MW-SPPS. CYS (34) was synthesized on Fmoc-Gln(Trt)-wang resin 
at both 0.05 and 0.10 mmol scales following the peptide synthesis – procedures 1 and 
2 respectively from Section 7.2.3. Procedure 1 afforded 77 mg of crude peptide (48%) 
whilst procedure 2 gave 175 mg of crude peptide (55%). c-CYS (36) was synthesized on 
rink amide MBHA resin at 0.10 mmol scale following the peptide synthesis – procedure 
6 from Section 7.2.3 and affording 170 mg of crude peptide (53%). Further purification 
of the crude material by RP-HPLC afforded both pure peptides with high purity of c-CYS 
(37) as seen by HRMS analysis (Section 7.6). CYS: MALDI-TOF MS m/z 3190.6 [M]+, 
3192.6 [M+H]+; 3214.6 [M+H+Na]+; while c-CYS: MALDI-TOF MS m/z 3231.5 [M]+, 
3253.5 m/z [M+Na]+. Figure 5.3 shows the MALDI spectrum of the crude CYS (34) 
peptide prior and after RP-HPLC purification; while Figure 5.4 shows the corresponding 
MALDI spectra of the crude c-CYS (36) before and after RP-HPLC purification. 
 
Figure 5.3: MALDI-TOF MS spectrum of CYS (34) before RP-HPLC (at the left) and after RP-HPLC (at the 
right). 
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Figure 5.4: MALDI-TOF MS spectrum of c-CYS (36) before RP-HPLC (at the left) and after RP-HPLC (at the 
right). 
 
5.2.2 Synthesis of azobenzene-peptide systems for photoisomerization 
The cross-linking reactions are carried out into buffer solutions to favour the reaction 
processes. Here we use TCEP and tris-HCl. TCEP (tris(2-carboxyethylphosphine)) is a 
reducing agent commonly used in biochemistry to break disulfide bonds as 
preparatory step for further reactions; tris-HCl (tris(hydroxymethil)aminomethane) is a 
buffer solution widely used in biological reactions to preserve the pH of the media 
whilst the desired reaction is happening. As we need a slightly basic pH to preserve 
thiol groups in their reduced state and avoid disulfide bond formation, a tris-HCl 
solution (pH 8.5) together with TCEP at pH (8.5) is used to maintain these thiols in their 
reduced state (–SH) until the addition of 4,4’-dichloroacetamido azobenzene (24) in a 
nucleophilic substitution reaction.  
The reaction is carried on in aqueous media with previous incubation of the peptide 
(either 34 or 36) into the buffer solutions at room temperature for a minimum of 2 
hours and under inert atmosphere (N2 or Ar). The reaction proceeds with the addition 
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of the azobenzene derivative in excess (in DMSO to help solubility) in the dark and with 
heating at 40 ˚C. Scheme 5.1 shows the conditions of reaction for cross-linking 24 with 
CYS (34) – the same conditions were applied to synthesize c-CYS (36) – and Scheme 5.2 
explains the mechanism of reaction by which this process happens. The crude of these 
reactions is lyophilized and purified by RP-HPLC. 
 
Scheme 5.1: Cross-linking reaction conditions to make CL (35) from CYS (34) and (24). 
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Scheme 5.2: Cross-linking reaction mechanism between azobenzene 24 and a thiol group from a peptide 
sequence. The nucleophilic substitution reaction generates HCl that stays in solution. 
 
The MALDI-TOF spectra of the cross-linked peptides 35 and 37 after RP-HPLC 
purification showed the right m/z masses for the calculated ions (Figure 5.5). Thus, CL 
(35): MALDI-TOF MS m/z 3484.1 [M+H]+, 3506.2 [M+Na]+; while the corresponding 
masses peaks for the c-CL (37) were: MALDI-TOF MS m/z 3524.9 [M]+, 3546.6 [M+Na]+. 
 
Figure 5.5: MALDI-TOF MS spectra of CL (35) at the left and of c-CL (37) at the right. 
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5.2.3 Photoisomerization of coiled-coil peptide systems 
After successfully synthesized the azobenzene-peptide structures 35 and 37, circular 
dichroism (CD) experiments were carried out to investigate: first, whether the 
combination of any of these with any of the peptide sequences PEP1 (25) or c-PEP1 
(28) formed blunt-ended coiled-coils; and second, whether irradiation with UV light 
could photoswitch any of these systems. As we explained in Figure 5.2, our initial aim 
was to investigate the photoswitching effects in each of the possible combinations. 
However, because of the lack of peptide 35 and the difficulties we found when trying 
to resynthesize it, we decide to focus on systems 1, 2 and 4 from Figure 5.2 and leave 
system 3 for future work. All CD measurements discussed next were recorded in PBS 
buffer at pH 7.4 at room temperature (21 °C). 
CD analysis of the individual peptides CL (35) and c-CL (37) were carried out to test the 
photoisomerization effect. We first thought that irradiating the azobenzene-containing 
peptides with 380 nm light for 20 min would be enough to promote a conformational 
change in their secondary structure, and 450 nm light would return the peptides back 
to their initial conformation. This was deduced from observing the big conformational 
change of the azobenzene 24 alone by UV spectroscopy under these conditions (Figure 
2.19). However, and due to the novelty of this type of experiment for us, we initially 
thought that irradiating 35 with 380 nm light for 20 min was not providing enough 
energy to induce the photoswitching of the peptide. Thus, we decided to increase the 
energy of irradiation to 340 nm to check whether that would be enough to confirm the 
photoisomerization of 35. 
Figure 5.6 shows the CD spectrum of 35 in the dark-adapted state (purple line) – this 
is, when the azobenzene is favored in the trans-isomer state – and the photoswitching 
effect after irradiating at 340 nm light for 20 min (red line). The concentration of this 
peptide solution was estimated to be around 50 µM (unfortunately, we did not have 
much of this peptide left when undertook this measurements, hence, the estimation). 
The negative bands at 222 nm and at 208 nm were indicative that this structure was 
not fully assembled as an α-helical conformation (purple line). The θ222nm/θ208nm 
coefficient was 0.77, when for a fully folded α-helical conformation a coefficient of 
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1.00 or higher is expected. Moreover, the isodichroic point seen between 203 nm and 
208 nm suggested the presence of a two-state equilibrium between helical and 
disordered forms of the peptide, being higher the α-helical content. Irradiation of this 
peptide at 340 nm for 20 min decreased the magnitude of the θ222nm minimum in a 
higher magnitude than the θ208nm minimum (dark red line). This produced a value of 
θ222nm/θ208nm = 0.72 which was lower than that found in the initial state. This proved a 
conformational change of 35 upon light irradiation. To return the peptide to the initial 
conformation, 450 nm light was used for 20 min (dotted purple line). The θ222nm/θ208nm 
coefficient was 0.76, which was almost the same as previously calculated when the 
peptide was in its initial state. Both bands at 222 nm and at 208 nm increased their 
magnitudes almost to the same point at where they were initially measured. This was 
another proof of the photoswitching ability of 35 and we concluded that peptide 35 
could undergo both trans-to-cis and cis-to-trans photoisomerization, with 20 min being 
enough to return most of the molecules from the cis to the trans-initial state. 
 
Figure 5.6: CD spectra of the photoisomerization of 50 µM CL (35) in PBS at pH 7.4 at 21 ˚C. The peptide 
sequence of CL (35) is shown. The residues Cys (in red on the sequence) are the binding sites through 
which the azobenzene 24 is attached: 
 CL:  EIAALEYENCALEQKIKALKCKIKALKQ 
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We also tested the photoisomerization effects of 37. As the level of experience in the 
synthesis of the cross-linked peptides at this point of the thesis was much higher, a 
larger amount of 37 was available for CD measurements. Samples at different 
concentrations of 20 µM, 50 µM, 100 µM and 200 µM in PBS at pH 7.4 and at room 
temperature (21 °C) were prepared to investigate the effects of concentration when 
photoswitching the peptide. Although the photoswitching effects were seen best when 
the concentration was higher, we found this a normal consequence as the more 
concentrated the more azobenzene-peptide structures can be found and detected, 
hence the better response when measuring CD. We only show the photoswitching 
effect at 100 µM (Figure 5.7) while the other spectra at different concentrations can 
be found in the Appendices.  
 
Figure 5.7: CD spectra of the photoisomerization of 100 µM c-CL (37) in PBS buffer at pH 7.4 at 21 ˚C. 
The peptide sequence (37) is shown. The residues Cys (in red on the sequence) are the binding sites 
through which the azobenzene 24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
 
 
-25000
-20000
-15000
-10000
-5000
0
5000
10000
190 200 210 220 230 240 250 260
M
R
E 
(d
eg
 m
o
l-1
cm
2
)
wavelength (nm)
c-CL - Trans-initial state
c-CL - Trans-to-cis (380nm, 20min)
c-CL - Return to trans (450nm, 20min)
Photoswitching investigations in de novo coiled-coil peptide systems 
153 
 
When observing the negative bands of the trans-initial state of 37 at the CD spectrum 
(purple line) in Figure 5.7, they showed a certain degree of α-helical content together 
with some disordered forms of the peptides as it happened with 35. After irradiating 
the peptide with 380 nm light for 20 min, the magnitude of the θ222nm minimum 
decreased producing a θ222nm/θ208nm value of 0.82 when the initial θ222nm/θ208nm = 0.89. 
This meant a significant loss in the α-helicity of the peptide structure. This turned out 
to be a clear proof of the trans-to-cis photoisomerization of the azobenzene-peptide 
structure. Irradiation of the cis-conformational state at 450 nm for 20 min seemed to 
be enough as to return most of the molecules of 37 to the trans-initial conformational 
state. Again, as for 35, the reversible photoisomerization of 37 was proven by CD 
spectroscopy. 
Since the azobenzene switch was strong enough to generate conformational changes 
in the structure of the individual peptides 35 and 37 upon 340 nm and 380 nm light 
respectively, we next mixed them with their partners PEP1 (25) and c-PEP1 (28) to 
investigate the photoswitching effects of such systems. As previously mentioned, we 
could only test these effects in the following coiled-coil systems (Figure 5.2):  
1) (PEP1+CL) (25+35); 
2) (PEP1+c-CL) (25+37); 
3) (c-PEP1+c-CL) (28+37). 
 
Figure 5.8 shows the CD spectrum of PEP1 (25) (blue line), CL (35) (purple line), and 
their mixture (green line) in an equal molar ratio of (1:1) at a total concentration of 15 
µM in PBS buffer at pH 7.4 at 21 °C. As we mentioned, we did not have much of 35, 
thus, low concentrations were used in this case. PEP1 showed a disordered structure 
with a θ222nm/θ208nm = 0.25, and CL exhibited certain degree of α-helicity together with 
disordered forms of the peptide. The interaction between both peptides produced a 
θ222nm/θ208nm = 0.84, indicating an increase in the α-helical content of the mixture, 
though, this structure contained some degree of random coil conformation. Irradiation 
of the peptide mixture with 340 nm light for 20 min exhibited a conformational change 
by CD spectroscopy (yellow line). The magnitude of the θ222nm minimum decreased in a 
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higher magnitude compared to the θ208nm minimum producing a θ222nm/θ208nm = 0.81 
and evidencing a loss in the α-helical content of the structure. This was indicative of a 
conformational switch from trans-to-cis. Though, the initial trans-conformation was 
recovered upon irradiation of the cis-isomer with 450 nm light for 20 min (dotted 
green line).  
  
Figure 5.8: CD spectrum of 80 µM solutions of PEP1 (25), CL (35), and their mixture (25+35) in PBS buffer 
at pH 7.4 at 21 ˚C, and the photoisomerization of the (25+35) system. The peptide sequences of PEP1 
(25) and CL (35) are shown. The residues Cys (in red on the sequence) are the binding sites through 
which the azobenzene 24 is attached: 
PEP1:  KIAALKQKNAALKQEIAALEYEIALEQ     
 CL:  EIAALEYENCALEQKIKALKCKIKALKQ 
 
This study confirmed the ability of the azobenzene chromophore (24) to photoswitch 
the conformational structure given by the peptide mixture of (25+35) despite the fact 
that the system did not fully assemble as an α-helical coiled-coil blunt-ended structure. 
In addition, we observed that irradiation at 450 nm for 20 min was almost enough to 
return all the azobenzene molecules to the trans-initial state making this a reversible 
process. 
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PEP1 was mixed in a molar ratio of (1:1) with c-CL at a total concentration of 100 µM in 
PBS buffer at pH 7.4 and at 21 °C forming what we considered a coiled-coil structure 
with a high degree of α-helical content as seen by CD spectroscopy in Figure 5.9. The 
CD spectrum of PEP1 (dotted blue line) exhibited a negative band near 198 nm, typical 
of a disordered conformation. The CD spectrum of c-CL (dotted purple line) exhibited 
two negative bands at 208 nm and 222 nm, producing a θ222nm/θ208nm = 0.89, which 
was a sign that its conformation had some degree of α-helicity together with 
disordered forms of the peptide. Irradiation of the c-CL peptide with 380 nm light for 
20 min exhibited structural changes by CD spectroscopy. A larger decrease in the 
magnitude of the θ222nm minimum than in θ208nm exhibited a loss in the degree of α-
helicity as determined by the coefficient θ222nm/θ208nm = 0.82 (dotted red line). 
 
Figure 5.9: CD spectrum of 100 µM solutions of PEP1 (25), c-CL (37), and their mixture (25+37) in PBS 
buffer at pH 7.4 at 21 ˚C, and the photoisomerization of the (25+37) system. The peptide sequences of 
PEP1 (25) and c-CL (37) are shown. The residues Cys (in red on the sequence) are the binding sites 
through which the azobenzene 24 is attached: 
PEP1:  KIAALKQKNAALKQEIAALEYEIALEQ     
 c-CL:           Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
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When 25 and 37 were mixed together (green line), an increase in the magnitude of the 
θ222nm minimum was indicative of a higher degree of α-helical content in the coiled-coil 
structure compared to the helical content shown by the individual peptides, producing 
a θ222nm/θ208nm = 0.98 for the trans-conformation. Irradiation of the mixture (25+37) 
with 380 nm light for 20 min induced a conformational change that meant a loss in the 
α-helical content of the peptide assembly (yellow line). Both the negative bands at 208 
nm and 222 nm decreased their magnitudes, exhibiting the θ222nm minimum a larger 
decrease compared to θ208nm and producing a θ222nm/θ208nm = 0.95 for the cis-irradiated 
structure. 
When we compared the conformational changes exhibited by c-CL (37) itself and by 
the mixture (25+37), we observed different responses that suggested a difference in 
sensitivity to UV light irradiation. Peptide 37 showed a higher change in the magnitude 
of the θ222nm minimum but also in the θ222nm/θ208nm value than when irradiating the 
peptide mixture. Irradiation of 37 with 380 nm light decreased this coefficient in 7 
units while (25+37) only decreased it in 3 units. As mentioned, we understood this 
response to irradiation with UV light as a sign of different sensitivity to 
photoisomerization depending on the stability of the peptide structure. In other 
words, the same level of energy put into trans-to-cis isomerization of the azobenzene 
when attached in the single peptide was not enough to cause the same effect when 
(25+37) were mixed together.  
Figure 5.10 shows the thermal denaturation curve of a 100 µM solution of (25+37) 
compared to a 100 µM solution of 37, each of them in PBS at pH 7.4. The melting point 
of the peptide mixture was slightly higher than the found for peptide 37 alone: TM 
(PEP1+c-CL) = 58.6 ˚C > TM(c-CL) = 54.6 ˚C. If we observe the curve of 37 (purple line), 
we see that the transition is not as noticeable as for (25+37) (green line). In the 
mixture, there is a large transition in the region of 40 to 60 ˚C that indicates evidences 
of disruption of the coiled-coil. From this data, we concluded that association of both 
peptides (PEP1+c-CL) increased the magnitude of the thermal stability of the coiled-
coil structure. 
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Figure 5.10: Thermal denaturation curves of 100 µM PEP1 (25), c-CL (37), and (PEP1+c-CL) (25+37) in 
PBS buffer at pH 7.4: TM (25) estimated lower than 32.3 ˚C; TM (37) = 54.6 ˚C; TM (28+37) = 58.6 ˚C. The 
peptide sequences of PEP1 (25) and c-CL (37) are shown. The residues Cys (in red on the sequence) are 
the binding sites through which the azobenzene 24 is attached: 
PEP1:  KIAALKQKNAALKQEIAALEYEIALEQ     
 c-CL:           Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
 
To summarise, we verified that the peptide mixture (PEP1+c-CL) produced a blunt-
ended coiled-coil structure with the ability to generate reversible photoisomerization 
upon irradiation with the appropriate wavelength. This mixture of peptides was found 
to be more α-helical, slightly more resistant to the photoswitching effect, and also 
showed a higher thermal stability than their single peptides PEP1 (25) and c-CL (37) 
when these were alone.  
When comparing systems 1 and 2, this is (PEP1+CL) and (PEP1+c-CL), we observed that 
the only difference was the double capping of CL in system 2. It seemed that the α-
helical content of the peptide mixture was higher when half of the peptide sequences 
from the mixture were bearing a N-terminal acetyl group and a C-terminal amide 
group. This effect produced interactions between peptides that provided higher 
resistance to the photoswitching effect. Thus, the photoswitching effect of the mixture 
(PEP1+CL) was larger than that of the mixture (PEP1+c-CL). For this reason, since 28 
and 37 were both double capped, we predicted a lower photoswitching effect for their 
mixture (c-PEP1+c-CL) than for the previous investigations.  
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Figure 5.11 shows the CD spectra of 100 µM solutions in PBS buffer at pH 7.4 and at 21 
°C of c-PEP1 (28) (dotted dark blue line), c-CL (37) (dotted purple line), and their 
mixture (28+37) (green line), as well as the photoisomerization effects showed after 
UV irradiation. The negative bands at 208 nm and 222 nm of 28 and 37 indicate some 
degree of α-helicity in their structures in equilibrium with disordered forms of the 
peptides. After mixing both peptides together, signs of association were observed by 
an increase in the magnitude of the θ222nm minimum. This produced a θ222nm/θ208nm = 
0.99 indicating an increase in the degree of α-helicity of the peptide structure. We 
believed that the mixture (28+37) favoured dimeric blunt-ended coiled-coils with a 
high α-helical content. Since irradiation of the peptide mixture with 380 nm light for 20 
min in a first attempt, 45 min in a second attempt, and 35 min in a last attempt did not 
generate any conformational change (yellow line), we also thought that the effect of 
the double capping of both individual peptides provided interactions that helped to 
stabilize the formation of blunt-ended heterodimers in a higher percentage. Thus, the 
energy used to photoswitch the azobenzene was insufficient in this case. 
Figure 5.12 shows the thermal denaturation curve of the coiled-coil structure (28+37) 
at 100 µM in PBS at pH 7.4 compared to the ones for 28 and 37 under the same 
conditions. The melting point of 28 was about 20 ˚C lower than the melting point of 37, 
indicating that 37 was thermally more stable than 28: TM (c-PEP1) = 32.3 ˚C < TM (c-CL) 
= 54.6 ˚C. However, the melting point observed for the peptide mixture after coiled-
coil formation was of a higher magnitude than any of the TM observed for the 
individual peptides: TM(c-PEP1+c-CL) = 67.7 ˚C. That indicated a higher thermal stability 
of the peptide mixture when assembled. This temperature was even higher than the 
TM observed for the previous coiled-coil structure (PEP1+c-CL). We concluded that the 
interactions provided for both the N-acetyl group and the C-amide group at the end of 
the peptide sequences seemed to be crucial to gain thermal stability when forming α-
helical blunt-ended coiled-coil structures. 
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Figure 5.11: CD spectrum of 100 µM solutions of c-PEP1 (28), c-CL (37), and their mixture (28+37) in PBS 
buffer at pH 7.4 at 21 ˚C, and the photoisomerization of the (28+37) system. The peptide sequences of 
PEP1 (25) and c-CL (37) are shown. The residues Cys (in red on the sequence) are the binding sites 
through which the azobenzene 24 is attached: 
c-PEP1:  Ac-KIAALKQKNAALKQEIAALEYEIALEQ-Am    
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
 
  
Figure 5.12: Thermal denaturation curves of 100 µM c-PEP1 (28), c-CL (37), and (c-PEP1+c-CL) (28+37) in 
PBS buffer at pH 7.4: TM (28) = 32.3 ˚C; TM (37) = 54.6 ˚C; TM (28+37) = 67.7 ˚C. 
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With all these results in hand, we could predict the results for the remaining peptide 
mixture (c-PEP1+CL) – this is system 3 from Figure 5.2, which we were not able to 
investigate as previously mentioned. Thus, as seen for the individual peptides, they 
would not form fully folded α-helical structures when alone. Instead, they would show 
some degree of α-helical content together with disordered forms of the peptides. 
However, upon their mixture, a peptide assembly with a higher α-helical content 
would be obtained. Since one of the individual peptides is double capped, this mixture 
would exhibit a higher α-helical content than that of (25+35) but similar to that of 
(25+37). In addition, this peptide system would be able to produce reversible 
photoisomerization by CD spectroscopy as observed in systems 1 and 2 – these are 
(25+35) and (25+37). Finally, the melting temperature would be higher than that of 
system 1 (PEP1+CL) but similar to system 2 (PEP1+c-CL), and lower than that of system 
4 (c-PEP1+c-CL). 
Figure 5.13 represents the θ222nm values of peptide 37 and each one of the peptide 
assemblies discussed in this section as a sign of the stability of their structures at room 
temperature (in the trans-conformation state), versus the magnitudes of the 
photoswitching effects in each of them (this being given as an absolute value). The 
lower the θ222nm value, the higher the α-helical content of each structure, and the 
higher the stability. Thus, the peptide assembly of (28+37) exhibited the largest degree 
of α-helical content and highest stability, this being due to the double capping of both 
individual peptides. In addition, (28+37) exhibited the largest resistance to the 
photoswitching effect. On the other hand, 37 showed the lowest degree of α-helical 
content, the least stability, and the largest photoswitching effect. 
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Figure 5.13: Representation of the stability (θ222nm trans) (y axys) vs. the photoswitching effects (x axys) 
of 37, (25+35), (25+37) and (28+37). 
 
Table 5.1 summarises peptide data of θ222nm, the ratio θ222nm/θ208nm and some values 
of TM obtained for the peptides and peptide mixtures from this Chapter. 
Peptide or peptide 
system 
conformation θ222  
(deg mol-1 cm2) 
θ222/θ208 TM (°C)  
CL (35) trans -15963.2 0.77 Not calc. 
 cis -14445.7 0.72  
c-CL (37) trans -20352.3 0.89 54.6 
 cis -16543.0 0.82  
(PEP1+CL) trans -24946.0 0.84 Not calc. 
 cis -22499.6 0.81  
(PEP1+c-CL) trans -23946.4 0.98 58.6 
 cis -21716.1 0.95  
(c-PEP1+c-CL) trans -26343.8 0.99 67.7 
 cis -26535.9 0.99  
Table 5.1: Peptide data obtained for CL (35), c-CL (37), (PEP1+CL) or (25+35), (PEP1+c-CL) or (25+37) and 
(c-PEP1+c-CL) or (28+37) in PBS at pH 7.4 and at 21 °C. The TM values were not calculated for all peptide 
mixtures due to a lack of peptide 35. 
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5.3 Summary 
We were able to synthesize peptide partners – both capped and uncapped – for blunt-
ended associations and for α-helical coiled-coil formation. These peptides were 
developed from the designed chassis BEP (26) and c-BEP (29) peptides described in 
Chapter 3. From them, we built Cys-containing peptides (34 and 36). These had the 
ability to attach the azobenzene derivative 24 through the thiols from the Cys residues. 
The resulting peptides were referred to as cross-linked peptides (35 and 37) and 
exhibited reversible photoswitching properties. The photoswitching degree was 
different depending on the peptide system they were forming. Peptides 35 and 37 
exhibited a larger switch when alone but also exhibited a certain degree of 
photoswitching when they were forming α-helical coiled-coil peptide assemblies: 
(25+35), (25+37) and (28+37). The lower the θ222nm value of each of the peptide 
assemblies, the higher the α-helical content of each structure, and the higher the 
stability. The structure produced by the mixture (28+37) exhibited the largest degree 
of α-helical content and highest stability, this being due to the double capping of both 
individual peptides. In addition, (28+37) exhibited the largest resistance to the 
photoswitching effect. 
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1 G.A. Woolley, Acc. Chem. Res. 2005, 38, 486-493.  
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Chapter 6 
Conclusions 
As we mentioned in the abstract and in the introductory chapter, this is considered to 
be an interdisciplinary research project in nature. It involves biomolecular design, for 
peptide design, and also both organic and inorganic chemistry, for the synthesis of 
biomolecular components that are incorporated into the peptide sequences to 
generate conformational switching. 
By making use of Pd-catalysed cross-coupling methodologies (Negishi reaction), we 
have been able to synthesize both Fmoc- and Boc-protected unnatural amino acids 
(pyridylalanine derivative analogues) for metal-minding investigations. These were: 
Fmoc-2-Pal-OtBu (8), Fmoc-3-Pal-OtBu (9), Boc-2-Pal-OBn (11) and Boc-3-Pal-OBn (12). 
The conditions of the syntheses and yields of the target compounds were optimized, 
being Sphos the ligand used in all cases: compound 8 achieved 60% as maximum yield 
being 2-bromopyridine the coupling reagent; compound 9 achieved 55% as maximum 
yield with 3-bromopyiridine as the coupling reagent; compound 11 achieved 51% as 
maximum yield with 2-iodopyridine as coupling reagent; and, compound 12 achieved 
45% as maximum yield being 3-iodopyridine the coupling reagent. This opens a wider 
scope to be used for the synthesis of other pyridyl-type amino acid analogues by using 
the Negishi methodology. 
We were not able to synthesize the initial target BSBCA for the photoisomerization 
experiments on our peptide systems. This azobenzene derivative was desired since we 
believed that the sulfonic groups forming part of the molecule would provide a higher 
solubility when attached to our peptide designs. Though, an alternative azobenzene 
derivative to BSBCA was successfully synthesized: 4,4’-dichloroacetamido-azobenzene 
(24), being this achieved in a maximum yield of 96% (0.495 g). Compound 24 was 
found to be completely soluble under our working conditions (either ddH2O or PBS 
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buffer at pH 7.4), and its photoisomerization properties were proved to be efficiently 
incorporated in our peptide designs. As achieved in the synthesis of the unnatural 
amino acids, we also enhanced the conditions and increased the reaction yields of 24. 
We first designed and then built a chassis for de novo coiled-coil self-assembling 
peptide systems in both modes of blunt-ended and sticky-ended heterodimers. We 
found out that for the formation of α-helical coiled-coil and fibrous structures, we 
needed to double cap the peptide sequences (28 and 29) in order to provide the 
required stabilization to produce these conformations. The design of these peptide 
sequences included tuneable positions to incorporate either the synthetic 
pyridylalanine amino acids, with metal-binding properties, or to be swapped with Cys 
residues, for the attachment of the azobenzene derivative (24) through thiol-bridge 
formation. 
When the chassis peptide-systems incorporated the unnatural pyridylalanine amino 
acid derivatives, some changes in their conformational structures were observed. In 
the case of the formation of blunt-ended heterodimers, all combinations of c-BEP (29) 
with each of the pyridyl-labelled peptides (30 to 33) produced thermally stable α-
helical coiled-coil structures as verified by thermal denaturation experiments. Their 
thermal denaturation curves proved that these peptide assemblies increased their TM 
about 20 ˚C compared to the most thermally stable peptide component (c-BEP in all 
cases) and between 30 ˚C and 40 ˚C compared to the least stable peptide component 
(the pyridyl-labelled peptides in all cases). Upon addition of the metal complex K2PtCl4, 
we found that the peptide assemblies dictated the final structure of the peptide 
systems and the addition of the Pt-complex did not appear to trigger any 
conformational changes. We thought that the assembly provided by the association 
between these peptides may be more energetically favourable than the possible 
structure produced by a conformational switch induced by the metal ion. All the 
peptide systems were more thermally stable after coiled-coil formation than the 
individual peptides as indicated by their TM. In addition, the TM of the metal-peptide 
structures exhibited a similar value to the one shown by the peptide structures 
without the metal additions. 
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In the case of the formation of sticky-ends heterodimers, not all combinations of SAF 
(27) with the pyridyl-labelled peptides 30 to 33 exhibited signs of α-helical coiled-coil 
and fibre formation by CD spectroscopy: the peptide assemblies of (27+30) and 
(27+32) showed the typical CD spectra pattern for α-helical coiled-coils and fibrous 
structures whilst the mixtures (27+31) and (27+33) did not exhibit evidences of α-
helical coiled-coil or fibre formation. From the assemblies that promoted fibre 
formation, and after checking the mixture (27+30) at a lower concentration (50 µM), 
we believed that higher concentrations of the peptide mixtures (higher than 100 µM) 
might show better and faster results of fibre formation (concentration-dependent), 
with the kinetics of these processes an important issue to take into account. In 
addition, the magnitude of the θ208nm and θ222nm minimums in the CD spectra of all 
these peptide assemblies appeared to be lower than what expected for these type of 
conformations. We thought that the insertion of the unnatural amino acids within the 
peptide sequences caused this effect since it was a common feature to all of the 
peptide mixtures. 
Moreover, when comparing (27+30) and (27+33), we observed that the insertion of 
the 3-pyridylalanine motif promoted α-helical coiled-coil and fibre formation, whilst 4-
pyridylalanine was unable to produce the same effect. We thought that the distancing 
from the nitrogen atom of the 3-pyridylalanine residue to the coiled-coil backbone 
could favor stabilizing interactions – such as hydrogen bonds – to promote the 
required structure. However, due to the distancing of the nitrogen atom in the 4-
pyridylalanine residue together with the electronic effects of a para-substituted pyridyl 
ring did not produce the same effect. When comparing (27+31) with (27+32), we 
thought that the different spacing of the two pyridylalanine motifs inserted within the 
sequences may be the cause of the different effects: the spacing i  i+4 in peptide 31 
(positions f and b of the heptad repeat) was insufficient, increasing steric hindrance 
between them and preventing fibre formation, whilst for an i  i+7 the greater 
spacing in peptide 32 (positions f and f of the heptad repeat) allowed for fibre 
formation. 
The metal-binding investigations that we undertook of the mixtures of SAF with the 
pyridyl-labelled peptides provided us with important information. In the first set of 
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experiments, where the metal complex was added to the 24 hours matured peptide 
assemblies, an increase in the chiral scattering of all the coiled-coils was observed. 
However, in the second set of experiments, different results were obtained. In this 
case, the Pt(II) complex was first mixed with the individual pyridyl-labelled peptides 
(not showing important conformational changes), and 24 hours later the SAF peptide 
was added. In this cases, the addition of SAF promoted conformational changes 
increasing the degree of α-helicity in all the mixtures. However, this was never enough 
to produce fully folded α-helical coiled-coils or fibres. We thought that the addition of 
the Pt(II) complex prior to the addition of SAF slowed the kinetics of the peptide 
assembly preventing the formation of fibrous structures. From these results, we 
concluded that the order in which the pyridyl-labelled peptides 30 to 33 were mixed 
either with 27 or the Pt(II) complex was important since the two ways produced 
different rearrangements. Therefore, in the mixtures of SAF with the pyridyl-labelled 
peptides, we observed that metal-binding produced conformational changes and was 
responsible for the final structure of the assemblies. 
As a future work for these metal-binding experiments, obtaining crystal structures of 
the metal-peptide assemblies would provide information about the precise 
arrangements. This would be a useful tool to understand the interaction modes 
between peptides and to what extent the conformation is driven by the metal 
complex. TEM of the matured fibres from all the peptide mixtures between SAF (27) 
and the pyridyl-labelled peptides could be used to compare whether the length or 
thickness of these fibres changes from that formed by the chassis peptides. In the 
same direction, different stoichiometries of metal-to-peptide could be investigated 
with the same peptide systems and compare their results. Since we tested 3- and 4-
pyridylalanine derivatives, it would be interesting to investigate the effects of 2-
pyridylalanine, as well as the effects of the insertion of different mixtures of these, e.g: 
2- and 3-pyridylalanines, 2- and 4-pyridylalanines, etc. It would also be interesting to 
use different type of ligands such as bipyridyl-derivatives and investigate it these could 
promote α-helical coiled-coil and fibre formation. In the same way, different metal 
ions and metal complexes could be examined for metal-binding. Different sizes of 
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metal ions or metal ions with different coordination geometries could produce 
different peptide assemblies at different metal-peptide stoichiometries. 
With respect to the photoswitching investigations of the peptide systems that we were 
able to build with the azobenzene derivative (24), we found different photoswitching 
efficiencies. We were able to synthesize peptide partners – both capped and uncapped 
– for blunt-ended like associations and for α-helical coiled-coil formation. These 
peptides were developed from the designed chassis BEP (26) and c-BEP (29) peptides, 
from which we built peptides 34 and 36. These peptides successfully attached the 
azobenzene derivative 24 through the thiol groups of the Cys residues forming the 
cross-linked peptides (35 and 37), which exhibited reversible photoswitching 
properties. The photoswitching degree was different in each peptide system: 35 and 
37 exhibited larger switches when alone but also exhibited a certain degree of 
photoswitching when they were forming α-helical coiled-coil peptide assemblies with 
their corresponding partners, always in a blunt-ended mode. In addition, the thermal 
stability of the peptide systems increased as the C-terminus and N-terminus of the 
peptide sequences were capped. Thus, the more capped ends, the higher the thermal 
stability, but also, the lower the switch efficiency of the peptide systems. 
The success of this photoswitching effect in simple systems encourages us to try it in 
larger systems which would add a whole extra layer of complexity to the assemblies. 
The use of azobenzene derivatives for photo-regulation of peptide sequences may 
provide a potential power source for protein motors, e.g. in a motor hub to influence 
the direction and efficiency of stepping. 
Overall, in this thesis, we were able to achieve our goals of designing and synthesizing 
self-assembling peptide sequences for both blunt-ended and sticky-ended coiled-coil 
formation. The use of molecular components generated conformational switching in 
the designed structures. The tools utilized for these structural rearrangements were 
both metal-binding – by incorporating unnatural amino acid analogues – and light 
irradiation – by amplifying up the photoswitching effect of the azobenzene 
chromophore after attachment on to different coiled-coil forming peptides. 
Experimental 
169 
 
Chapter 7 
Experimental 
7.1 General experimental 
7.1.1 Reagents 
For the synthesis of unnatural amino acids, the reagents iodine, triphenyl phosphine, 
bis(dibenzylideneacetone)palladium(0), and imidazole were purchased from Alfa Aesar 
(Heysham, Lancashire, UK). The amino acid Fmoc-L-Ser-OH was purchased from both 
Novabiochem (Darmstadt, Germany) and Mimotopes Ltd. (Wirral, UK). All the other 
reagents were purchased from Sigma-Aldrich Company Ltd. (Gillingham, Dorset, UK). 
All reagents, except Zn(dust) which was acid washed, were used as received without 
further purification.  
For the synthesis of the azobenzene derivatives, all the reagents: 2,5-
diaminobenzenesulfonic acid (15), 4,4’-aminoacetanilide (20), glacial acetic acid, acetic 
anhydride, hydrogen peroxide (33%), sodium hydroxide, hydrochloric acid (37%), 
chloroacetyl chloride and potassium carbonate were purchased from Sigma-Aldrich 
Company Ltd. (Gillingham, Dorset, UK) and used as received withouth further 
purification. 
For the synthesis of the peptide sequences, the Fmoc-protected L-amino acid 
derivatives, dimethyl sulfoxide (DMSO), Tris(2-carboxyethyl)phosphine hydrochloride 
solution (TCEP-HCl), trifluoroacetic acid (TFA), Tris(hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl), piperidine, 1-Methyl-2-pyrrolidinone (NMP), and 
triisopropylsilane (TIPS) were purchased from Sigma-Aldrich Company Ltd. (Gillingham, 
Dorset, UK). Amino acid side chain functionality was protected as follows: Fmoc-
Asn(Trt)-OH, Fmoc-Cys(Trt)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Glu(tBu)-OH, Fmoc-Lys(Boc)-
OH, Fmoc-Tyr(tBu)-OH. Alanine, Isoleucine and Leucine were not side chain protected. 
Experimental 
170 
 
N,N’-Diisopropylethylamine (DIPEA), N,N’-Dimethylformamide (DMF), and the Fmoc-
protected unnatural amino acids Fmoc-L-3-pyridylalanine-OH and Fmoc-L-4-
pyridylalanine-OH were purchased from AGTC Bioproducts Ltd. (Hessle, UK). Both the 
preloaded Fmoc-Gln(Trt)-wang resin (100-200 mesh) and rink amide MBHA resin were 
purchased from Novabiochem (Darmstadt, Germany). N,N′-Diisopropylcarbodiimide 
(DIC) was purchased from Fluorochem (Derbyshire, UK). Anhydrous 1-
hydroxybenzotriazole (HOBt) was purchased from CEM peptides (Buckingham, UK). 
(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) was 
purchased from Apollo Scientific Limited (Stockport, Cheshire, UK). All reagents were 
used as received without further purification.  
For the metal-binding investigations, the platinum complex K2PtCl4 was purchased 
from Sigma-Aldrich Company Ltd. (Gillingham, Dorset, UK). This was used as received 
without further purification. 
For the synthesis of the azobenzene-peptide systems, the reagents dimethyl sulfoxide 
(DMSO), Tris(2-carboxyethyl)phosphine hydrochloride solution (TCEP-HCl), 
Tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl), and sodium hydroxide 
(NaOH) were purchased from Sigma-Aldrich Company Ltd. (Gillingham, Dorset, UK). A 
solution of NaOH (0.1M) was used to adjust the pH to 8.5 for both TCEP and Tris buffer 
solutions. The peptides were used as obtained after HPLC purification. 
 
7.1.2 General experimental: NMR, IR and ESI-MS spectroscopy 
NMR spectra were collected using a Bruker Avance 400 MHz at 400 MHz for 1H NMR 
measurements and at 100 MHz for 13C NMR measurements. Chemical shifts are 
reported in ppm and are referenced to residual solvent peaks: CHCl3 (1H 7.26 ppm, 13C 
77.0 ppm) and DMSO (1H 2.50 ppm, 13C 39.5 ppm); multiplicities; s = singlet, d = 
doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets, dt, doublet of 
triplets, m = multiplet, t = triplet, q = quartet, bd = broad doublet, bs = broad singlet, 
app s = apparent singlet, app d = apparent doublet, app t = apparent triplet, app td = 
apparent triplet doublet. J couplings are measured in Hertz (Hz). All reactions were 
monitored by TLC using Merck precoated silica gel plates. Column chromatography 
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was performed using silica gel (40-60 mM) using the solvent system indicated. All 
reported yields refer to the isolated yield and the product purity was estimated to be 
>95% by 1H NMR. 
IR spectra were recorded on a Perkin Elmer Spectrum RX1 fitted with an ATR 
attachment, intensities as; s = strong, m = medium, w = weak, v = very, bd = broad. All 
absorptions measured in cm-1.  
Electro-Spray Ionization Mass Spectra (ESI-MS) were collected on a Waters TQD mass 
spectrometer and accurate mass spectra were collected on a Waters LCT Premier XE 
mass spectrometer. 
 
7.1.3 Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass 
spectrometry (MALDI-TOF MS) 
Characterization of peptides was achieved by MALDI-TOF mass spectrometry. MALDI 
spectra were collected using an Autoflex II ToF/ToF mass spectrometer (Bruker 
Daltonik GmBH) equipped with a 337 nm nitrogen laser. All peptides were dissolved in 
deionized water (1 mg/mL) for MS analysis. MS data was processed using FlexAnalysis 
2.0 (Bruker Daltonik GmBH). 
 
7.1.4 Purification of crude peptides by RP-HPLC 
Crude peptides were purified by reversed-phase high-performance liquid 
chromatography (RP-HPLC) using a Speck and Burke Analytical C-18 column (5.0 µm, 
10.0 x 250 mm) attached to a PerkinElmer Series 200 LC Pump and 785A UV/Vis 
Detector. For preparative runs, concentrations up to 30 mg/mL (1.0 mL) were injected 
and peak fractions of interest pooled and lyophilized. Since all the peptide sequences 
synthesized in this thesis were water soluble, all samples were prepared by dissolving 
the peptide powder in H2O and the solution centrifuged before injection to remove 
undissolved material. A flow rate of 2 mL/min was used for all separations. The 
aqueous phase (solvent A) consisted of a mixture (v/v) 95% H2O/5% CH3CN with 0.1% 
TFA while the organic phase (solvent B) consisted of a mixture (v/v) 5% H2O/95% 
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CH3CN with 0.1% TFA. Initial HPLC injections of each peptide sample were set to 90 
min for linear gradients of 0-100% of solvent B to detect different compound peaks, 
and either shorter times (60 min) or shorter gradients (from solvent A to B) applied for 
subsequent injections depending on each peptide sequence. Analytical runs of the 
crude peptides after MALDI analysis were used to confirm the presence of a single 
peptide within the pure fraction. These were small-scale runs (1 mg/mL loading) in a 
30 minutes linear gradient of 0-100% of solvent B. A UV-Vis lamp was used as detector 
and 280 nm was the wavelength selected in all cases to monitor and detect the 
chromophore of the Tyr amino acid – which was part of all the peptide sequences. 
 
7.1.5 Ultraviolet-visible spectroscopy (UV-Vis) 
UV/Vis absorbance spectra were measured with a Unicam UV2-300 spectrometer 
using quartz cuvettes of 10 mm pathlength. All peptides were dissolved and measured 
in double distilled water (ddH2O) for peptide-concentration determination when using 
PBS (10x) as the buffer solution of the sample, and were dissolved within the buffer 
solution when either PBS (1x) or MOPS were used as solvent/buffer of the samples. 
Peptide samples were prepared from 1-5 mg of peptide powder dissolved in 1-2 mL of 
solvent (ddH2O, PBS or MOPS) and the absorbance recorded maximums at 280 nm 
corresponding to the absorption of Tyr, which is the chromophore for all the peptide 
sequences and shows a molar extinction coefficient of ε = 1280 cm-1mol-1 at 280 nm at 
neutral pH.1 For the labelled peptides with pyridylalanine amino acids, a maximum at 
262 nm was observed and a molar extinction coefficient of ε = 3400 cm-1mol-1 at 262 
nm was used as this is the value for picoline, which shows similarity with the chemical 
structure of the pyridylalanine motifs.  
Photoisomerization of the azobenzene derivative (24) in DMSO was monitored by 
UV/Vis and the concentration of the dark-adapted (trans isomer) azobenzene 
derivative was determined by the molar exctinction coefficient at 367 nm (ε = 28000 
cm-1mol-1).2 
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The Beer-Lambert law (Equation 7.1) was used to calculate the concentration of each 
peptide sample: 
𝐴 =  𝜀 𝑥 𝑐 𝑥 𝑙     (Eq. 7.1) 
A being the absorbance, c being the concentration of the peptide sample (mol/L), l 
being the path length of the beam of light throughout the cuvette that contains the 
sample (1 cm in our case), and ε the molar extinction coefficient (cm-1mol-1). 
Since the absorbance was determined by the spectrometer and we knew the values of 
l = 1 and the molar extinction coefficient (ε) at 280 nm (for the Tyr), at 262 nm (for the 
picoline), or at 367 nm (for the azobenzene), the concentration was calculated by: 
𝑐 =  
𝐴
𝜀
      (Eq. 7.2) 
 
7.1.6 Circular dichroism spectroscopy (CD) 
Circular dichroism (CD) is the biophysical technique used to determine the secondary 
structure of our peptides and peptide mixtures. It gives us a value of the differential 
absorbance of left- and right- handed circularly polarised light (Equation 7.3): 
∆𝐴 = 𝐴 (𝐿𝐻𝐶𝑃) − (𝑅𝐻𝐶𝑃)    (Eq. 7.3) 
Where A is absorbance, LHCP is left-handed circularly polarised light, and RHCP is right-
handed circularly polarised light. 
In general, when compound concentration and cell path length are taken into account, 
we obtain the molar circular dichroism (∆ε) (Equation 7.4): 
∆𝜀 =  𝜀 (𝐿𝐻𝐶𝑃) −  𝜀 (𝑅𝐻𝐶𝑃) =  
∆𝐴
(𝑐 𝑥 𝑙)
   (Eq. 7.4) 
Where c is the molar concentration, l is the path length (cm), and ε (LHCP) and ε 
(RHCP) are the molar extinction coefficients for the left- and right-handed circularly 
polarised light respectively. 
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However, CD measurements are usually reported in degrees of ellipticity (θ) or molar 
ellipticity (or mean residue ellipticity, MRE), which is circular dichroism corrected for 
concentration and it is calculated as shown in Equation 7.5 next: 
𝑀𝑅𝐸 =  
𝜃 (222𝑛𝑚)
(𝑐 𝑥 𝑁)
    (Eq. 7.5) 
Where θ222nm is the ellipticity at 222 nm, c is the molar concentration, and N is the 
number of amino acids involved in the peptide or peptide mixture being measured. 
CD measurements were performed using a Jasco Model J-1500 spectropolarimeter 
fitted with a Jasco J815 MCB-100 mini circulation bath. All measurements were carried 
out in thermostated quartz cuvettes of 1 mm path length. Temperatures were 
measured using a microprobe placed directly into the sample cell. All peptide samples 
for CD analysis were measured in buffer solutions of either PBS or MOPS. These 
solutions were prepared from stock solutions of higher concentrations than the 
required ones mixed with a 1/10 (v/v) of buffer solution when the buffer was PBS 
(10x). When using PBS (1x) or MOPS, the stock solutions were prepared in the buffer 
solutions and diluted to the required concentration. CD measurements were recorded 
at concentrations of: 20, 50, 100 and 200 µM to investigate concentration-dependence 
effects. Both PBS and MOPS buffer solutions were adjusted with NaOH to the 
corresponding pH: PBS at pH 7.4 and MOPS at pH 8.5. 
Thermal denaturation curves were measured by monitoring the θ222nm (mean residue 
ellipticity at 222 nm) at various temperatures ranging from 10 ˚C to 90 ˚C with a 
temperature gradient of 0.5 ˚C/min and equilibrating each reached temperature for 10 
seconds prior to next measurement. The thermal denaturation multianalysis program 
calculator method was based on what is explained next. 
Assuming that the peptide (or peptide mixture) in solution is in equilibrium at certain 
temperature such (Equation 7.6): 
     (Eq. 7.6) 
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Where N and D are the peptide (or peptide mixture) before and after denaturation 
respectively, KD is the equilibrium constant for peptide denaturation and [N] and [D] 
represent the concentration of non-denaturated and denaturated peptides. 
If denaturation occurs or not can be evaluated thermodynamically using the ∆GD free 
energy, which can be expressed in terms of KD as: 
∆𝐺𝐷  =  − 𝑅𝑇 𝑙𝑛 𝐾𝐷    (Eq. 7.7) 
In addition, since: 
∆𝐺𝐷  =  − ∆𝐻 −  𝑇∆𝑆   (Eq. 7.8) 
The enthalpy and entropy can be determined using the following equation: 
ln 𝐾𝐷 = − 
∆𝐻
𝑅
 𝑥 
1
𝑇
+  
∆𝑆
𝑅
   (Eq. 7.9) 
Since KD and T are known, the ∆H value can be found from the slope of a graph of ln KD 
against –(1/T), and the ∆S value from the intercept of a van’t Hoff graph. In addition, if 
KD = 1, in Eq. 7.9, that would mean that [N] = [D], so this would give the denaturation 
temperature value (TM) (Equation 7.10): 
𝑇𝑀 =  
∆𝐻
∆𝐺
    (Eq. 7.10) 
Photo-isomerization of the cross-linked peptides was accomplished by irradiating 
peptide solutions with either 380 nm or 450 nm light for a minimum of 20 min. 
 
7.1.7 Transmission electronic microscopy (TEM) 
For TEM measurements, images were obtained using a JEOL 2100F FEG TEM with a 
schottky field emitter operating at 200 kV, a Gatan Orius camera for acquiring high 
quality images over a wide field of view as well as diffraction patterns, a video 
capturing software using Digital Micrograph platform for dynamic experiments, a 
GATAN GIF tridiem with 4 megapixel UltrascanTM 1000 CCD camera used for energy 
filtered imaging and CBED, and a JEOL HAADF/bright field PMT and Gatan ADF/bight 
field PMT for STEM imaging. 
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Samples at 100 µM of the corresponding peptides in 10 mM MOPS at pH 8.5 were 
prepared. Fixation and embedding of the samples is carried out on the dark side of a 
carbon film grid. A droplet of the sample is added onto the grid and left for 30 seconds 
before sucking off the excess of liquid with filter paper. A droplet of double distilled 
water (ddH2O) is added onto the grid to avoid it getting dry and after 20 seconds is 
sucked off with filter paper. This washing step with ddH2O is repeated once more 
before continuing with the negative staining. A droplet of an uranyl acetate solution 
(used as negative staining) is added onto the grid and dried with filter paper after 30 
seconds. The sample is then ready to be inserted into the microscope and be analysed. 
 
7.2 General experimental procedures 
7.2.1 General procedure for the palladium-catalysed cross-coupling of 
protected iodoalanines: Negishi chemistry. 
Acid washed zinc dust (4 eq.) was placed in a pyrex test tube flask fitted with a screw 
top that could be opened when chemicals were added at the time that vacuum or 
argon were applied. The reaction flask was evacuated under heating at 100 ˚C for at 
least 30 minutes with vigorous stirring. After cooling to 70 ˚C under argon, and having 
stopped the vacuum line, anhydrous DMF (0.5 mL) and I2 (20 mg) were added and the 
light grey suspension stirred for 15 minutes. The reaction mixture was then cooled to 
50 ˚C followed by the addition of the corresponding iodoalanine, 7 or 10 (1 eq) in DMF 
(1 mL). After stirring for 5 minutes under argon, addition of the catalyst Pd(dba)2 (0.03 
eq), the ligand (0.09 eq) and the relevant aryl halide (1 eq) were added and the 
resulting black mixture stirred at 50 ˚C under argon for a minimum of 5 hours. The 
reaction mixture was sealed to keep in the Argon and cooled to room temperature 
whilst stirring overnight. Next step was purification via column chromatography 
without work-up (SiO2; 80/20 Hexane/EtOAc  100% EtOAc). After purification, work-
up was needed to remove the DMF remaining in the pyridylalanine derivatives. 
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7.2.2 Automated Fmoc Solid-Phase Peptide Synthesis 
All peptides were synthesized using solid-phase methods on an automated CEM 
Liberty1 single-channel microwave peptide synthesizer equipped with a Discover 
microwave unit. All resins were left to swell in the appropriate solvent (DMF or DCM, 
see individual syntheses in Section 7.2.3) for a minimum of 2 hours at room 
temperature before starting the couplings. All reactions were carried out using the 30 
mL polytetrafluoroethylene (PTFE) reaction vessel, with microwave heating and 
agitation by bubbling nitrogen gas. Couplings were carried out using a 5-fold excess of 
Fmoc-protected amino acid, activator (10 equiv) and activator base (20 equiv) unless 
otherwise stated. For double and triple couplings the reaction vessel was drained after 
each cycle and fresh reagents were added. Amino acid side chain functionality was 
protected as described in Section 7.1.1. Fmoc deprotections were carried out using a 
20% (v/v) solution of piperidine in DMF in all cases. 
Microwave-assisted couplings 
Microwave couplings at 0.05 mmol scale were carried out for 10 min at 75 ˚C and 20 W 
power unless otherwise stated. Cys residues were coupled at low temperature: 30 min 
at room temperature followed by 10 min at 50 ˚C (20 W). The Fmoc group was 
removed by a single treatment with piperidine solution at 75 ˚C (35 W) for 3 min. For 
0.1 mmol scale syntheses the power was increased to 25 W for couplings and 45 W for 
deprotections. 
Room temperature couplings 
Couplings at room temperature were carried out for 60 min. The Fmoc group was 
removed by two successive treatments with piperidine solution (5 min, then 10 min). 
Peptide sequences capping 
Acetylation of the N-terminus was accomplished by suspending the peptide-resin in a 
20% (v/v) solution of acetic anhydride in DMF for 30-45 min. 
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Cleavage of peptides from resin 
TFA cleavage of all peptides from resin was achieved by treating the acid-labile 
peptide-resin with 2.85 mL TFA and 0.15 mL deionized water, with 0.15 mL TIPS as 
scavenger for a minimum of 3 hours at room temperature. The resin was then 
removed by filtration and the filtrate was added dropwise to 35 mL of ice-cold diethyl 
ether. After centrifugation the supernatant was removed and the pellets suspended in 
fresh ether and centrifuged again. Following further centrifugation, the supernatant 
was discarded. The resulting solid peptide was dissolved in deionized water and 
lyophilized. 
 
7.2.3 General experimental procedures for peptide synthesis 
Peptide synthesis – Procedure 1 
Fmoc-Gln(Trt)-wang resin was used (0.59 mmol/g substitution, 0.05 mmol) and 
swollen in DMF for three hours. Both couplings and deprotections were carried out 
under microwave-assistance (see Section 7.2.2). PyBOP was the activator and 
DIPEA/NMP used as the activator base. Peptide cleavage from resin was carried out as 
described in Section 7.2.2. 
Peptide synthesis – Procedure 2 
Fmoc-Gln(Trt)-wang resin was used (0.59 mmol/g substitution, 0.10 mmol) and 
swollen in DMF for three hours. Couplings were microwaved-assisted whilst 
deprotections were carried out under conditions of room temperature (see Section 
7.2.2). PyBOP was the activator and DIPEA/NMP the activator base. Peptide cleavage 
from resin was carried out as described in Section 7.2.2. 
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Peptide synthesis – Procedure 3 
Fmoc-rink amide MBHA resin was used (0.59 mmol/g substitution, 0.01) and swollen in 
DCM for three hours. Both couplings and deprotections were carried out under 
microwave-assistance (see Section 7.2.2). HOBt was the activator and DIC the coupling 
reagent. After completion of the synthesis, the peptide was capped on the N-terminus. 
Peptide cleavage from resin was carried out as described in Section 7.2.2. 
Peptide synthesis - Procedure 4 
Fmoc-Gln(Trt)-wang resin was used (0.59 mmol/g substitution, 0.10 mmol) and 
swollen in DCM for three hours. Both couplings and deprotections were carried out 
under microwave-assistance (see Section 7.2.2). HOBt was the activator and DIC the 
coupling reagent. Peptide cleavage from resin was carried out as described in Section 
7.2.2. 
Peptide synthesis – Procedure 5 
Fmoc-rink amide MBHA resin was used (0.59 mmol/g substitution, 0.10 mmol) and 
swollen in DCM for three hours. Microwave conditions of couplings and deprotections 
were used from residues 1 to 14. Room temperature conditions of couplings and 
deprotections were used from position 15 until completion of the peptide sequence 
(see Section 7.2.2). HOBt was the activator and DIC the coupling reagent. After 
completion of the synthesis, the peptide was capped on the N-terminus. Peptide 
cleavage from resin was carried out as described in Section 7.2.2. 
Peptide synthesis – Procedure 6 
Fmoc-rink amide MBHA resin was used (0.59 mmol/g substitution, 0.10 mmol) and 
swollen in DCM for three hours. Microwave coupling and deprotection conditions were 
used except for couplings 1 and 25 to 28 which used room temperature coupling and 
deprotections conditions (see Section 7.2.2). Cys residues were coupled at low 
temperature: 30 min at room temperature followed by 10 min at 50 ˚C (20 W). HOBt 
was the activator and DIC the coupling reagent. After completion of the synthesis, the 
peptide was capped on the N-terminus. Peptide cleavage from resin was carried out as 
described in Section 7.2.2. 
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7.2.4 General procedure for metal-binding investigations 
A stock solution of the metal-complex K2PtCl4 was prepared by dissolving the red 
crystals in a 10 mM MOPS buffer solution at pH 8.5 and at room temperature (21 ˚C). 
By diluting this stock solution with the same buffer solution, different concentrations 
were prepared as needed for each one of the combinations of the metal-peptide 
assemblies. The solutions at a known concentration were mixed with the peptide 
mixtures and CD measurements were recorded at different times at 21 ˚C. 
 
7.2.5 General procedure for intramolecular cross-linking of the 
azobenzene derivative (24) to a Cys-containing peptide 
Intramolecular cross-linking of the Cys-containing peptides by compound 24 could be 
achieved as follows. A solution of the Cys-containing peptide in ddH2O (1 eq, 0.079 mM 
to 3.1 mM) was combined with a 5 mM Tris-buffer solution (pH 8.5) and TCEP (5 mM, 
pH 8.5) and incubated at room temperature under inert conditions (N2 or Ar) for a 
minimum of 1 hour. The reaction flask was protected from light with aluminium foil 
and immersed into an oil bath at 40 ˚C. When the temperature of the solution reached 
40 ˚C, a solution of azobenzene (24) in DMSO (0.78 eq) was added dropwise and 
stirred for 20 min in the dark. Another addition of a more concentrated solution of 24 
in DMSO (13.6 eq) was added dropwise and stirred for another 20 min in the dark. The 
reaction flask was then exposed to light while stirring for another 20 min. The crude 
product was lyophilized before purification by RP-HPLC. 
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7.3 Synthesis of pyridylalanine containing amino acids and precursors 
Fmoc-Ser(OH)-OtBu (6) 
Fmoc-L-Serine (5.00 g, 15.27 mmol) and tert-
butyl 2,2,2-trichloroacetimidate (8.85 g, 22.91 
mmol) were dissolved in ethyl acetate (75 mL) 
and the reaction was left to stir at r.t. for 24 h. 
The reaction mixture was concentrated under 
vacuum and the crude product was then 
purified via column chromatography (SiO2; 80/20 hexane/EtOAc  100% EtOAc) to 
afford 6 as a white solid (5.54 g, 94%). vmax(solid)/cm-1 3479.4 (w bd, O-H), 3373.3 (w, 
N-H), 2963.5 (w, C-HAr), 1736.8 (s, C=O), 1678.6 (vs, C=O), 1537.4 (s, N-H), 1259.4 (C-O); 
1H NMR δ 1.42 (s, 9H, tBu), 3.87 (m, 2H, β-CH2), 4.16 (t, 1H, J = 7.2 Hz, Fmoc-CH), 4.26 
(m, 1H, α-H), 4.35 (d, 2H, J = 9.6 Hz, Fmoc-CH2), 5.60 (d, 1H, J = 7.2 Hz, NH), 7.25 (app 
td, 2H, Jortho = 7.2 Hz, Jmeta = 1.2 Hz, Ph), 7.34 (app td, 2H, Jortho = 7.2 Hz, Jmeta = 1.2 Hz, 
Ph), 7.54 (app d, 2H, J = 7.2 Hz, Ph), 7.70 (app d, 2H, J = 7.2 Hz, Ph); 13C NMR δ 26.9 
(tBu), 46.2 (α-CH), 55.6 (Fmoc-CH), 62.7 (β-CH2), 66.2 (Fmoc-CH2), 81.9 (tBu), 118.9 
(CHAr), 124.1 (CHAr), 126.1 (CHAr), 126.7 (CHAr), 140.3 (CAr), 142.7 (CAr), 155.3 (NH-CO), 
168.4 (COOtBu); (ESI+) m/z 407.2 [M+Na]+; HRMS calculated for C22H25NO5Na 406.1630 
[M+Na]+, found 406.1612.  
The data obtained is consistent with that given in the literature.3 
 
Fmoc-Ala(I)-OtBu (7) 
Fmoc-Ser(OH)-OtBu 6 (5.19 g, 13.50 mmol),  
triphenylphosphine (3.56 g, 13.58 mmol), 
imidazole (0.92 g, 13.58 mmol) and iodine 
(solid) (1.75 g, 13.83 mmol) are dissolved in 
DCM (100 mL) . The reaction was left to stir at 
r.t. for 24 h. and then concentrated under 
vacuum. The crude product was purified via column chromatography (SiO2; 90/10 
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hexane/EtOAc  100% EtOAc) to give 7 as a sticky yellow solid (3.58 g, 54%). 
vmax(solid)/cm-1 3383.6 (w, N-H), 2968.0 (w, C-HAr), 1734.9 (s, C=O), 1698.4 (vs, C=O), 
1510.3 (s, N-H), 1387.5 (s, C-O); 1H NMR δ 1.52 (s, 9H, tBu), 3.60 (m, 2H, β-CH2-I), 4.25 
(app t, 1H, J = 4.4 Hz, α-H), 4.35 (dd, 1H, J = 4.4 and 4.0 Hz, Fmoc-CH), 4.42 (m, 2H, 
Fmoc-CH2), 5.68 (d, 1H, J = 4.0 Hz, NH), 7.32 (m, 2H, Ph), 7.4 (t, 2H, J = 4.4 Hz, Ph), 7.61 
(d, 2H, J = 4.4 Hz, Ph), 7.76 (d, 2H, J = 4.4 Hz, Ph); 13C NMR δ 27.9 (tBu), 47.1 (α-CH), 
54.0 (Fmoc-CH), 67.1 (I-CH2), 67.3 (Fmoc-CH2), 83.6 (tBu), 120.0 (CHAr), 125.2 (CHAr), 
127.1 (CHAr), 127.7 (CHAr), 141.3 (CAr), 143.7 (CAr),  155.3 (NHCO), 168.1 (COOtBu); 
(ESI+) m/z 516.2 [M+Na]+; HRMS calculated for C22H24NO4INa 516.0625 [M+Na]+, found 
516.0648. 
The data obtained is consistent with that given in the literature.4 
 
Fmoc-2-Pyridylalanine-OtBu (8) 
According to general procedure, coupling of zinc 
reagent 14, prepared from iodide 7 (0.71 mmol, 
0.35 g) with 2-bromopyridine (0.71 mmol, 67 μL) 
gave 8 as a light yellow-orange sticky solid (0.25 
g, 60%). vmax(solid)/cm-1 3380.5 (w bd, N-H), 
2965.3 (w, C-HAr), 1719.1 (s bd, C=O), 1449.6 (m, 
N-H), 1151.9 (s, C-O); 1H NMR δ 1.30 (s, 9H, tBu), 3.25 (m, 2H, β-CH2), 4.16 (app t, 2H, J 
= 7.6 Hz, Fmoc-CH), 4.27 (d, 2H, J = 7.6 Hz, Fmoc-CH2), 4.60 (m, 1H, α-H), 6.22 (d, 1H, J 
= 8 Hz, NH), 7.09 (d, 2H, J = 7.6 Hz, Py), 7.23 (app t, 2H, J = 7.2 Hz, Ph), 7.32 (t, 2H, J = 
7.6 Hz, Ph), 7.52 (m, 3H; 1H from Py and 2H from Ph), 7.69 (d, 2H, J = 7.2 Hz, Ph), 8.47 
(bd, 1H, J = 3.2 Hz, Py); 13C NMR δ 27.9 (tBu), 39.4 (Fmoc-CH2), 47.2 (Fmoc-CH), 53.9 (α-
CH), 67.0 (β-CH2), 81.8 (tBu), 119.9 (CHAr), 121.8 (CHPy), 123.8 (CHPy), 125.2 (CHAr), 
127.0 (CHAr), 127.6 (CHAr), 136.4 (CHPy), 141.2 (CAr), 144.0 (CAr), 149.1 (CHPy), 156.0 
(CPy), 157.4 (NHCO), 170.5 (COOtBu); (ESI+) m/z 467.7 [M+Na]+; HRMS calculated for 
C29H27N2O4Na 467.1971 [M+Na]+, found 467.1934. 
 
Experimental 
183 
 
Fmoc-3-Pyridylalanine-OtBu (9) 
According to general procedure, coupling of 
zinc reagent 14, prepared from iodide 7 (0.72 
mmol, 0.35 g) with 3-bromopyridine (0.72 
mmol, 0.11 g) gave 9 as a light yellow-orange 
sticky solid (0.17 g, 55%). vmax(solid)/cm-1 
3379.9 (w bd, N-H), 2960.8 (w, C-HAr), 1714.1 (s 
bd, C=O), 1449.5 (m, N-H), 1150.6 (s, C-O); 1H NMR δ 1.35 (s, 9H, tBu), 3.03 (m, 2H, β-
CH2), 4.14 (t, 2H, J = 6.4 Hz, α-H), 4.34 (m, 2H, Fmoc-CH2), 4.48 (m, 1H, Fmoc-CH), 5.30 
(d, 1H, J = 9.6 Hz, NH), 7.14 (app dd, 2H, J = 4.0 and 8.0 Hz, Py), 7.26 (m, 2H, Ph), 7.34 
(app t, 2H, J = 7.2 Hz, Ph), 7.40 (d, 1H, J = 7.6 Hz, Py), 7.51 (m, 2H, Ph), 7.70 (d, 2H, J = 
7.6 Hz, Ph), 8.36 (s, 1H, Py), 8.43 (bd, 1H, J = 4.0 Hz, Py); 13C NMR δ 28.0 (tBu), 35.7 
(Fmoc-CH2), 47.2 (Fmoc-CH), 54.8 (α-CH), 66.9 (β-CH2), 83.0 (tBu), 120.0 (CHAr), 123.2 
(CHPy), 125.0 (CHAr), 127.0 (CHAr), 127.7 (CHAr), 136.9 (CHPy), 141.3 (CAr), 143.7 (CAr), 
148.4 (CHPy), 150.6 (CHPy), 155.5 (CPy), 157.8 (NHCO), 170.0 (COOtBu); (ESI+) m/z 445.4 
[M+H]+; HRMS calculated for C29H27N2O4 445.2127 [M+H]+, found 445.2130. 
 
Boc-2-Pyridylalanine-OBn (11) 
According to general procedure, coupling of zinc 
reagent 14, prepared from Boc-Ala(I)-OBn, 10 
(1.23 mmol, 0.50 g) with 2-iodopyridine (1.23 
mmol, 0.25 g) gave the Boc-protected pyridyl 
amino ester 11 as a sticky and bright yellow oil 
(0.22 g, 51%). vmax(solid)/cm-1 3199.6 (w, N-H), 2979.3 (w, C-HAr), 1706.3 (s bd, C=O), 
1497.5 (m, N-H), 1159.1 (vs, C-O); 1H NMR δ 1.35 (s, 9H, tBu), 3.18 (dd, 1H, J = 4.4 and 
14.4 Hz, β-CH2), 3.28 (dd, 1H, J = 5.2 and 14.4 Hz, β-CH2), 4.67 (m, 1H, α-H), 4.99 (d, 1H, 
J = 12.4 Hz, OCH2Ph), 5.09 (d, 1H, J = 12.4 Hz, OCH2Ph), 5.91 (d, 1H, J = 8.0 Hz, NH), 6.94 
(d, 1H, J = 7.6 Hz, Py), 7.03 (m, 1H, Py), 7.22 (m, 5H, Ph), 7.45 (td, 2H, J = 1.6 and 7.6 Hz, 
Py), 8.38 (bd, 1H, J = 4 Hz, Py); 13C NMR δ 28.3 (tBu), 39.1 (CH2Py), 53.0 (α-CH), 66.9 
(CH2OBn), 79.7 (CtBu), 121.7 (CHPy), 123.7 (CHPy), 128.0 (CHPh), 128.2 (CHPh), 128.4 
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(CHPh), 130.9 (CPh), 135.3 (CPy), 136.4 (CHPy), 149.1 (CHPy), 155.5 (COOBn), 171.8 
(OCONH); (ESI+) m/z 380.3 [M+H+Na]+; HRMS calculated for C20H24N2O4 357.1824 
[M+H]+, found 357.1814. 
 
Boc-3-Pyridylalanine-OBn (12) 
According to general procedure, coupling of zinc 
reagent 14, prepared from Boc-Ala(I)-OBn, 10 
(1.32 mmol, 0.54 g) with 3-iodopyridine (1.32 
mmol, 0.27 g) gave the Boc-protected pyridyl 
amino acid 12 as a yellow powdery solid (0.21 g, 
45%). vmax (solid)/cm-1 3197.9 (w, N-H), 2976.2 (w, C-HAr), 1738.3 (s, C=O), 1704.0 (vs, 
C=O), 1537.4 (m, N-H), 1165.2 (vs, C-O); 1H NMR δ 1.34 (s, 9H, tBu), 2.97 (dd, 1H, J = 
5.2 Hz and 14.4, β-CH2), 3.07 (dd, 1H, J = 4.4 and 14.4 Hz, β-CH2), 4.57 (m, 1H, α-H), 
4.98 (m, 1H, NH), 5.05 (d, 1H, J = 12.0 Hz, OCH2Ph), 5.11 (d, 1H, J = 12.0 Hz, OCH2Ph), 
7.07 (m, 1H, Py), 7.26 (m, 5H, Ph), 7.31 (m, 1H, Py), 8.27 (s, 1H, Py), 8.40 (bd, 1H, J = 2.4 
Hz, Py); 13C NMR δ 28.2 (tBu), 35.5 (CH2Py), 54.1 (α-CH), 67.4 (CH2OBn), 80.1 (CtBu), 
123.3 (CHPy), 128.61 (CHPh), 128.63 (CHPh), 128.64 (CHPh), 131.6 (CPh), 134.9 (CPy), 136.7 
(CHPy), 148.4 (CHPy), 150.5 (CHPy), 154.9 (COOBn), 171.1 (OCONH); (ESI+) m/z 357.3 
[M+H]+; HRMS calculated for C20H24N2O4 357.1804 [M+H]+, found 357.1814. 
 
7.4 Synthesis of azobenzene derivative and precursors 
2-Acetylamino-5-aminoazobenzenesulfonic acid (16a) 
2,5-Diaminobenzenesulfonic acid (15) (8.20 g, 43.56 mmol) was 
suspended in glacial acetic acid (200 mL). The reaction flask is 
sealed and immersed in an oil bath at 94 ˚C. Acetic anhydride 
(5.1 mL, 53.58 mL) is then added dropwise while stirring under 
reflux. The reaction is left to stir for 2 hours and 30 min at 94 ˚C. 
The flask is removed from the oil bath and its reaction content is 
left to cool down to room temperature. The mixture was filtered through P8 coarse 
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filter paper using a Hirsch funnel under aspirator vacuum. The reaction flask was rinsed 
with hot acetic anhydride (3 x 5 mL). The crude product was collected from the filter 
and left to dry using a vacuum pump. A pink solid was yielded (9.52 g, 97%) which after 
RP-HPLC purification in a gradient 0-100% of solvent B – this being (v/v) 5% H2O/95% 
CH3CN with 0.1% TFA as explained in Section 7.1.4 – over 20 min afforded compound 
16a at a retention time of 9.90 min (5.93 g, 59%). vmax(solid)/cm-1 3389.5 (w, N-H), 
1670.6 (m, C=O), 1525.0 (s, CAr-CAr), 1289.6 (m, C-O) 1016.9 (s, C-N); 1H NMR (DMSO-
d6) δ 2.06 (s, 3H, CH3), 7.27 (dd, 1H, J = 6.4 and 8.8 Hz, CHbAr), 7.69 (d, 1H, J = 2.4 Hz, 
CHaAr), 8.38 (d, 1H, J = 8.8 Hz, CHcAr), 10.35 (s, 1H, NH); 13C NMR (DMSO-d6) δ 25.3 
(CH3), 121.1 (Cc), 121.8 (Ca), 121.9 (Cb), 124.4 (CNH2) 134.9 (CSO3H) 136.6 (Cacetamido), 
168.3 (CO); (ESI-) m/z 230.8 [M]-; HRMS calculated for C16H14Cl2N4O2 230.2406 [M+H]+, 
found 229.9103. 
The data obtained is consistent with that given in the literature.5 
 
2,5-Diacetylaminobenzenesulfonic acid (16b) 
2,5-Diaminobenzenesulfonic acid (15) (8.20 g, 43.56 mmol) was 
suspended in glacial acetic acid (200 mL). The reaction flask was 
sealed and immersed in an oil bath at 94 ˚C. Acetic anhydride 
(5.1 mL, 53.58 mL) was then added dropwise while stirring 
under reflux. The reaction was left to stir for 2 hours and 30 min 
at 94 ˚C. The flask was removed from the oil bath and its 
content was left to cool down to room temperature. The 
mixture was filtered through P8 coarse filter paper using a Hirsch funnel under 
aspirator vacuum. The reaction flask was rinsed with hot acetic anhydride (3 x 5 mL). 
The crude product was collected from the filter and left to dry using a vacuum pump. A 
pink solid was yielded (9.52 g, 97%) which after RP-HPLC purification in a gradient 0-
100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in 
Section 7.1.4 – over 20 min afforded compound 16b at a retention time of 12.88 min  
(2.22 g, 24%). vmax (solid)/cm-1 3390.7 (w, N-H), 1675.0 (m, C=O), 1530.7 (s, CAr-CAr), 
1291.5 (m, C-O) 1019.0 (s, C-N); 1H NMR (DMSO-d6) δ 2.01 (s, 3H, CH3), 2.03 (s, 3H, 
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CH3), 7.57 (dd, 1H, J = 2.4 and 8.8 Hz, CHbAr), 7.86 (d, 1H, J = 2.4 Hz,  CHaAr), 8.16 (d, 1H, 
J = 8.8 Hz,  CHcAr), 9.92 (s, 1H, NH), 10.35 (s, 1H, NH); 13C NMR (DMSO-d6) δ 24.3 (CH3), 
25.3 (CH3), 118.2 (CHAr), 120.3 (CHAr), 120.4 (CHAr), 130.9 (CSO3H), 134.2 (CAcetamido), 
135.9 (CAcetamido), 167.6 (CO), 168.4 (CO); (ESI-) m/z 270.9 [M]-; HRMS calculated for 
C16H14Cl2N4O2 272.2703 [M+H]+, found 270.9762. 
 
4,4’-Di(acetylamino)-azobenzene (22) 
4,4’ aminoacetanilide (20) (15.00 g, 0.099 mol) 
was dissolved in acetic acid (297 mL). The flask 
was wrapped with aluminium foil to protect 
the reaction from light. Hydrogen peroxide 
(33%) (30 mL) was then added slowly whilst 
stirring at room temperature. After 6 hours stirring the mixture, deionized water (350 
mL) was added and left to stir for 20 minutes. The precipitated brown product was 
filtered off and washed with water (250 mL). After drying under reduced pressure, 
compound 22 was afforded as a brown solid (4.21 g, 14%). vmax(solid)/cm-1 3318-3192 
(s bd, N-H amide), 2983 (s, C-HAr), 1646 (m, C=O), 1599 and 1533 (s, N=N), 1270 (C-O), 
1155 (m, Ph-N); 1H NMR (DMSO-d6) δ 2.10 (s, 6H, CH3), 7.79 (d, 4H, J = 8.8 Hz, CHAr), 
7.83 (d, 4H, J = 8.8 Hz, CHAr), 10.28 (s, 2H, NH); 13C NMR (DMSO-d6) δ 23.1 (CH3), 118.1 
(CHAr), 122.3 (CHAr), 140.9 (CAr), 146.5 (CAr), 167.7 (CO); (ESI-) m/z 295.20 [M]-; HRMS 
calculated for C16H16N4O2 296.3317 [M+H]+, found 297.1347. 
The data obtained is consistent with that given in the literature.6 
 
4,4’-Diamino-azobenzene (23) 
4,4’-di(acetylamino)-azobenzene (22) (1.45 g, 4.89 
mmol) was suspended in methanol (80 mL). Whilst 
stirring, concentrated HCl (40 mL) was added and the 
mixture was heated under reflux for 3 hours. The 
solvent was removed in vacuo, and the residue was 
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taken up in water (80 mL). The solution was basified to pH 8.5 by adding dropwise 
NaOH (1M). The precipitated product was filtered off, and was washed twice with 
water (40 mL). The filter cake was taken up in acetone. Removal of the solvent yielded 
23 as a dark brown solid (0.67 g, 84%). vmax(solid)/cm-1 3352 (m, N-H2 stretching 
vibrations), 2982 (m, C-HAr), 1623 and 1581 (s, N=N), 1148 (m, Ph-N); 1H NMR (DMSO-
d6) δ 5.74 (s, 4H, NH2), 6.63 (d, 4H, J = 2.0 Hz, CHAr), 7.52 (d, 4H, J = 2.0 Hz, CHAr); 13C 
NMR (DMSO-d6) δ 113.9 (CHAr), 124.2 (CHAr), 143.6 (CNH2), 151.4 (CN=N); (ESI+) m/z 
213.08 [M]+, 236.06 [M+Na]+; HRMS calculated for C12H12N4 212.2678 [M+H]+, found 
213.1117. 
The data obtained is consistent with that given in the literature.7 
 
4,4’-Dichloroacetamide-azobenzene (24) 
4,4’-diamino-azobenzene (23) (0.30 g, 1.88 
mmol) was suspended in acetonitrile (150 
mL). Whilst stirring at room temperature, 
potassium carbonate (0.78 g, 5.65 mmol) 
and chloroacetyl chloride (0.45 mL, 5.65 
mmol) are added and left to stir for 6 hours at room temperature. The reaction flask is 
immersed in an ice bath for 30 min before filtering it off under reduced pressure. 
Water (20 mL) is used to wash the reaction flask. Drying the product under reduced 
pressure yielded 24 as a dark purple solid (0.495 g, 96%). vmax(solid)/cm-1 3272-3143 
(m bd, N-H amide), 2982 (s, C-HAr), 1676 (m, C=O), 1619 and 1553 (s, N=N), 1295 (C-O), 
1246 (vs, CH2-Cl), 1150 (m, Ph-N); 1H NMR (DMSO-d6) δ 4.33 (s, 4H, CH2), 7.82 (d, 4H, J 
= 8.8 Hz, CHAr), 7.89 (d, 4H, J = 8.8 Hz, CHAr), 10.66 (s, 2H, NH); 13C NMR (DMSO-d6) δ 
43.6 (CH2), 119.6 (CHAr), 123.5 (CHAr), 141.1 (CAr), 148.0 (CAr), 165.0 (CO); (ESI-) m/z 
363.09 [M]-; HRMS calculated for C16H14Cl2N4O2 365.2106 [M+H]+, found 365.0578. 
The data obtained is consistent with the iodo-derivative given in the literature.8 
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7.5 Synthesis of peptide sequences 
PEP1, KIAALKQKNAALKQEIAALEYEIEALEQ (25) 
Synthesized via automated SPPS on low loaded Fmoc-Gln(Trt)-wang resin (0.59 
mmol/g substitution). Peptide synthesis – procedure 1 (Section 7.2.3) at a 0.05 mmol 
scale produced 78 mg crude peptide (50%) whilst procedure 2 (Section 7.2.3) at a 0.10 
mmol scale gave 235 mg crude peptide (75%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.18 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3127.5 [M]+, 3128.5 [M+H]+, 3149.6 [M+Na]+, 3151.5 [M+H+Na]+; 
HRMS calculated for C140H236N36O44 1564.3761 [M+2H]2+, found 1564.3783 [M+2H]2+. 
 
BEP, EIAALEYENAALEQKIKALKQKIKALKQ (26) 
Synthesized via automated SPPS on low loaded Fmoc-Gln(Trt)-wang resin (0.59 
mmol/g substitution) following peptide synthesis – procedure 1 (Section 7.2.3) at a 
0.05 mmol scale produced 90 mg crude peptide (57%). Analytical RP-HPLC using a 
linear gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% 
TFA as explained in Section 7.1.4 –  over 30 min showed a retention time of the pure 
peptide at 13.86 min. Final purification was achieved by RP-HPLC as described in 
Section 7.1.4. MALDI-TOF MS m/z 3183.5 [M]+, 3184.5 [M+H]+; HRMS calculated for 
C144H248N38O42 1592.4312 [M+2H]2+, found 1592.4298 [M+2H]2+. 
 
SAF, KIKALKQKIKALKQEIAALEYENAALEQ (27) 
Synthesized via automated SPPS on low loaded Fmoc-Gln(Trt)-wang resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 1 (Section 7.2.3) on a 0.05 
mmol scale produced 72 mg crude peptide (45%) whilst using procedure 4 (Section 
7.2.3) at a 0.10 mmol scale produced 235 mg (74%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
Experimental 
189 
 
at 13.50 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3183.3 [M]+, 3184.3 [M+H]+, 3206.4 [M+Na]+; HRMS calculated for 
C144H248N38O42 1592.4312 [M+2H]2+, found 1592.9265 [M+2H]2+. 
 
c-PEP1, CH3O-KIAALKQKNAALKQEIAALEYEIEALEQ-NH2 (28) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) following peptide synthesis – procedure 3 (Section 7.2.3) at a 
0.10 mmol scale gave 258 mg crude peptide (82%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.86 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3191.5 [M+Na]+, 3207.4 [M+K]+; HRMS calculated for 
C142H239N37O44 1584.8894 [M+2H]2+, found 1584.8926 [M+2H]2+. 
 
c-BEP, CH3O-EIAALEYENAALEQKIKALKQKIKALKQ-NH2 (29) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 3 (Section 7.2.3) at a 0.10 
mmol scale gave 222 mg crude peptide (69%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 14.68 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3224.7 [M]+, 3225.7 [M+H]+, 3246.7 [M+Na]+; HRMS calculated for 
C146H251N39O42 1612.9445 [M+2H]2+, found 1613.4443 [M+2H]2+. 
 
c-3PAL14, CH3O-KIAALKQKNAALK(Pal)EIAALEYEIEALEQ-NH2 (30) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 5 (Section 7.2.3) on a 0.10 
mmol scale gave 208 mg crude peptide (65%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
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explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.56 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3211.8 [M+Na]+, 3233.7 [M+2Na]+; HRMS calculated for 
C145H239N37O43 1063.5972 [M+3H]3+, found 1063.9231 [M+3H]3+. 
 
c-3PAL10PAL14, CH3O-KIAALKQKN(Pal)ALK(Pal)EIAALEYEIEALEQ-NH2 (31) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 5 (Section 7.2.3) at a 0.10 
mmol scale gave 274 mg crude peptide (84%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.19 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3288.8 [M+Na]+; HRMS calculated for C150H242N38O43 1633.4052 
[M+2H]2+, found 1633.4093 [M+2H]2+. 
 
c-3PAL7PAL14, CH3O-KIAALK(Pal)KNAALK(Pal)EIAALEYEIEALEQ-NH2 (32) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 5 (Section 7.2.3) at a 0.10 
mmol scale produced 137 mg crude peptide (43%). (Some peptide was lost during 
preparation). Analytical RP-HPLC using a linear gradient of 0-100% of solvent B – this 
being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as explained in Section 7.1.4 –  over 30 
min showed a retention time of the pure peptide at 15.35 min. Final purification was 
achieved by RP-HPLC as described in Section 7.1.4. MALDI-TOF MS m/z 3208.3 [M]+, 
3231.2 [M+Na]+; 3232.2 [M+H+Na]+; 3254.3 [M+2Na]+; HRMS calculated for 
C147H235N37O43 1070.2561 [M+3H]3+, found 1070.2534 [M+3H]3+. 
 
c-4PAL14, CH3O-KIAALKQKNAALK(Pal)EIAALEYEIEALEQ-NH2 (33) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) following peptide synthesis – procedure 5 (Section 7.2.3) at a 
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0.10 mmol scale gave 190 mg crude peptide (60%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.72 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3211.9 [M+Na]+, 3227.4 [M+K]+; HRMS calculated for 
C145H239N37O43 1594.8920 [M+2H]2+, found 1594.9025 [M+2H]2+. 
 
CYS, EIAALEYENCALEQKIKALKCKIKALKQ (34) 
Synthesized via automated SPPS on low loaded Fmoc-Gln(Trt)-wang resin (0.59 
mmol/g substitution) following peptide synthesis – procedures 1 and 2 (Section 7.2.3). 
Procedure 1 (0.05 mmol scale) gave 77 mg crude peptide (48%) whilst procedure 2 
(0.10 mmol scale) afforded 175 mg crude peptide (55%). Analytical RP-HPLC using a 
linear gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% 
TFA as explained in Section 7.1.4 – over 30 min showed a retention time of the pure 
peptide at 13.33 min. Final purification was achieved by RP-HPLC as described in 
Section 7.1.4. MALDI-TOF MS m/z 3190.6 [M]+, 3192.6 [M+H]+; 3214.6 [M+H+Na]+. 
 
c-CYS, CH3O-EIAALEYENCALEQKIKALKCKIKALKQ-NH2 (36) 
Synthesized via automated SPPS on low loaded Fmoc-rink amide MBHA resin (0.59 
mmol/g substitution) using peptide synthesis – procedure 6 (Section 7.2.3) at a 0.10 
mmol scale gave 170 mg crude peptide (53%). Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 12.29 min. Final purification was achieved by RP-HPLC as described in Section 7.1.4. 
MALDI-TOF MS m/z 3231.5 [M]+, 3253.5 m/z [M+Na]+; HRMS calculated for 
C144H248N38O41S2 646.5535 [M+5H]5+, found 646.9664 [M+5H]5+. 
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7.6 Synthesis of cross-linked azobenzene-peptide systems 
CL, (EIAALEYENCALEQKIKALKCKIKALKQ + 24) (35) 
A solution of CYS (34) in water (2 mL, 0.079 mM) was incubated in Tris-HCl pH 8.5 (4 
mL, 5 mM) and TCEP-HCl pH 8.5 (2 mL, 0.088 mM) and stirred at room temperature, 
for a minimum of 2 hours under N2. The reaction flask was protected from light with 
aluminium foil and the solution heated up to 40 ˚C. When the temperature of the 
solution reached 40 ˚C, a solution of azobenzene (24) in DMSO (4 mL, 0.064 mM) was 
added dropwise and left to stir for 20 min in the dark. Another addition of a more 
concentrated solution of 24 in DMSO (3 mL, 1.06 mM) was added dropwise and left to 
stir for another 20 min in the dark. The reaction flask was then exposed to light while 
stirring for 20 min. The crude product was then lyophilized and final purification was 
achieved by RP-HPLC as described in Section 7.1.4. MALDI-TOF MS m/z 3484.1 [M+H]+, 
3506.2 [M+Na]+. 
 
c-CL, (CH2O-EIAALEYENCALEQKIKALKCKIKALKQ-NH2 + 24) (37) 
A solution of c-CYS (36) in water (15 mL, 3.47 mM) was incubated in Tris-HCl pH 8.5 (5 
mL, 5 mM) and TCEP-HCl pH 8.5 (5 mL, 5 mM) and stirred at room temperature, for a 
minimum of 2 hours under N2. The reaction flask was protected from light with 
aluminium foil and the solution heated up to 40 ˚C. When the temperature of the 
solution reached 40 ˚C, a solution of azobenzene (24) in DMSO (4 mL, 3.5 mM) was 
added dropwise and left to stir for 20 min in the dark. Another addition of a more 
concentrated solution of 24 in DMSO (2 mL, 65 mM) was added dropwise and left to 
stir for another 20 min in the dark. The reaction flask was then exposed to light while 
stirring for 20 min. The crude product was then lyophilized and final purification was 
achieved by RP-HPLC as described in Section 7.1.4. Analytical RP-HPLC using a linear 
gradient of 0-100% of solvent B – this being (v/v) 5% H2O/95% CH3CN with 0.1% TFA as 
explained in Section 7.1.4 –  over 30 min showed a retention time of the pure peptide 
at 15.19 min. MALDI-TOF MS m/z 3524.9 [M]+, 3546.6 [M+Na]+; HRMS calculated for 
C160H260N42O43S2 705.5765 [M+5H]5+, found 705.5862 [M+5H]5+. 
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APPENDICES 
Chapter 3 – Development of the chassis of de novo coiled-coil 
self-assembling peptide systems 
 
Figure A3.1: CD spectra of PEP1 (25) in PBS buffer at pH 7.4 at different concentrations at 21 ˚C. 
 
 
 
Figure A3.2: CD spectra of BEP (26) in PBS buffer at pH 7.4 at different concentrations at 21 ˚C. 
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Figure A3.3: CD spectra of (PEP1+BEP) (25+26) in PBS buffer at pH 7.4 at different concentrations and at 
21 ˚C. 
 
 
 
 
Figure A3.4: Thermal denaturation curves of (PEP1+BEP) (25+26) in PBS buffer at pH 7.4 at different 
concentrations. 
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Figure A3.5: CD spectra of SAF (27) in PBS buffer at pH 7.4 at different concentrations at 21 ˚C. 
 
 
 
 
Figure A3.6: CD spectra of (PEP1+SAF) (25+27) in PBS buffer at pH 7.4 at different concentrations and at 
21 ˚C. 
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Figure A3.7: Thermal denaturation curves of (PEP1+SAF) (25+27) in PBS buffer at pH 7.4 at different 
concentrations. 
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20 µM, pH 7.4 θ222nm(deg mol-1 cm2) θ222nm/ θ208nm % helicity 
PEP1 (25) -3870.34 0.40 12.4 
BEP (26) -9080.66 0.68 29.2 
SAF (27) -4123.95 0.52 13.2 
PEP1 + BEP (25+26) -13072.90 0.74 36.9 
PEP1 + SAF (25+27) -2334.43 0.36 6.6 
Table A3.1: Summarised data obtained at pH 7.4 from peptides 25, 26 and 27 and the mixtures (25+26) 
and (25+27) at 20 µM in PBS at 21 °C. 
 
 
50 µM, pH 7.4 θ222nm(deg mol-1 cm2) θ222nm/ θ208nm % helicity 
PEP1 (25) -2382.16 0.33 7.7 
BEP (26) -9712.21 0.69 31.2 
SAF (27) -2833.79 0.45 9.1 
PEP1 + BEP (25+26) -13417.70 0.80 37.9 
PEP1 + SAF (25+27) -2648.90 0.38 7.5 
Table A3.2: Summarised data obtained at pH 7.4 from peptides 25, 26 and 27 and the mixtures (25+26) 
and (25+27) at 50 µM in PBS at 21 °C. 
 
 
200 µM, pH 7.4 θ222nm(deg mol-1 cm2) θ222nm/ θ208nm % helicity 
PEP1 (25) -1931.11 0.30 6.2 
BEP (26) -8674.98 0.69 27.9 
SAF (27) -3633.71 0.51 11.7 
PEP1 + BEP (25+26) -13218.30 0.84 37.3 
PEP1 + SAF (25+27) -3154.03 0.46 8.9 
Table A3.3: Summarised data obtained at pH 7.4 from peptides 25, 26 and 27 and the mixtures (25+26) 
and (25+27) at 200 µM in PBS at 21 °C. 
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Figure A3.8: CD spectra of c-PEP1 (28) in MOPS at pH 8.5 at different concentrations at 21 ˚C. 
 
 
 
 
Figure A3.9: Thermal denaturation curves of c-PEP1 (28) in MOPS at pH 8.5 at different concentrations. 
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Figure A3.10: CD spectra of c-BEP (29) in MOPS at pH 8.5 at different concentrations at 21 ˚C. 
 
 
 
 
Figure A3.11: Thermal denaturation curves of c-BEP (29) in MOPS at pH 8.5 at different concentrations. 
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Figure A3.12: CD spectra of SAF (27) in MOPS at pH 8.5 at different concentrations at 21 ˚C. 
 
 
 
 
Figure A3.13: Thermal denaturation curves of SAF (27) in MOPS at pH 8.5 at different concentrations. 
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Figure A3.14: CD spectra of 100 µM solutions of c-PEP1 (28), c-BEP (29) and (c-PEP1+c-BEP) (28+29) in 
10 mM MOPS buffer at pH 8.5 and at 10 ˚C. 
 
 
 
Figure A3.15: CD spectra of 100 µM solutions of c-PEP1 (28), SAF (27) and (c-PEP1+SAF) (28+27) in 10 
mM MOPS buffer at pH 8.5 and at 10 ˚C. 
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Chapter 4 – Coiled-coil self-assembling peptide systems 
susceptible to conformational changes upon metal-binding 
 
Figure A4.1: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL14 (30) and (c-BEP+c-3PAL14) (29+30) 
in 10 mM MOPS buffer at pH 7.2 at 21 ˚C. The peptide sequences are shown. X = 3-pyridylalanine (3-Pal) 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Figure A4.2: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL14 (30) and (c-
BEP+c-3PAL14) (29+30) in 10 mM MOPS buffer at pH 7.2. TM (c-BEP) = 49.4 ˚C; TM (c-3PAL14) = 34.2 ˚C; 
TM (c-BEP+c-3PAL14) = 70.0 ˚C. 
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Figure A4.3: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL10PAL14 (31) and (c-BEP+c-
3PAL10PAL14) (29+31) in 10 mM MOPS buffer at pH 7.2 at 21 ˚C. The peptide sequences are shown. X = 
3-Pal:  
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
 
 
Figure A4.4: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL10PAL14 (31) and (c-
BEP+c-3PAL10PAL14) (29+31) in 10 mM MOPS buffer at pH 7.2. TM (c-BEP) = 49.4 ˚C; TM (c-
3PAL10PAL14) = 31.4 ˚C; TM (c-BEP+c-3PAL10PAL14) = 68.2 ˚C. 
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Figure A4.5: CD spectra of 100 µM solutions of c-BEP (29), c-3PAL7PAL14 (32) and (c-BEP+c-
3PAL7PAL14) (29+32) in 10 mM MOPS buffer at pH 7.2 at 21 ˚C. The peptide sequences are shown. X = 
3-Pal 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
 
Figure A4.6: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL7PAL14 (32) and (c-
BEP+c-3PAL7PAL14) (29+32) in 10 mM MOPS buffer at pH 7.2. TM (c-BEP) = 49.4 ˚C; TM (c-3PAL7PAL14) = 
30.0 ˚C; TM (c-BEP+c-3PAL7PAL14) = 66.2 ˚C. 
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Figure A4.7: CD spectra of 100 µM solutions of c-BEP (29), c-4PAL14 (33) and (c-BEP+c-4PAL14) (29+33) 
in 10 mM MOPS buffer at pH 7.2 at 21 ˚C. The peptide sequences are shown. X = 4-Pal 
c-BEP:   Ac-EIAALEYENAALEQKIKALKQKIKALKQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
 
Figure A4.8: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-4PAL14 (33) and (c-
BEP+c-4PAL14) (29+33) in 10 mM MOPS buffer at pH 7.2. TM (c-BEP) = 49.4 ˚C; TM (c-4PAL14) = 30.2 ˚C; 
TM (c-BEP+c-4PAL14) = 65.2 ˚C. 
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Peptide or peptide 
systems 
pH θ222  
(deg mol-1 cm2) 
θ222/θ208 % helicity TM (°C) 
c-BEP (29) 7.2 -22912.9 0.97 73.6 49.4 
 8.5 -20860.2 1.00 67.0 50.6 
c-3PAL14 (30) 7.2 -12033.5 0.92 38.6 34.2 
 8.5 -12216.4 0.91 39.2 36.8 
c-3PAL10PAL14 (31) 7.2 -7445.4 0.75 23.9 31.4 
 8.5 -8107.6 0.79 26.0 29.2 
c-3PAL7PAL14 (32) 7.2 -8358.0 0.83 26.8 30.0 
 8.5 -5356.7 0.72 17.2 < 25.0 
c-4PAL14 (33) 7.2 -8564.4 0.75 27.5 30.2 
 8.5 -10045.1 0.80 32.3 31.1 
(29+30) 7.2 -22575.5 1.01 63.7 70.0 
 8.5 -29760.4 1.07 84.0 69.1 
(29+31) 7.2 -19306.8 1.02 54.5 68.2 
 8.5 -23813.6 1.06 67.2 66.6 
(29+32) 7.2 -23560.0 1.04 66.5 66.2 
 8.5 -27542.0 1.09 77.7 66.8 
(29+33) 7.2 -21462.7 1.00 60.6 65.2 
 8.5 -26179.5 1.04 73.9 68.0 
Table A4.1: Summary of the obtained data of 100 µM solutions of all the individual peptides and peptide 
systems of Section 4.3 in 10 mM MOPS at pH 8.5 and at 21 °C compared to the obtained data at pH 7.2 
under the same conditions of peptides concentration and temperature. These peptide data consists of: 
ellipticity at 222 nm (θ222), the ellipticity ratio between 222 nm and 208 nm (θ222/θ208), the percentage of 
helicity, and the melting temperature (TM). 
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Figure A4.9: CD spectra of 100 µM (c-BEP+c-3PAL10PAL14) (29+31) in 10 mM MOPS at pH 8.5 at 21 ˚C 
after 48 hours, and the result after the addition of the metal complex K2PtCl4 at different intervals of 
time: t=0 (purple line), after 15 hours (blue line), after 20 hours (yellow line) and after 45 hours (green 
line). 
 
 
Figure A4.10: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL10PAL14 (31), their 
mixture (29+31), and their mixture with the K2PtCl4 complex (29+31+Pt(II)) in 10 mM MOPS buffer at pH 
8.5. TM (29) = 50.6 ˚C; TM (31) = 29.2 ˚C; TM (29+31) = 66.8 ˚C; TM (29+31+Pt(II)) ~ 65.0 ˚C. 
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Figure A4.11: CD spectra of 100 µM (c-BEP+c-3PAL7PAL14) (29+32) in 10 mM MOPS at pH 8.5 at 21 ˚C 
after 48 hours, and the result after the addition of the metal complex K2PtCl4 at different intervals of 
time: t=0 (purple line), after 15 hours (blue line), after 20 hours (yellow line) and after 45 hours (green 
line). 
 
 
 
Figure A4.12: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-3PAL7PAL14 (32), their 
mixture (29+32), and their mixture with the K2PtCl4 complex (29+32+Pt(II)) in 10 mM MOPS buffer at pH 
8.5. TM (29) = 50.6 ˚C; TM (32) < 25 ˚C; TM (29+32) = 66.8 ˚C; TM (29+32+Pt(II)) = 70.7 ˚C. 
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Figure A4.13: CD spectra of 100 µM (c-BEP+c-4PAL14) (29+33) in 10 mM MOPS at pH 8.5 at 21 ˚C after 
48 hours, and the result after the addition of the metal complex K2PtCl4 at different intervals of time: t=0 
(purple line), after 15 hours (blue line), after 20 hours (yellow line) and after 45 hours (green line). 
 
 
 
Figure A4.14: Thermal denaturation curves of 100 µM solutions of c-BEP (29), c-4PAL14 (33), their 
mixture (29+33), and their mixture with the K2PtCl4 complex (29+33+Pt(II)) in 10 mM MOPS buffer at pH 
8.5. TM (29) = 50.6 ˚C; TM (33) = 31.1 ˚C; TM (29+33) = 68.0 ˚C; TM (29+33+Pt(II)) = 68.5 ˚C. 
 
 
-30000
-25000
-20000
-15000
-10000
-5000
0
5000
10000
15000
190 200 210 220 230 240 250 260
M
R
E 
(d
eg
 m
o
l-1
cm
2
)
wavelength (nm)
(29+33) t=48h
(29+33) t=48h + Pt(II) t=0
(29+33) t=48h + Pt(II) t=15h
(29+33) t=48h + Pt(II) t=20h
(29+33) t=48h + Pt(II) t=45h
-30000
-25000
-20000
-15000
-10000
-5000
0
10 20 30 40 50 60 70 80 90
M
R
E 
(d
eg
 m
o
l-1
cm
2
)
Temperature (˚C)
c-BEP (29)
c-4PAL14 (33)
(29+33)
(29+33+Pt(II))
Appendices 
211 
 
  
Figure A4.15: CD spectra of 50 µM (c-BEP+c-3PAL14) (29+30) in 10 mM MOPS at pH 8.5 and at 21 ˚C at 
different intervals of time for the first 9 hours, and the result after the addition of the metal complex 
K2PtCl4 at the initial time (purple line) and after 12 hours (green line). 
 
 
 
Figure A4.16: CD spectra of 50 µM (c-BEP+c-3PAL10PAL14) (29+31) in 10 mM MOPS at pH 8.5 at 21 ˚C at 
different intervals of time for the first 9 hours, and the result after the addition of the metal complex 
K2PtCl4 at the initial time (purple line) and after 12 hours (green line). 
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Figure A4.17: CD spectra of 50 µM (c-BEP+c-3PAL7PAL14) (29+32) in 10 mM MOPS at pH 8.5 and at 21 
˚C at different intervals of time for the first 9 hours, and the result after the addition of the metal 
complex K2PtCl4 at the initial time (purple line) and after 12 hours (green line). 
 
 
 
Figure A4.18: CD spectra of 50 µM (c-BEP+c-4PAL14) (29+33) in 10 mM MOPS at pH 8.5 and at 21 ˚C at 
different intervals of time for the first 9 hours, and the result after the addition of the metal complex 
K2PtCl4 at the initial time (purple line) and after 12 hours (green line). 
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Figure A4.19: CD spectra of 100 µM solutions of SAF (27), c-3PAL14 (30) and (SAF+c-3PAL14) (27+30) in 
10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
 
Figure A4.20: CD spectra of 100 µM solutions of SAF (27), c-3PAL10PAL14 (31) and (27+31) in 10 mM 
MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL10PAL14:  Ac-KIAALKQKNXALKXEIAALEYEIEALEQ-Am 
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Figure A4.21: CD spectra of 100 µM solutions of SAF (27), c-3PAL7PAL14 (32) and (27+32) in 10 mM 
MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 3-pyridylalanine (3-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-3PAL7PAL14:  Ac-KIAALKXKNAALKXEIAALEYEIEALEQ-Am 
 
Figure A4.22: CD spectra of 100 µM solutions of SAF (27), c-4PAL14 (33) and (SAF+c-4PAL14) (27+33) in 
10 mM MOPS buffer at pH 8.5 at 21 ˚C. The peptide sequences are shown. X = 4-pyridylalanine (4-Pal) 
SAF:   Ac-KIKALKQKIKALKQEIAALEYENAALEQ-Am    
 c-4PAL14:  Ac-KIAALKQKNAALKXEIAALEYEIEALEQ-Am 
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Chapter 5 – Photoswitching investigations in de novo coiled-coil 
peptide systems 
 
Figure A5.1: Photoisomerization of CL (35) at an estimated concentration of 25µM in ddH2O at 21 ˚C. 
The peptide sequence of CL (35) is shown. The residues Cys (in red on the sequence) are the binding 
sites through which the azobenzene 24 is attached: 
 CL:  EIAALEYENCALEQKIKALKCKIKALKQ 
 
 
Figure A5.2: Photoisomerization of c-CL (37) 20µM in PBS at pH 7.4 at 21 ˚C. The peptide sequence (37) 
is shown. The residues Cys (in red on the sequence) are the binding sites through which the azobenzene 
24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
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Figure A5.3: Photoisomerization of c-CL (37) 50µM in PBS at pH 7.4 at 21 ˚C. The peptide sequence (37) 
is shown. The residues Cys (in red on the sequence) are the binding sites through which the azobenzene 
24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
 
 
Figure A5.4: Photoisomerization of c-CL (37) 200µM in PBS at pH 7.4 at 21 ˚C. The peptide sequence (37) 
is shown. The residues Cys (in red on the sequence) are the binding sites through which the azobenzene 
24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
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Figure A5.5: CD spectrum of the trans-initial conformation of c-CL (37) in PBS at pH 7.4 at different 
concentrations at 21 ˚C. The peptide sequence (37) is shown. The residues Cys (in red on the sequence) 
are the binding sites through which the azobenzene 24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
 
 
Figure A5.6: CD spectrum of the cis-irradiated conformation of c-CL (37) in PBS at pH 7.4 at different 
concentrations at 21 ˚C. The peptide sequence (37) is shown. The residues Cys (in red on the sequence) 
are the binding sites through which the azobenzene 24 is attached: 
 c-CL:  Ac-EIAALEYENCALEQKIKALKCKIKALKQ-Am 
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